Perspectives on the Economics of Aging by Peter Adams et al.
This PDF is a selection from a published volume from the
National Bureau of Economic Research
Volume Title: Perspectives on the Economics of Aging
Volume Author/Editor: David A. Wise, editor
Volume Publisher: University of Chicago Press
Volume ISBN: 0-226-90305-2
Volume URL: http://www.nber.org/books/wise04-1
Conference Date: May 17-20, 2001
Publication Date: June 2004
Title: Healthy, Wealthy, and Wise? Tests for Direct Causal
Paths between Health and Socioeconomic Status
Author: Peter Adams, Michael D. Hurd, Daniel L. McFadden,
Angela Merrill, Tiago Ribeiro
URL: http://www.nber.org/chapters/c10350This chapter consists of four components: (1) the paper Healthy, Wealthy
and Wise? Tests for Direct Causal Paths between Health and Socioeconomic
Statusby Peter Adams, Michael D. Hurd, Daniel McFadden, Angela Mer-
rill, and Tiago Ribeiro, which originally was presented at the conference
and then appeared in the Journal of Econometrics, Vol. 112: (2003); (2) a
new addendum that describes updates in data and analysis since its publi-
cation; (3) additional appendix tables; and (4) the authors’ response to com-
ments on the paper.
11.1 Introduction
11.1.1 The Issue
The links between health, wealth, and education have been studied in a
number of populations, with the general ﬁnding that higher socioeconomic
status (SES) is associated with better health and longer life.1 In a survey of
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1. See Backlund, Sorlie, and Johnson (1999); Barsky et al. (1997); Bosma et al. (1997);
Chandola (1998, 2000); Davey-Smith, Blane, and Bartley (1994); Drever and Whitehead
(1997); Ecob and Smith (1999); Elo and Preston (1996); Ettner (1996); Feinstein (1992);this literature, Goldman (2001) notes that this association has been found
in diﬀerent eras, places, genders, and ages, and occurs over the whole range
of SES levels, so that it is not linked solely to poverty. The association holds
for a variety of health variables (most illnesses, mortality, self-rated health
status, psychological well-being, and biomarkers such as allostatic load)
and alternative measures of SES (wealth, education, occupation, income,
level of social integration).2 There has been considerable discussion of the
causal mechanisms behind this association, but there have been relatively
few natural experiments that permit causal paths to be deﬁnitively identi-
ﬁed.3 In this paper, we test for the absence of direct causal links in an el-
derly population by examining whether innovationsin health and wealth in
a panel are inﬂuenced by features of the historical state.
Figure 11.1 depicts possible causal paths for the health and SES innova-
tions that occur over a short period. An individual’s life history is built
from these period-by-period transitions. First, low SES may lead to fail-
ures to seek medical care and delay in detection of conditions, reduced ac-
cess to medical services, or less eﬀective treatment.4 Also, increased risk of
health problems may result from increased stress or frustration, or in-
creased exposure to environmental hazards, that are associated with low
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Fitzpatrick et al. (1997); Fitzpatrick and Dollamore (1999); Fox, Goldblatt, and Jones (1985);
Goldblatt (1990); Haynes (1991); Hertzman (1999); Humphries and van Doorslaer (2000);
Hurd (1987); Hurd and Wise (1989); Kaplan and Manuck (1999); Karasek et al. (1988);
Kitawaga and Hauser (1973); Lewis et al. (1998); Leigh and Dhir (1997); Luft (1978); Mar-
mot et al. (1991); Marmot, Bobak, and Davey-Smith (1995); Marmot et al. (1997); Martin
and Preston (1994); Martin and Soldo (1997); McDonough et al. (1997); Murray, Yang, and
Qiao (1992); Power, Matthews, and Manor (1996); Power and Matthews (1998); Rodgers
(1991); Ross and Mirowsky (2000); Schnall, Landsbergis, and Baker (1994); Seeman et al.
(2002); Shorrocks (1975); Stern (1983); Wadsworth (1991); Whitehead (1988); Wilkinson
(1998); and Woodward et al. (1992).
2. The associations can become more complex when multiple health conditions and mul-
tiple SES measures are studied. Competing risks may mask the hazard for late-onset diseases;
for example, elevated mortality risk from cardiovascular diseases in low SES groups may in-
duce an apparent reverse relationship between SES and later-onset cancer in the surviving
population (Adler and Ostrove 1999). Longer-run measures of SES such as education, occu-
pation, and wealth appear to have a stronger association with health status than current in-
come (Fuchs 1993). Using carefully measured wealth, we ﬁnd that it explains most of the as-
sociation with health, and education conditioned on wealth is not systematically correlated
with health.
3. Papers examining explicit causal mechanisms include Chapman and Hariharran (1994);
Dohrenwend et al. (1992); Evans (1978); Felitti et al. (1998); Fox, Goldblatt, and Johnson
(1985); Goldman (1994); Kelley, Hertzman, and Daniels (1997); and McEwen and Stellar
(1993).
4. There may be an important distinction between direct causal mechanisms inﬂuencing
mortality, conditioned on health status, and direct causal mechanisms inﬂuencing onset of
health conditions. For mortality, an SES gradient could be due to diﬀerentially eﬀective treat-
ment of acute health conditions. For morbidity, an SES gradient could reﬂect diﬀerentials in
prevention and detection of health conditions. These involve diﬀerent parts of the health care
delivery system, and diﬀer substantially in the importance of individual awareness and dis-
cretion, and allocation of costs between Medicare and the individual.SES.5 These factors could provide direct causal links from SES history to
health events. Second, poor health may reduce the ability to work or look
after oneself, and increase medical care expenditures, leading to reduced
income and less opportunity to accumulate assets. This could provide a di-
rect causal link from health to changes in SES.
There may also be hidden common factors that lead to ecological associ-
ation of health and SES. For example, unobserved genetic heterogeneity
may inﬂuence both resistance to disease and ability to work. Causal links
may be reinforced or confounded by behavioral response. Behavioral fac-
tors such as childhood nutrition and stress, exercise, and smoking may in-
ﬂuence both health and economic activity level. For example, tastes for
work and for “clean living,” whether genetic or learned, may inﬂuence both
health and earnings. Finally, rational economic decision making may in-
duce robust consumers to accumulate in order to ﬁnance consumption over
a long-expected retirement, or unhealthy individuals to spend down assets.
Preston and Taubman (1994), Smith and Kington (1997a, b), and Smith
(1998, 1999) give detailed discussions of the various causal mechanisms
that may be at work and the role of behavioral response from economic
consumers. The epidemiological literature (Goldman 2001) uses a diﬀerent
terminology for the causal paths: Links from SES to health innovations are
termed causal mechanisms, while links from health to SES are termed se-
lectionor reverse causationmechanisms. Apparent association due to mea-
surement errors, such as overstatement of the SES of the healthy or under-
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Fig. 11.1 Possible causal paths for SES and health
5. For example, industrial and traﬃc pollution, and poor dwelling ventilation are risk fac-
tors for lung disease, and housing prices and household income are negatively correlated with
air pollution levels in census data (Chay and Greenstone 1998).detection of illnesses among the poor, are called artifactual mechanisms.6
This literature classiﬁes all common factors in terms of their implicit initial
action as either causal or selection mechanisms.7
11.1.2 This Study
We study the population of elderly Americans aged seventy and older,
and in this population test for the absence of direct causal paths from SES
to innovations in health, and from health status to innovations in SES.
These hypotheses will in general be accepted only if no causal link is pres-
ent and there are no persistent hidden factors that inﬂuence both initial
state and innovations. Rejection of one of these hypotheses does not dem-
onstrate a direct causal link, because this may be the result of common hid-
den factors. However, in an elderly population persistent hidden factors
will often be manifest in observed covariates, so that once these covariates
are controlled, the residual impact of the hidden factors on innovations
will be small. For example, genetic frailty that is causal to both health
problems and low wages, leading to low wealth, may be expressed through
a health condition such as diabetes. Then, onset of new health conditions
that are also linked to genetic frailty may be only weakly associated with
low wealth, once diabetic condition has been entered as a covariate. Thus,
in this population, rejection of the hypotheses may provide useful diagnos-
tics for likely causal paths.
The objectives and conclusions of this paper are limited. We study only
elderly Americans, for whom Medicare provides relatively homogeneous
and comprehensive health care at limited out-of-pocket cost to the indi-
vidual. This population is retired, so new health problems do not impact
earnings. Statements about the presence or absence of direct causal mech-
anisms in this population, given previous health and SES status, say noth-
ing about the structure of these mechanisms in a younger population,
where associations of health and SES emerge as a result of some pattern of
causation and operation of common factors.
Our tests for the absence of causality do not address the question of how
to identify invariant models and causal links when these tests fail. If a test
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6. Consider phenomena such as underestimation of the hazard of a disease due to compet-
ing risks from other illnesses or death. In an unfortunate discrepancy in terminology, econo-
mists would call this a selection eﬀect, while epidemiologists would classify it as an artifactual
mechanism rather than a selection mechanism.
7. Usually, one can argue that observed association must originate from some initial causal
action so that common factors originate from some initial direction of causation. However,
there is no apparent initial causal action for genetically linked conditions such as Down syn-
drome, which increase mortality risk and preclude work. Further, as a practical matter, it is
often impossible to make observations at the high frequencies that would be required to iden-
tify causal chains when feedbacks are nearly instantaneous. Then common factors will ap-
pear at feasible levels of detection to operate simultaneously, and their true causal structure
will not be identiﬁed. For these reasons, there would be considerable merit in adding common
mechanisms to the epidemiologist’s classiﬁcation.for the absence of a direct causal path is rejected, it may be possible
through natural or designed experiments to separate causal and ecological
eﬀects; see Angrist, Imbens, and Rubin (1996), Heckman (2000, 2001).
Suppose a strictly exogenous variable is causal to SES, and clearly not it-
self directly causal to health or causal to common factors. Then, an asso-
ciation of this variable with innovations in health conditions can only be
through a direct causal link from SES to health. A variable with these prop-
erties is termed a proper instrument or control variable for SES. Proper in-
struments are hard to ﬁnd. They can be obtained through designed exper-
iments, where random treatment assignment precludes the possibility of
confounding by common factors, provided recruitment and retention of
experimental subjects does not reintroduce confounding. For example, an
experiment that randomly assigned co-payment rates and coverage within
Medicare for prescription drugs or assisted living could provide evidence
on direct causal links from SES to health conditions, provided attrition
and compliance are not problems. Occasionally, natural experiments may
provide random treatment assignment. Economic events that impact in-
dividuals diﬀerently and that are not related to their prior SES or health
are potentially proper instruments. For example, a tax change that aﬀects
wealth diﬀerently in diﬀerent states is arguably a proper instrument, as is 
a change in mandated Medicaid coverage that has a diﬀerential impact
across states. Individual events such as receipt of inheritances may be
proper instruments, although they would be confounded if they are antic-
ipated, or if the probability of their occurrence is linked to health status;
see Meer, Miller, and Rosen (2001). Weak association between SES and a
proper instrument for it makes it diﬃcult to obtain precise estimates of di-
rect causal eﬀects; see Staiger and Stock (1997).
Section 11.2 of this paper discusses the foundation for econometric
causality tests, and sets out the models for the dynamics of health and SES
that will be used for our analysis. Section 11.3 describes the panel study
and data that we use. Section 11.4 describes the association of SES and
prevalence of health conditions in the initial wave of the panel. Section 11.5
analyzes incidence of new health conditions, and presents tests for non-
causality of SES for the incidence of health innovations. Section 11.6 tests
for the absence of a causal link from health conditions to wealth accumu-
lation and other SES indicators. Section 11.7 uses our estimated models for
prevalence and incidence to simulate life histories for a current population
aged seventy under counterfactual (and unrealistically simplistic) inter-
ventions that assume a major health hazard can be removed, or SES shifted
for the entire population. This simulation accounts consistently for co-
morbidities and competing hazards over the life course. The purpose of
this exercise is to demonstrate the feasibility of using our modeling ap-
proach for policy applications when the models pass the causality tests de-
scribed in next section. Finally, section 11.8 gives conclusions and outlines
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11A.1 to 11A.11 with detailed estimation results and the data and com-
puter routines we use, are posted on the internet at http://elsa.berkeley.edu/
wp/hww/hww202.html.
11.2 Association and Causality in Panel Data
11.2.1 Testing Causality
The primary purpose of this study is to test for direct causal links be-
tween SES and health. There is a large literature on the nature of causality
and the interpretation of “causality tests.”8 Our analysis ﬁts generally
within the approach of Granger (1969), Sims (1972), and Hoover (2001),
but our panel data structure permits some reﬁnements that are not avail-
able in a pure time series setting.
Let Y t denote a K-vector of demographic, health, and socioeconomic
random variables for a household at date t and interpret a realization of
these variables as an observation in one wave of a panel survey. Let Y t be
the information set containing the history of this vector through date t. Let
(1) f(Y tY t 1) 
  f1(Y1tY t 1)   f2(Y2tY 1t, Y t 1)   ...     fK(Y KtY1t, . . . , Y K 1,t, Y t 1)
denote a model of the conditional distribution of Y tgiven Y t–1. Without loss
of generality, we have written this model as a product of one-dimensional
conditional distributions, given history and given components of Y t deter-
mined previously. Writing the model in this way does not imply that the
components of Y t form a causal chain, as they may be simultaneously de-
termined, or determined in some causal sequence other than the speciﬁed
sequence. However, the model structure simpliﬁes if the current compo-
nents of Y t in the speciﬁed order do form a causal chain or are condition-
ally independent. If one takes Wold’s view that causal action takes time,
then for suﬃciently brief time intervals, fK(Y KtY1t, . . . , Y K–1,t, Y t–1) will not
depend on contemporaneous variables, and what Granger calls instanta-
neous causalityis ruled out. In practice, time aggregation to observation in-
tervals can introduce apparent simultaneous determination. Conversely, in
applications where time aggregation is an issue, one can treat observed
variables as indicators for some latent causal chain structure deﬁned for
very short time intervals.
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8. See Dawid (2000); Freedman (1985, 2001); Granger (1969); Sims (1972); Zellner (1979);
Swert (1979); Engle, Hendry, and Richard (1983); Geweke (1984); Gill and Robins (2001);
Heckman (2000, 2001); Holland (1986, 1988); Pearl (2000); Robins (1999); Sobel (1997,
2000); Hendry and Mizon (1999); and Woodward (1999).We shall focus on ﬁrst-order Markov processes, specializations of (1) in
which only the most recent history conveys information,
(2) f(Y tY t 1)   f(Y tY t 1) 
  f1(Y1tY t 1)   f2(Y2tY1t, Y t 1) 
  ...     fK(Y KtY1t, . . . , Y K 1,t, Y t 1).
Note that if (1) is a higher-order Markov process, then (2) can be obtained
by expanding the variables in Y t to include higher-order lags. Greater gen-
erality could be achieved via a hidden Markov structure in which the ob-
served Y t are deterministic functions of a latent ﬁrst-order Markov pro-
cess.9 We leave this extension for future research.
Model (2) is validfor a given history Y t–1 if it is the true conditional dis-
tribution of Y t given this history. Term f a structural or causal model, or a
(probabilistic) law, for Y t relative to a family of histories if it has the invari-
ance property that it is valid for each history in the family. Operationally,
this means that within speciﬁed domains, f has the transferability prop-
ertythat it is valid in diﬀerent populations where the marginal distribution
of Y t–1 changes, and the predictability or invariance under treatments prop-
erty that it remains valid following policy interventions that alter the mar-
ginal distribution of Y t–1. By including temporal or spatial variables in Y, it
is possible to weaken invariance requirements to ﬁt almost any application.
Done indiscriminately, this creates a substantial risk of producing an
“overﬁtted” model that will be invalid for any “out-of-sample” policy in-
terventions. Then, proposed models should be as generic as possible. How-
ever, it may be necessary in some applications to model “regime shifts” that
account for factors that are causal for some populations or time periods,
and not for others.
Suppose the vector Y t   (Ht, St, Xt) is composed of subvectors Ht, St,
and Xt, which will later be interpreted as health conditions, SES status, and
strictly exogenous variables, respectively. We say that Sis conditionally non-
causal for H, given X, if f(HtHt–1, Xt–1) is a valid model; that is, given Ht–1
and Xt–1, knowledge of St–1 is not needed to achieve the invariance proper-
ties of a causal model. Conversely, if f(HtHt–1, St–1, Xt–1)  f(HtHt–1, Xt–1),
then knowledge of St–1 contributes to the predictability of Ht. Note that ei-
ther one or both conditional noncausality of S for H and conditional non-
causality of H for S may hold. If either holds, then H and S can be arrayed
in a (block) causal chain, and if both hold, then H and S are conditionally
independent. Writing model (2) as a product of univariate conditional
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9. Any discrete-time stationary stochastic process can be approximated (in distribution for
restrictions to a ﬁnite number of periods) by a ﬁrst-order hidden Markov model so there is no
loss of generality in considering only models of this form; see Kunsch, Geman, and Kehagias
(1995).probabilities fi(HitH1t, . . . , Hi–1,t, Ht–1, St–1, Xt–1), one can test for condi-
tional noncausality of S for each component Hi. It is possible to have a
causal chain in which S is conditionally causal to a previous component of
H, and this component is in turn “instantaneously” causal to Hj, yet there
is no direct causal link from S to Hi. Placing S after H in the vector Y, we
have conditional probabilities f(StHt, Ht–1, St–1, Xt–1). There may be instan-
taneous conditional independence of H and S, with the conditional distri-
bution of St not depending on Ht or conditional noncausality of H for S,
with the conditional distribution not depending on Ht–1, or both. The state-
ment that X is strictly exogenous in a valid model (2) is equivalent to the
condition that H and S are conditionally noncausal for X in this model.10
The conventional deﬁnition of a causal model or probabilistic law re-
quires that f be valid for the universe of possible histories (except possibly
those in a set that occurs with probability zero); see Pearl (2000). It is pos-
sible to reject statistically a proposed causal model by showing that it is
highly improbable that an observed sample with a given history was gen-
erated by this model. It is far more diﬃcult using statistical analysis to con-
clude inductively that a proposed model is valid for the universe of possible
histories. We have the far more limited objective of providing a foundation
for policy analysis, where it is the invariance property under policy inter-
ventions that is crucial to predicting policy consequences. We have deﬁned
validity and noncausality as properties of a model, and of the outcomes of
a process of statistical testing that could in principle be conducted on this
model. Only within the domain where the model is valid, and invariance
conﬁrms that the model is accurately describing the true data generation
process, can these limited positivistic model properties be related to the
causal structure embedded in the true data generation process. Further, we
can choose the domain over which invariance will be tested to make the
deﬁnition operational and relevant for a speciﬁc analysis of policy inter-
ventions. Similarly, our deﬁnition of conditional noncausality is a posi-
tivistic construct in the spirit of the purely statistical treatment of “causal-
ity” by Granger (1969), and the test we will use is simply Granger’s test for
the absence of causality, augmented with invariance conditions. Thus, for
example, if our analysis using this framework concludes that SES is not
conditionally causal for new health events within the domain where the
Medicare system ﬁnances and delivers health care, then this ﬁnding would
support the conclusion that policy interventions in the Medicare system to
increase access or reduce out-of-pocket medical expenses will not alter the
conditional probabilities of new health events, given the health histories of
enrollees in this system. It is unnecessary for this policy purpose to answer
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10. Econometricians have traditionally used the term strictly exogenous to refer to proper-
ties of variables in the true data generation process, a stronger nonpositivistic version of this
condition.the question of whether the analysis has uncovered a causal structure in
any deeper sense. Econometric analysis is better matched to the modest
task of testing invariance and noncausality in limited domains than to the
grander enterprise of discovering universal causal laws. However, our em-
phasis on invariance properties of the model, and on tests for Granger
causality within invariant families, is consistent with the view of philoso-
phers of science that causality is embedded in “laws” whose validity as a
description of the true data generation process is characterized by their in-
variance properties; see Pearl (2000), Feigl (1953), and Nozick (2001).
11.2.2 Some Speciﬁc Formulations
Starting from class (2), we consider operational models of the linear la-
tent variable form
(3) Y∗
it   Y 1,t 1i   ...     Y i 1,t i 1,i   Y  t 1 i    i    iεit
with
(4) Y it   ψi(Y∗
it, Y t 1),
where Y∗ is a latent variable, εit is an unobserved disturbance that is stan-
dard normal and independent across i and t, and ψ is a partial observabil-
ity mapping that depends on the latent variable, and possibly on the lagged
variables. For example, for a chronic health condition such as diabetes, 
Y itwill indicate whether there has ever been a diagnosis of the disease, with
Y it   max{Y i,t–1, 1(Y∗
it   0)}. For an acute condition such as a heart attack,
Y it   1(Y∗
it   0) indicates a new occurrence. Components of Y may be bi-
nomial or ordered discrete variables such as health status, or continuous
variables such as household income. In this model, the  ’s,  ,  , and   are
parameters; restrictions are imposed as necessary for identiﬁcation. In (3),
the linearity in variables and parameters, the ﬁrst-order Markov property,
and the triangular dependence of Y∗
it on previous components of Yt are
not, in themselves, particularly restrictive, as one can approximate any
continuous Markov model of form (2) by a form (3) in which Ytis expanded
to include transformations and interactions to suﬃcient order. The nor-
mality assumption is also not restrictive in principle. A latent random vari-
able with conditional cumulative distribution function (CDF) F(Y∗
1tYt–1)
and the partial observability transformation (4) can be redeﬁned using 
the standard normal CDF   as  Y 1t ∗∗    –1(F(Y∗
1tYt–1)) and Y1t  
ψ1(F –1( (Y 1t ∗∗)Yt–1), Y1,t–1); this gives a version of models (3) and (4) in
which the disturbance is standard normal.11 The same construction can be
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11. For the CDF F of a random variable Y, deﬁne F(y–)   supy <yF(y ) and F –1(p)  
min{x F(x )   p}. Deﬁne the random variable Z   h(Y)   –1(F(Y–)   U[F(Y) – F(Y–)]),
where U is a uniform (0, 1) random variable. Then Z is a.s. standard normal. Deﬁne Y∗  
F –1( (Z)). Then, Y∗   Y a.s., so that Y is given a.s. by a nondecreasing transformation of a
standard normal random variable.applied to the remaining components of Yt. The causal chain assumption
is innocuous when the time interval is too short for most causal actions to
operate, and the components of Yt are conditionally independent. How-
ever, the causal chain assumption is a more substantive restriction when
the time interval is long enough for multiple events to occur, as it precludes
even the feedbacks that would appear in multiple iterations of a true causal
chain. Of course, the generally nonrestrictive approximation properties of
models (3) and (4) do not imply that a particular speciﬁcation chosen for
an application is accurate, and failures of tests for invariance can also be
interpreted as diagnostics for inadequate speciﬁcations.
In models (3) and (4), a binomial component i of Yt with the partial ob-
servability mapping max{Yi,t–1, 1(Y∗
it   0)} and the identifying restriction
 i 1 satisﬁes Y it 1 if Y i,t–1  1, and otherwise is one with the probit prob-
ability
(5) fi(Y it   1Y1t, . . . , Y i 1,t, Yt 1) 
   (Y1,t 1i   ...     Yi 1,t i 1,i  Y  t 1  i    i).
Analogous expressions can be developed for ordered or continuous com-
ponents.
11.2.3 Measurement Issues
A feature of the panel we use is that the waves are separated by several
years, and the interviews within a wave are spread over many months, with
the months between waves diﬀering across households. If model (2) applies
to short intervals, say months, then the transition from one wave in month
t to another in month t   s is described by the probability model
(6) f(Yt sYt)   ∑
Yt 1,...,Yt s 1
f(Yt 1Y t)   ...     f(Y t sY t s 1).
Direct computation of these probabilities will generally be intractable, al-
though analysis using simulation methods is possible.
A major additional complication in our panel is that interview timing
appears to be related to health status, with household or proxy interviews
delayed for individuals who have died or have serious health conditions.
This introduces a spurious correlation between apparent time at risk and
health status that will bias estimation of structural parameters. To study
empirical approximations to (6) and corrections for spurious correlation,
we consider a simple model of interview delay. Let p    (    x) denote
the monthly survival probability for an individual who was alive at the pre-
vious wave interview, where xis a single time-invariant covariate that takes
the value –1, 0,  1, each with probability 1/3. Counting from the time of
the previous wave interview, let k denote the number of months this indi-
vidual lives, and c denote the month that interviews begin for the current
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ability of a month passing without being contacted, and let m denote the
month of initial contact. Assume that an individual who is living at the time
of initial contact is interviewed immediately, but for individuals who have
died by the time of initial contact, there is an interview delay, with r denot-
ing the probability of an additional month passing without a completed in-
terview with a household member or proxy. Let n denote the number of
months of delay in this event. Assume that m and n are not observed, but
the actual interwave interval t, equal to m if the individual is alive at time
of initial contact, and equal to m notherwise, is observed. The density of
k is pk–1(1 – p) for k   1. The density of m is qm–c(1 – q) for m   c. Let d
beanindicator for the event that the individual is dead at the time of initial
contact. The probability of t and d   0 is h(0, t)   qt–c(1 – q)pt, the product
of the probability of contact at t and the probability of being alive at t. The
probability of t and d   1, denoted h(1, t), is the sum of the probabilities
that the individual is dead at an initial contact month m, with c   m   t,
and the subsequent interview delay is n   t – m, or
(7) h(1, t)  ∑
t
m c
(1   pm)qm c(1   q)rt m(1   r).
If r   pq, then h(1, t)   (1 – q)(1 – r){(qt–c 1 – rt–c 1)/(q – r) – pc((pq)t–c 1 –
rt–c 1)/(pq– r)}. Then, the probability of an observed interwave interval tis
h(t)   h(0, t)   h(1, t), and the conditional probability of d   1, given t, is
P(1t)  h(1, t)/h(t). Absent interview delay, the conditional probability of
d   1 given t would be simply pt–1(1 – p). The parameter values   –
2.47474,   0.3, c   22, q   0.85, and r   0.5 roughly match our panel.
For these values, the median interwave interval is 25.5 months, and at t  
34, 87 percent of the interviews have been completed.
Figure 11.2 plots the inverse normal transformations of the true death
rate pt–1(1 – p) and the apparent death rate P(1t) against log(t) for each
value of the covariate x. The true relationship is to a reasonable empirical
approximation linear in x and in log(t). Then, in the absence of interview
delay, one could approximate p, given x, with reasonable accuracy by esti-
mating a probit model for death of the form  (   x  log(t)), and then
estimating p using the transformation p   (1 –  (    x   log(t)))1/t for
the observed interwave interval t.13 However, the ﬁgure shows that inter-
view delay induces a sharp gradient of apparent mortality hazard with in-
terwave interval, so that an estimated model will not extrapolate to realis-
tic mortality hazards over shorter periods. A simple imputation of time at
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12. It does not matter for the example if the previous wave interview month is ﬁxed or has
a distribution, provided the relative interwave interval c is ﬁxed, and current wave outcomes
are independent of the timing of the previous wave interview.
13. A Box–Cox transformation of time at risk, z   4(t1/4 – 1), gives a somewhat better ap-
proximation in the probit model than log(t), but has no appreciable eﬀect on the accuracy of
estimated monthly transition probabilities.risk up to initial contact leads again to models that work well with the pro-
cedure just outlined for estimation of p conditioned on x. A simple im-
puted time of initial contact for those who have died is the observed inter-
wave interval less the diﬀerence in the mean interwave interview times for
dead and living respondents. This imputation can be adjusted further so
that the extrapolated annual death rate,  (   log(12)   x), matches the
sample average mortality rate. We do the additional adjustment for our
panel, with results that are almost identical to the simple imputation of
time of initial contact.
We conducted a Monte Carlo calculation of the approximations above
in a sample of 50,000. In this simulation, the empirical approximation to
observed mortality in the absence of interview delay is  (–3.1053   
0.5327x   0.652 log(t)). With interview delay and the simple imputation
described above,  (–2.9900  0.5349x 0.6174 log(t)) is the empirical ap-
proximation.14 Table 11.1 gives the annual mortality rates implied by these
approximations. From these results, we conclude ﬁrst that in the absence of
interview delay, the probit model  (   log(t)    x) provides an ade-
quate approximation to exact annual mortality rates as a function of time
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Fig. 11.2 Eﬀect of interview delay (cumulative mortality hazard    –1
[death probability])
14. The model estimated with interview delay and without imputation, is  (–4.6639  
0.5349x   1.1178 log(t)).at risk, across values of the covariate x that substantially change relative
risk, and second that this remains true in the presence of interview delay
when one imputes the initial contact time for dead subjects.
These conclusions on the accuracy of the approximation should extend
to the exact interwave transition probabilities (6) in our Markov model,
supporting use of the probit approximation
(8) fi(Yi,t s   1Y 1t s, . . . , Y i 1,t s, Y t) 
   (Y 1,t s 1i   ...     Y i 1,t s i 1,i   Y  t i    i    i log(s)),
where s   ti2 – ti1 is the imputed months between initial contact for a wave
and previous wave interview, for estimation of incidence between waves.
For simulation of yearly transitions, we use the approximation
(9) fi(Y i,t 12   1Y 1t 12, . . . , Y i 1,t 12, Y t) 
  1   (1    (Y 1,t 1 1i   ...     Y i 1,t 1 i 1,i  Y  t i    i    i log(s)))12/s
≈  (Y 1,t 1 1i   ...     Y i 1,t 1 i 1,i  Y  t i    i    i log(s))12/s,
where sis the median interwave interval, and the ﬁnal approximation holds
when the probability of a transition is small. Formula (9) generalizes to any
probability of a transition from the status quo, with the probability of re-
maining at the initial state deﬁned so that all the transition probabilities
sum to one. We expect this formula to approximate well the probabilities
of no new health conditions in a sample population over periods corre-
sponding to the observed interwave intervals.
Estimation of models based on (2)–(8) is straightforward. Because of the
independence assumption on the disturbances and the absence of common
parameters across equations, the estimation separates into a probit, or-
dered probit, or ordinary least-squares regression for each component of
Y, depending on whether the partial observability mapping is binary,
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Table 11.1 Approximation Accuracy with Interview Delay (%)
Exact Approximate Approximate Annual
Annual Annual Mortality Mortality Rate with
Mortality Rate without Interview Delay and
x Rate Interview Delay Error Imputed Contact Time Error
0 7.71 7.90 2.41 7.93 2.79
–1 3.27 3.06 –6.55 3.07 –6.03
 1 16.41 16.71 1.80 16.75 2.05
Avg. 9.13 9.22 0.98 9.25 1.34
Note: The approximate annual mortality rate is given by 1 – (1 –  (    x   log(t)))12/t, where t is the
exact or imputed initial contact time and the model is estimated from the data generated by the Monte
Carlo experiment.ordered, or linear. Conventional likelihood ratio tests can be used for the
signiﬁcance of explanatory variables.
11.3 The AHEAD Panel Data
11.3.1 Sample Characteristics
Our data come from the Asset and Health Dynamics among the Oldest
Old (AHEAD) study.15This is a panel of individuals born in 1923 or earlier
and their spouses. At baseline in 1993 the AHEAD panel contained 8,222
individuals representative of the noninstitutionalized population, except
for oversamples of blacks, Hispanics and Floridians. Of these subjects,
7,638 were over age sixty-nine; the remainder were younger spouses. There
were 6,052 households, including individuals living alone or with others, in
the sample. The wave 1 surveys took place between October 1993 and Au-
gust 1994, with half the total completed interviews ﬁnished before Decem-
ber 1993. The wave 2 surveys took place approximately twenty-four months
later, between November 1995 and June 1996, with half the total completed
interviews ﬁnished by the beginning of February 1996. The wave 3 surveys
took place approximately twenty-seven months after that, between January
1998 and December 1998, with half the total completed interviews ﬁnished
near the beginning of March 1998. In each wave, there was a long but thin
tail of late interviews, heavily weighted with subjects who had moved, or re-
quired proxy interviews due to death or institutionalization. Subjects never
interviewed, directly or by proxy, are excluded from the calculation of the
distribution of interview months. The AHEAD is a continuing panel, but it
has now been absorbed into the larger Health and Retirement Study
(HRS), which is being interviewed on a three-year cycle.
The AHEAD panel has substantial attrition, with death being the pri-
mary, but not the only, cause. A signiﬁcant eﬀort has been made to track
attritors, and identify those who have died through the National Death
Register. Figure 11.3 describes outcomes for the full age-eligible sample.
For subjects where a proxy interview was possible, an “exit interview” gives
information on whether decedents had a new occurrence of cancer, heart
attack, or stroke since the previous wave. From the 6,743 age-eligible indi-
viduals who did not attrit prior to death, we formed a working sample for
analysis consisting of 6,489 by excluding 254 additional individuals with
critical missing information.Figure 11.4describes their outcomes. In a few
cases, attritors in wave 2 rejoined the sample in wave 3, but we treat these
as permanent attritors because the missing interview makes the observa-
tion unusable.
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15. The AHEAD survey is conducted by the University of Michigan Survey Research Cen-
ter for the National Institute on Aging; see Soldo et al. (1997).Fig. 11.3 Age-eligible sample outcomes
Fig. 11.4 Working sample outcomesThe restriction of the AHEAD panel to the noninstitutionalized elderly
in wave 1 selects against those with the highest mortality risk, particularly
at the oldest ages, but the impact of this selection attenuates over time. For
white females, ﬁgure 11.5 compares the observed annual mortality rate in
the AHEAD panel with the expected annual mortality rate from the 1997
life tables for the United States (U.S. Census 1999).16 Between waves 1 and
2, the AHEAD mortality risk is substantially below the life table for ages
above seventy-ﬁve, reﬂecting the selection eﬀect of noninstitutionalization.
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Fig. 11.5 Mortality hazard for AHEAD white females
16. The AMR for the AHEAD sample is the actual death rate between waves for each ﬁve-
year segment of ages in the initial wave, annualized using the median 25.5 month interval be-
tween the waves. The AMR from the life tables is obtained by applying life table death rates
by month to the actual months at risk for each individual in the ﬁve-year segment of ages inBetween waves 2 and 3, this eﬀect has essentially disappeared. There is a
persistent divergence of the mortality risks above age ninety. In this range,
the AHEAD data is sparse, so the curve is imprecisely determined. How-
ever, the life tables derived from historical mortality experience may over-
state current mortality risk at advanced ages. Figure 11.6 makes the same
mortality experience comparisons for the full AHEAD working sample
and draws the same conclusions.17
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the initial wave to calculate expected deaths between waves. This is annualized. For these cal-
culations, the distribution of months at risk for decedents is assumed to be the same as that
for survivors.
17. The construction mimics ﬁgure 11.5, with life table rates applied using the age, sex, and
race of each subject.
Fig. 11.6 Mortality hazard for AHEAD working sample11.3.2 Descriptive Statistics
The AHEAD survey provides data on health and socioeconomic status,
as well as background demographics. A list of the health conditions we
study, with summary statistics, is given in table 11.2. A list of the socioeco-
nomic conditions and demographic variables we use is given in table 11.3.
Table 11A.2 lists the variable transformations used in our statistical anal-
ysis.18 In setting up causality tests, using the framework set out in section
11.2, we will use the health conditions, followed by the socioeconomic con-
ditions, in the order given in these tables. We list cancer, heart disease, and
stroke ﬁrst because they may be instantaneously causal for death, and be-
cause we have information from decedent’s exit interviews on new occur-
rence of these diseases. We group the remaining health conditions by de-
generative and chronic conditions, then accidents, then mental conditions,
because if there is any contemporaneous causality, it will plausibly ﬂow in
this order. Similarly, if there is contemporaneous causality between health
and socioeconomic conditions, it plausibly ﬂows from the former to the
latter.
11.3.3 Constructed Variables
The collection and processing of some of the variables requires com-
ment. The AHEAD has an extensive battery of questions about health
conditions, including mental health. Most health conditions are asked for
in the form “Has a doctor ever told you that you had . . . ?” However, for
cancer, heart disease, and stroke, subjects are also asked if there was a new
occurrence since the previous interview, and for some conditions such as
arthritis, incontinence, and falls, the questions in wave 1 ask for an occur-
rence in the past twelve months. We note that there are some major groups
of health conditions that were not investigated in AHEAD: degenerative
neurological diseases, kidney and liver diseases, immunological disorders
other than arthritis, sight and hearing problems, back problems, and acci-
dents other than falls. The body mass index (BMI) index is calculated from
self-reported height and weight. Information is collected on the number of
limitations for six activities of daily living (ADL), and on the number of
limitations for ﬁve instrumental activities of daily living (IADL). A high
ADL limitation count indicates that the individual has diﬃculty with per-
sonal self-care, while a high IADL limitation count indicates diﬃculty in
household management. The study collects data on self-assessed health
status, where the subject is asked to rate his or her health as excellent, very
good, good, fair or poor. We use an indicator for a poor/fair response. No
reference is made to other groups such as “people your age.” The study
contains the Center for Epidemiologic Studies Depression scale (CESD)
432 P. Adams, M. D. Hurd, D. McFadden, A. Merrill, and T. Ribeiro














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































.battery of questions measuring general mood, and from this we form an 
indicator for depression.
The AHEAD is linked to Medicare records. There is insuﬃcient detail
to permit reconciliation of self-reports on objective health conditions
against diagnoses in the medical records, but errors in self-reports are an
issue. We ﬁnd small, but signiﬁcant, inconsistencies across waves of
AHEAD in reported chronic conditions. A study of Canadian data for a
younger population ﬁnds substantial discrepancies between self-reported
conditions and diagnoses from medical records, particularly for chronic
conditions such as arthritis; see Baker, Stabile, and Deri (2001). These
authors also ﬁnd support for a “self-justiﬁcation” hypothesis that non-
workers are more likely to make false positive claims for health conditions.
If this reporting behavior carries into old age, then the reduction in SES as
a consequence of spotty employment would induce an artifactual associa-
tion of self-reported health conditions and SES.
The study measures cognition using a battery of questions which test
several domains (Herzog and Wallace 1997): Learning and memory are as-
sessed by immediate and delayed recall from a list of ten words that were
read to the subject; reasoning, orientation, and attention are assessed from
serial 7s, counting backwards by 1, and the naming of public ﬁgures, dates,
and objects.19 This score reﬂects both long-term native ability and health-
related impairments due to health events. We carry out the following sta-
tistical analysis to reduce the eﬀect of native ability so that we can concen-
trate on health-related loss of cognitive function. First, we analyze a
“nonimpaired” sample of younger individuals, born between 1942 and
1947, who were administered the same cognitive battery in the 1998 Health
and Retirement Study (HRS) as were the AHEAD subjects. For these
younger individuals, where health-related impairment of cognitive func-
tion is rare, we carry out a least absolute deviation (LAD) regression of the
cognitive score on education level, sex, and race. We use this ﬁtted regres-
sion to predict a “baseline” nonimpaired cognitive score for each member
of the AHEAD sample. An additional adjustment is required because av-
erage education levels were rising rapidly early in the twentieth century,
due to changes in child labor laws and introduction of compulsory educa-
tion. We assign each AHEAD subject a “1923 cohort equivalent” educa-
tion level by ﬁrst regressing education on sex, race, and birth cohort, using
a speciﬁcation search to ﬁnd interactions and nonlinearities, and then
adding to their actual years of education the diﬀerence in the mean years
of education for their sex–race cohort and the corresponding 1923 sex–
race cohort. We then calculate for each AHEAD sample member the devi-
ation of their cognitive score from this adjusted baseline. As a normaliza-
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19. Serial 7s asks the subject to subtract 7 from 100, and then to continue subtracting from
each successive diﬀerence for a total of ﬁve subtractions.tion, we assign a threshold such that 15 percent of AHEAD subjects aged
seventy–seventy-four in wave 1 fall below the threshold. We then use the
same threshold in other age groups and other waves to deﬁne an indicator
for cognitive impairment.20
11.3.4 Measurement of Wealth
The AHEAD individuals and couples are asked for a complete inventory
of assets and debts, and about income sources. Subjects are asked ﬁrst if
they have any assets in a speciﬁed category, and, if so, they are asked for the
amount. A nonresponse to the amount is followed by unfolding bracket
questions to bound the quantity in question, and this may result in com-
plete or incomplete bracket responses. Through the use of unfolding brack-
ets, full nonresponse to asset values was reduced to levels usually less than
5 percent, much lower than would be found in a typical household survey.
Generally, median responses among full respondents for an asset category
are comparable to other economic surveys, such as the Survey of Con-
sumer Finance (SCF). However, changes in reported assets between waves
contain outliers that suggest signiﬁcant response errors between waves.
For couples, where both members are asked the questions on assets, there
is also substantial intersubject response variation. It is possible that these
repeated reports could be used to control statistically for response error in
couples. However, there are systematic diﬀerences between respondents,
and we use the asset responses only from the individual that a couple says
manages the household ﬁnances. There may also be an issue of bias in re-
sponses recovered by unfolding brackets. Hurd et al. (1998) used experi-
mental variation in the bracket sequences for two ﬁnancial questions on
wave 2 of AHEAD, and found that anchoring to the bracket quantities was
signiﬁcant.
For complete or incomplete bracket responses in an asset category, we
impute continuous quantities using hot deck methods. In wave 1, if infor-
mation on ownership of an asset is missing for a subject, but this subject
does give ownership status in wave 2, then we impute wave 1 ownership by
drawing from the conditional empirical distribution of those who have the
same response in wave 2 and give a response in wave 1. For subjects miss-
ing ownership in both waves 1 and 2, we draw an ownership pair from the
empirical distribution of ownership pairs for those giving responses. Given
ownership and complete or incomplete bracket information, we draw from
the empirical distribution of wave 1 continuous responses that are consis-
tent with the subject’s bracket. In later waves, we have adopted a ﬁrst-order
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20. When an interview was done with a proxy, the cognitive battery was not given, but the
interviewee was asked if the respondent was cognitively impaired. In our analysis, we treat
proxy interview status as a component of the state that appears as a contemporaneous expla-
nation of cognitive impairment; the coeﬃcient on this variable compensates for diﬀerences in
the deﬁnitions of cognitive impairment.Markov cross-wave hot deck imputation procedure that assigns a continu-
ous quantity within the given response bracket. First, missing ownership is
imputed by choosing randomly from respondents, conditional on owner-
ship in the previous wave. Then, given ownership, we impute a quantitative
change in the item from the previous wave by drawing from the empirical
distribution of subjects with complete responses that fall in the corres-
ponding brackets in the current and the previous wave. This assures that
imputed changes will have the same empirical distribution as observed
changes, given the conditioning information available. This procedure
does not revise previous wave imputations, so analyses based on earlier
waves are not aﬀected. We have experimented with cross-item imputation
methods, where bracket information on some asset categories would be
used to reﬁne the conditioning used in the imputation of other asset cate-
gories. We have found that this has very little eﬀect on the imputed vari-
ables or on the results obtained from analyses that use these variables.
Therefore, we carry out all imputations one item at a time.
Measured wealth is accumulated over eleven asset categories, including
imputed items. We distinguish liquid wealth, composed of IRA balances,
stocks, bonds, checking accounts, and certiﬁcates of deposit, less debt; and
nonliquid wealth, composed of net homeowner equity, other real estate, ve-
hicles and other transportation equipment, businesses, and other assets.
The variation in reported wealth of AHEAD households by asset category
is substantial from wave to wave, suggesting that in addition to real volatil-
ity and reallocation of wealth portfolios, there are serious reporting prob-
lems with assets. Values of businesses owned and real estate are problem-
atic items, because current market valuations may be unavailable to
respondents, and subjective valuations may be unreliable. Suppose that W t
is measured wealth of household in wave t, in 1997 dollars, and that W t  
Wt ∗    t, where Wt ∗ is true wealth and  t is reporting error. To minimize
the impact of extreme outliers in wealth and wealth changes, which we be-
lieve are a particular problem due to gross reporting errors, our statistical
analysis will use bounded transformations of measured wealth.
The equations of motion for real wealth satisfy dWi∗/dt   rWi∗   Si,
where i   T, N, L indexes total wealth or its nonliquid and liquid compo-
nents, r is the instantaneous real rate of return, including unrealized capi-
tal gains, and Si is the ﬂow of savings to the wealth component. Make the
logistic transformation Zi   1/(1   exp(–ciW i   di)), where ci and di are
chosen so that in AHEAD wave 1 the median and the semi-interquartile
range of Zi are one-half. Then, Zi is a monotone transformation of mea-
sured wealth that is less sensitive to extremes. The equation of motion for
Zi is dZi/dt – rZi(1 – Zi)(log(Zi/(1 – Zi))   di)   ciZi(1 – Zi)Si   ciZi(1 –
Zi)(d /dt – r ). We assume that over an inter-wave interval, this equation
of motion can be approximated by
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  Sit
#      it,
where t indexes the wave, mt is the interval in months between waves t – 1
and t, Rtis the S&P real rate of return over the given interval, Sit
#is the mea-
sured part of ciZi,t–1(1 – Zi,t–1)Si,t–1, attenuated at extreme values of Zi,t–1, and
the disturbance  it includes the measurement error ciZi,t–1(1 – Zi,t–1)(( it –
 i,t–1)/mt–1 – r t–1) and the unmeasured part of ciZi,t–1(1 – Zi,t–1)Si,t–1. We
assume v is homoskedastic. This is consistent with a measurement error 
in observed wealth that is heteroskedastic, with gross measurement errors
more likely when true wealth is near its extremes.21 The disturbance in (10)
may be serially correlated; however, we have not incorporated this into our
analysis. The eﬀect of the transformation is to substantially reduce the in-
ﬂuence of outliers in the distribution of changes in measured wealth. In
application, we specify Sit
# to be a linear function of transformed nonliquid
and liquid wealth, ZT,t–1(1 – ZT,t–1)l o g ( ZN,t–1/(1 – ZN,t–1)) and ZT,t–1(1 –
ZT,t–1) log(ZL,t–1/(1 – ZL,t–1)), and of other SES, demographic, and health
variables, scaled by ZT,t–1(1 – ZT,t–1).
11.3.5 Mortality and Observed Wealth Change
A problem with the analysis of wealth changes is that terminal wealth is
not observed following the death of a single, or the death of both members
of a household, introducing a selection eﬀect. A second problem is that a
household death may have a direct impact on the wealth of a survivor, due
to the expenses associated with a death and the disposition of the estate.
There are also severe wealth measurement problems following a household
death, because a death typically requires a valuation of assets, and in many
cases changes the ﬁnancially responsible respondent. For this reason, we
will analyze separately wealth changes for singles and for couples, allow a
regime shift following the death of one member of a couple, and account
for the selection that occurs when there are no survivors.
For a single female, we adopt a bivariate selection model,
(11) Y∗
ft  Yf,t 1 f ε, yft  1(Y∗
ft  0), Ywt Yw,t 1 w Y  w,t w  ε κ , 
Ywt observed if yft   1,
Zit   Zi,t 1   Rt 1Zi,t 1(1   Zi,t 1)(log(Zi,t 1/(1   Zi,t 1))   di)
       
mt
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21. Heteroskedasticity in (10) will arise from selection eﬀects, described later, as well as pos-
sibly from a failure of the transformation to fully control the eﬀects of gross reporting errors.
When working with this model, we use standard error estimates that are robust with respect
to heteroskedasticity of unknown form and do not attempt direct tests of the implicit error
speciﬁcation underlying transformation (10).where the ﬁrst latent equation determines survival, yft  1, the second equa-
tion corresponds to the transformed wealth change equation (10) with de-
pendence on the previous state Yw,t–1 and the previously determined com-
ponents Y  w,t of the current state, with the wealth change observed for
survivors. The disturbance εf has mean zero, variance one, and a density
f(ε). The disturbance   is independent of ε, and has mean zero and vari-
ance one. The correlation of the disturbances in the selection and wealth
change equations is    /( 2   κ2)1/2, and the unconditional variance of
the wealth change equation is  2    2   κ2. When ε and   are standard
normal, this is the conventional bivariate normal selection model. How-
ever, speciﬁcation tests for normality fail, and for robustness we adopt a
more ﬂexible speciﬁcation, approximating the density f(ε) by an Edge-
worth expansion,




where the  j are parameters and Hj(ε) are Hermite orthogonal polynomi-
als; see Newey, Powell, and Walker (1990). Let  jk(a)     
a εkHj(ε) (ε)dε.
Then, the polynomials Hj(ε) and the partial moment functions   jk(a) can
be constructed using the recursions
(13) H0(ε)   1, H1(ε)   ε, and Hj(ε)   εHj 1(ε)   (j   1)Hj 2(ε)f or j   1,
 00(a)    ( a),  01(a)    (a), and
 0k(a)   ak 1 (a)   (k   1) 0,k 2(a) for k   1,
  j0(a)   Hj 1(a) (a) and  jk(a)   akHj 1(a) (a)   k  j 1,k 1(a)
for k   0, for j   0.
Table 11A.1 derives these results and gives the leading terms for Hjand   jk:
We require that f integrate to one and have unconditional mean zero and
variance one; this forces  0   1,  1   0, and  2   0. The free parameters  j
for j 2 determine higher-order moments of ε. For example, skewness and
kurtosis are determined by Eε3   6 3 and Eε4   3   24 4. With these re-
strictions, we have, ﬁnally
(14) E(εε   a)   and
E(ε2ε   a)   .
We use the Edgeworth approximation and these conditional expectations
with J   4. We then have
 ( a)   a (a)  ∑
j
j 3 j  j2(a)
    
 ( a)  ∑
j
j 3 j  j0(a)
 (a)  ∑
j
j 3  j j1(a)
   
 ( a)  ∑
J
j 3  j  j0(a)
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wtε   Y f,t 1 f)
  Y w,t 1 w   Y  w,t w    .
We estimate this conditional expectation in a two-step procedure. First, the
parameters  f of the selection equation are estimated by maximum likeli-
hood, and substituted into expression (15) for the expectation of the wealth
change equation.22 Then, the parameters in this conditional expectation
are estimated using nonlinear least squares. The disturbance ζ    ε   κ 
– E(εε   – Yf,t–1 f) has mean zero and variance:
(16) E(ζ2ε   Yf,t 1  f) 
  κ2    2     
2 .
We regress the squared residuals from the estimation of (15) on the right-
hand-side variables in (16) to obtain an estimate of κ2. Finally, we estimate
the covariance matrix for the parameter estimates using the generalized
method of moments “sandwich” formula, with the Eicker-White proce-
dure used for robustness against heteroskedasticity of unknown form, and
the delta method used to incorporate the eﬀects of variance in the ﬁrst-
stage selection parameter estimates.
Next consider the eﬀects of death and selection on couples. We adopt a
trivariate selection model with selection equations
(17) Y∗
ft   Y f,t 1  f   εf, Y∗
mt   Ym,t 1 m   εm, yft   1(Y∗
ft   0), 
ymt   1(Y∗
mt   0)
for the female and male members of the couple, respectively, where εf and
εm are assumed to be independent with zero mean and unit variance, and
densities gf(εf) and gm(εm). The independence assumption could fail if
there are hidden common factors in mortality risk for both household
members; for example, indirect eﬀects of smoking. However, the frequency
of multiple deaths in a household between waves is suﬃciently rare in the
AHEAD data so that mortality risk interactions are empirically not iden-
tiﬁed. We distinguish three regimes (yf, ym) in which wealth change is ob-
served: intact couples where both members survive (1,1), the female sur-
vives the death of her spouse (1,0), and the male survives the death of his
∑
J
j 0  j  j1( Yf,t 1 f)
   
∑
J
j 0  j  j0( Yf,t 1 f)
∑
J
j 0  j  j2( Yf,t 1  f)
   
∑
J
j 0  j  j0( Yf,t 1  f)
 (Y f,t 1 f)  ∑
4
j 3  j  j1( Y f,t 1 f)
    
 (Yf,t 1 f)  ∑
4
j 3  j  j0( Yf,t 1 f)
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22. We ﬁnd that the coeﬃcients of the index in the mortality model are not sensitive to the
Edgeworth generalization, and in estimation of the model for wealth change use the ﬁrst-stage
probit models for mortality estimated earlier, with invariance imposed, to obtain the indices
that appear in the selection eﬀects.spouse (0,1). We will let Yt
0   [Y ht–1Y mt–1yft  Y  ftymt   Y  mt] denote the vector
of variables that explain wealth change, where Y ht–1, Y ft–1, and Y mt–1 are, re-
spectively, previous wave common, female, and male variables, Y  ft are pre-
viously determined components of the current state for females, observed
only for survivors and hence zeroed out for nonsurvivors, and Y  mt are the
analogous previously determined components of the current state for
males, again observed only for survivors. We assume that in an observed
regime jk the wealth change model takes the form
(18) Y wt Yt
0 wjk ( f   f1( j k 1))εf ( m   m1( j k 1))εm κjk ,
where   is independent of εf and εm, with zero mean and unit variance. For
intact couples, unobserved dependence of wealth change on selection is re-
ﬂected in the parameters  f and  m, a direct extension of the bivariate se-
lection model to the trivariate case with two independent selection eﬀects.
For intact couples, the correlations of the disturbances in the selection and
wealth change equations are  f    f /(κ2
11    f
2    2
m)1/2 and  m    m/(κ2
11  
 f
2    2
m)1/2. The coeﬃcients  jk and the standard deviation κjk are allowed
to vary by regime, to capture the observed and unobserved economic
eﬀects of a death on valuation and reporting of assets. In addition, the se-
lection eﬀects are allowed to shift, from  f to  f –  f for the female selection
disturbance, and from  m to  m –  m for the male selection disturbance. We
incorporate these eﬀects to accommodate an apparent interaction in which
unexpected survival of a couple (for example, εf and εm large positive) in-
creases dissaving, perhaps due to additional medical and living expenses
linked to overcoming high mortality hazards, but the unexpected death of
a spouse (for example, εf large negative) also increases dissaving, perhaps
because revaluations of assets tend to be more drastic in circumstances
where mortality hazard is low.
We adopt the Edgeworth approximation (12) for each of the densities
gf(εf) and gm(εm). In regime jk with j   k   0, letting sf   2yf – 1 and sm  
2ym – 1, one has
(19) E(Y wtjk)   Yt
0 wjk   sf( f   yf f)
  
  sm( m   Ym m) 
   .
As in the case of singles, we estimate the conditional expectation (19) by
nonlinear least squares after plugging in estimates of  f and  m from the
earlier mortality models. A ﬁnal stage, analogous to (16), regresses the
 (Y m,t 1 m)  ∑
4
j 3  j  j1( Y m,t 1 m)
     
 (smYm,t 1 m)   sm∑
4
j 3  j  j0( Ym,t 1 m)
 (Y f,t 1 f)  ∑
4
j 3  j  j1( Y ft 1  f)
     
 (sfYf,t 1 f)   sf∑
4
j 3  j  j0( Y f,t 1 f)
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2sf) –
(E(εfsf))2, and E(ε2
msm) – (E(εmsm))2; the coeﬃcient on the intercept is an
estimate of κ2
jk. Because the number of deaths among couples is relatively
small, we impose the constraints  w10    w01 for empirical identiﬁcation.
Household income in AHEAD is also susceptible to measurement error,
and to minimize its eﬀect, we use income quartiles as explanatory variables.
These are obtained by converting all incomes to 1997 dollars, determining
the quartiles for the pooled incomes of all subjects in all waves, and using
the thresholds thus established to classify each observed subject income.
AHEAD respondents rate the safety of their neighborhood and the condi-
tion of their dwelling on a ﬁve-point scale, from poor to excellent; we use
indicators for poor or fair responses.
11.4 Socioeconomic Status and Prevalence of Health Conditions
11.4.1 Descriptive Statistics
We ﬁrst give some descriptive statistics on the prevalence of health con-
ditions in the AHEAD population. Table 11.4 shows prevalence rates in
the AHEAD sample in wave 1, classiﬁed by age and sex, for the health con-
ditions listed in table 11.2. Generally, prevalence of health conditions does
not show a strong age gradient, indicating broadly that morbidity rates
among survivors do not increase much with age. Selection eﬀects from ini-
tial noninstitutionalization and from mortality may be responsible. The
major exception is cognitive impairment, which rises as age increases. The
prevalence of acute and degenerative conditions among survivors fall after
about age eighty, reﬂecting the eﬀect of selection due to deaths from these
conditions. Males have higher prevalence of acute and degenerative dis-
eases than do females, but females have higher prevalence of mental and
chronic conditions, and accidents.
Figure 11.7 shows the age gradients of wealth, income, and education in
wave 1 of the AHEAD sample. These gradients reﬂect substantial cohort
eﬀects, as well as life-cycle and composition eﬀects. Work, income, and as-
set accumulation patterns of the AHEAD population were impacted by
World War II, and those over age eighty experienced the Great Depression
during their prime working years. The United States was substantially rural
when the AHEAD population was born, and education was truncated for
work for many members of this population. In addition to cohort eﬀects,
the curve for assets reﬂects life-cycle decumulation of assets through the re-
tirement years, and the curve for income reﬂects the rising proportion of
widows in the survivors to older ages. There is an additional compositional
eﬀect from the association of SES and mortality: Higher SES is selected
preferentially among survivors. However, in aggregate cross section, the
life-cycle and cohort eﬀects dominate the compositional eﬀects.
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To examine the association of SES and health conditions, we estimate a
series of binomial probit models of the form
(20) P(Y it   1Y 1t, . . . , Y i 1,t, W t, Xt),
where the Y itare indicators for the prevalence of various health conditions,
W t denotes a vector of SES conditions, and Xt denotes other demographic
variables. The health conditions appear in the same sequence as in table
11.2, with previous conditions in (20) providing information on associa-
tion among health conditions. Included in W tare indicators for the top and
bottom quartiles of wealth and income, indicators for ten or more years of
education (high school) and for fourteen or more years of education (col-
lege), and indicators for poor or fair neighborhood safety and dwelling
condition.
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Table 11.4 Prevalence of Health Conditions, by Age and Sex
White Females White Males
Condition 70–74 75–79 80–84 85–89 90  70–74 75–79 80–84 85–89 90 
Cancera 0.122 0.137 0.168 0.141 0.127 0.132 0.185 0.202 0.187 0.093
Heart diseasea 0.244 0.275 0.361 0.339 0.370 0.361 0.390 0.423 0.368 0.296
Strokea 0.051 0.069 0.104 0.121 0.133 0.066 0.12 0.102 0.130 0.148
Lung diseasea 0.109 0.123 0.108 0.082 0.055 0.151 0.171 0.173 0.093 0.056
Diabetesa 0.121 0.097 0.107 0.088 0.055 0.133 0.145 0.112 0.104 0.074
High blood 
pressurea 0.481 0.510 0.537 0.582 0.448 0.433 0.477 0.418 0.321 0.167
Arthritisb 0.222 0.285 0.267 0.328 0.254 0.167 0.205 0.196 0.161 0.167
Incontinenceb 0.228 0.263 0.266 0.331 0.365 0.085 0.138 0.145 0.161 0.259
Fallb 0.082 0.096 0.116 0.138 0.133 0.044 0.046 0.048 0.088 0.056
Hip fracturea 0.032 0.052 0.079 0.127 0.138 0.020 0.031 0.041 0.067 0.056
Cognitive 
impairment 0.120 0.149 0.338 0.452 0.635 0.137 0.173 0.291 0.446 0.500
Psychiatric 
diseasea 0.149 0.137 0.105 0.082 0.044 0.094 0.092 0.071 0.036 0.056
Depression 0.070 0.117 0.131 0.099 0.116 0.048 0.050 0.071 0.083 0.093
Smoker 0.133 0.095 0.058 0.040 0.017 0.142 0.123 0.082 0.041 0.093
ADL 
impairmentc 0.375 0.544 0.829 1.266 2.16 0.285 0.499 0.691 1.114 1.444
IADL 
impairmentc 0.293 0.340 0.662 1.099 2.011 0.304 0.422 0.658 0.964 1.426
Self-reported 
health 0.273 0.348 0.387 0.393 0.42 0.263 0.364 0.437 0.332 0.296
aAHEAD 1993 (wave 1) question: “Has a doctor ever told you . . . /Do you have . . . /Have you ever
...? . ”
bAHEAD 1993 (wave 1) question: “During the last 12 months, have you . . . ?”.
cAverage number; max(ADL)   6, max(IADL)   5.The detailed estimation results can be found at http://elsa.berkeley.edu/
wp/hww/hww202.html. Sample sizes are not adequate for comparable
models for non-whites. We ﬁnd the expected patterns of comorbidity, with
a strong association of heart disease, stroke, lung disease, and arthritis, and
a strong association of diabetes, heart disease, and high blood pressure. In-
continence is associated with cancer and stroke, and for women with dia-
betes, high blood pressure, and arthritis. Falls, hip fractures, and strokes
are associated. Psychiatric diseases and depression are associated with
arthritis and falls. BMI is positively associated with diabetes, high blood
pressure, and arthritis, and negatively associated with lung disease. Cur-
rent smokers have lower BMI, are less likely to have diabetes, and are more
likely to be depressed. Numbers of ADLs and IADLs are positively asso-
ciated with most acute diseases, arthritis, falls, hip fractures, cognitive im-
pairment, and psychiatric disease. A poor or fair self-reported health sta-
tus is associated with most acute and chronic diseases, with ADLs and
IADLs, and with depression.
Some covariates are associated with health conditions, and may be risk
factors for these conditions. Widowhood is associated with increased can-
cer and heart disease for women, increased psychiatric disease for men,
and increased lung disease and depression for both men and women. For
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Fig. 11.7 Cohort gradients (education, wealth, and income)women, father’s age at death is associated with heart disease, and mother’s
age at death is associated with high blood pressure. For men, father’s age at
death is associated with high blood pressure and arthritis.
We generally ﬁnd a statistically signiﬁcant association of SES and preva-
lence of health conditions, as summarized in table 11.5. It is noteworthy
that for males the prevalence of the acute diseases, cancer, heart disease,
and stroke are not strongly associated with SES, contrary to literature ﬁnd-
ings for younger populations. This may be the result of early onset of these
diseases, particularly among the poor and among smokers, that selects out
of the AHEAD population those males most at risk for these diseases.
Overall, wealth is the SES component most commonly associated with
health conditions. Education, neighborhood rating, and dwelling rating
are occasionally signiﬁcant, and income is almost never signiﬁcant. Table
11.6 summarizes the SES components that are individually signiﬁcant in
their association with various health conditions and indicates the sign of
the correlation. For a number of these conditions, prevalence rates are in-
suﬃcient to detect the eﬀects of SES components with satisfactory power.
However, for heart disease, high blood pressure, arthritis, cognitive im-
pairment, and self-rated health status, sample sizes should guarantee reli-
able indicators of association.
11.4.3 Relative Risk
To provide an indication of the direction and magnitude of the associa-
tion of health conditions and SES, we calculate relative risk for low SES
versus high SES, where the deﬁnition of low SESis bottom quartiles for in-
come and wealth, less than a high school education, and a poor/fair neigh-
borhood and dwelling, and the deﬁnition of high SES is top quartiles for
income and wealth, a college education, and a good or better neighbor-
hood and dwelling. Relative risk is deﬁned as the AHEAD sample average
of the ratio of the two probabilities, all other variables remaining at the ob-
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Table 11.5 Summary of Associations of SES and Health Conditions AHEAD Wave 1
SES Association White Females White Males
1 percent level Heart disease, stroke, lung disease, dia- Lung disease, cognitive impairment, 
betes, cognitive impairment, depression,  BMI, current smoker, ADL impair-
BMI, IADL impairment, self-reported  ment, IADL impairment, self-reported 
health status health status
5 percent level Cancer, HBP, Arthritis HBP, depression
Not signiﬁcant Incontinence, fall, hip fracture, psychi- Cancer, heart disease, stroke, diabetes, 
atric condition, current smoker, ADL  arthritis, incontinence, fall, hip frac-
impairment ture, psychiatric condition
Note: HBP   high blood pressure; BMI   body mass index (high or low); ADL   activities of daily liv-
ing (impairment requiring assistance with personal care); IADL  instrumental activities of daily living
(impairment requiring assistance with household management).Table 11.6 Signiﬁcant Associations of SES Components and Health Conditions, by Gender
Unsafe Dwelling 
Wealth Income Education Neighborhood Poor/Fair
Condition FMFMFMFMFM
Cancer RT










impairment TT TT TT TT R RR
Psychiatric 
condition T
Depression TT R R
BMI TT TT TT
Current smoker TT R
ADL impairment TT
IADL impairment TT TT
Poor/Fair self-rated 
health TT TT T R RR RR
Notes: The table summarizes 180 two-tailed signiﬁcance tests, so that if the tests were independent, one
would expect about 9 of the 41 signiﬁcant coeﬃcients at the 5 percent level by chance, and about 2 of the
23 signiﬁcant coeﬃcients at the 1 percent level by chance.
R   positive at 5 percent level; RR   positive at 1 percent level; T   negative at 5 percent level; TT
  negative at 1 percent level. See table 11.5 notes for explanations of abbreviations.
Table 11.7 Relative Risk of High vs. Low SES for Various Health Conditions, by Gender
Relative Risk Relative Risk Relative Risk
Condition F M Condition F M Condition F M
Cancer 1.97 0.98 HBP 0.76∗∗ 0.65∗∗ Cognitive impairment 0.53∗∗ 0.17∗∗
Heart disease 0.46∗∗ 0.75∗∗ Arthritis 0.80 0.60∗∗ Psychiatric 1.14 0.64
Stroke 0.61 0.43∗∗ Incontinence 0.83 0.71 Depression 0.34∗∗ 0.21∗∗
Lung disease 0.30∗∗ 0.33∗∗ Fall 0.68 0.44∗∗ Smoke now 0.27∗∗ 0.23∗∗
Diabetes 0.19∗∗ 0.65 Hip fracture 0.82 0.83 Health poor/fair 0.31∗∗ 0.34∗∗
Notes: High SES is deﬁned as top quartile in wealth and income, college education, and good neigh-
borhood and welling; low SES is deﬁned as bottom quartile in wealth and income, less than a high school
education, and poor neighborhood and welling. Associations in AHEAD wave 1. See table 11A.3 for an
pdated version of these results.
∗∗Relative risks that are signiﬁcantly diﬀerent from one at the 5 percent level.served levels for the subjects. Table 11.7 summarizes the relative risks for
the various health conditions. Note that the prevalence models are de-
scribing only association, not causation, so that relative risk numbers can-
not be interpreted causally. With the statistically insigniﬁcant exception of
cancer and psychiatric conditions for females, high SES is associated with
lower prevalence. Thus, we conﬁrm in the AHEAD population the litera-
ture ﬁndings of a systematic association of SES with mortality and mor-
bidity risk and show that this association extends across a variety of acute,
degenerative, chronic, and mental health impairments.
11.5 Incidence of Health Conditions and Tests for Causality 
in the AHEAD Panel
11.5.1 Models of Incidence
Following the format described in section 11.2, we use the incidence of
new health problems (or recurrence of cancer, heart disease, stroke, incon-
tinence, falls, and hip fractures), conditioned on initial demographic,
health, and SES status, to test for the absence of direct causal pathways. We
deﬁne incidence for a group of health conditions to be the occurrence of a
condition that was not previously reported, or a recorded reoccurrence in
the case of an acute condition (cancer, heart disease, stroke). The descrip-
tive statistics in table 11.2 provide information on rates of incidence of
these conditions between waves.23
We estimate models for incidence of each health condition, conditioned
on previously considered incidences of health conditions, the prevalence of
health conditions in the previous wave of the panel, and on SES and de-
mographic variables in the previous wave. The models are binomial probit
except for BMI, which is ﬁtted with a linear model using ordinary least
squares (OLS), and numbers of ADL and IADL impairments, which are
fitted as ordered probits. Detailed parameter estimates can be found at
http://elsa.berkeley.edu/wp/hww/hww202.html. Again, the data do not per-
mit the same analysis of nonwhites. The models are estimated by stacking
the data for wave 1 to wave 2 transitions above the data for wave 2 to wave
3 transitions. Table 11.8 summarizes the health conditions and covariates
that are signiﬁcant risk factors for the incidence of health conditions. The
associations reﬂect a number of known comorbidities, but show relatively
few associations of SES components and incidence of health conditions.
11.5.2 Causality Tests
Figure 11.8gives the structure of the invariance and causality tests we re-
port. We test only whether the model parameters are invariant between the
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23. The incidence rates in table 11.2 can be converted to crude annual rates via the formula





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































ewave 1 to 2 transitions and the wave 2 to 3 transitions. We exclude inter-
cepts, age splines, and log of time at risk terms from the invariance test. The
reason for doing so is that these terms will capture variations in survey re-
contact procedure across waves. However, we ﬁnd in most cases that there
is no signiﬁcant diﬀerence in the age spline coeﬃcients across the diﬀerent
transitions. The models are estimated unconstrained, and with the imposi-
tion of invariance, noncausality of SES, or both. Likelihood ratio tests are
conducted for invariance, with and without noncausality imposed, and for
noncausality conditioned on invariance. Because the invariance test with-
out noncausality of SES imposed and the noncausality test conditioned on
invariance are nested, they should give the same conclusion, at compatible
signiﬁcance levels, and as a joint test of invariance and noncausality. In ac-
cordance with section 11.2, we take acceptance of the joint hypothesis as
evidence that there is not a direct causal path from SES to incidence of the
given health condition and take this as support for the proposition that dif-
ferential access to medical care and SES-linked environmental hazards are
not causing incidence rates to vary with SES.
The test results are given in table 11.9. The columns of numbers in these
tables are, respectively, signiﬁcance levels for the invariance test with SES
variables included, the invariance test with SES variables excluded, the
noncausality test conditioned on invariance, and the joint test of invari-
ance and noncausality. The ﬁnal columns in the table give the relative risk
for high versus low SES (see section 11.4.3), and the signiﬁcance level of a
T-test of the null hypothesis that the relative risk is one.
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Fig. 11.8 Invariance and causality tests
Note: LL denotes log likelihood for speciﬁed condition, an unconditional invariance test is
denoted by “I,” a conditional test for no direct SES causality, given invariance, is denoted by






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































.In a majority of cases, our test for invariance is accepted. For cancer and
heart disease incidence, it is necessary to separate models for those with
and without a previous occurrence of the condition. For females, excep-
tions where invariance is rejected at the 1 percent level are mortality and
ADL count. Exceptions for males are cancer with a previous occurrence,
mortality, ADL count, BMI, and IADL count. The failure of the mortal-
ity models to satisfy invariance may be related to the initial selection of a
noninstitutionalized population in wave 1 of the AHEAD panel. Of
course, in addition to the question of the power of our test to detect in-
variance failures, our single test of invariance across waves falls consider-
ably short of the battery of invariance tests that would be desirable to es-
tablish that the model system has the stability and sensitivity required for
policy applications.
For females, the tests for noncausality of the SES variables, conditioned
on a maintained hypothesis of invariance, are rejected for arthritis and psy-
chiatric disease at the 5 percent level and for cognitive impairment and self-
rated health at the 1 percent level. Notably, these are all chronic or mental
conditions where Medicare coverage is limited and the cost of drugs or as-
sistance may be substantial. For males, this test for noncausality is rejected
for cancer with a previous occurrence, heart disease with no previous
occurrence, lung disease, diabetes, cognitive impairment, and self-rated
health at the 5 percent level, and for IADL count at the 1 percent level. The
results of the joint test for invariance and noncausality are roughly consis-
tent with the separate tests. For conditions such as cancer with a previous
occurrence and IADL count for males, cognitive impairment for females,
and mortality for both females and males, the noncausality test results may
be confounded by the failure of invariance.
The relative risks in table 11.9 should not be interpreted causally, since
again the cases where noncausality is rejected and the relative risks are sub-
stantially diﬀerent from one may be due to a common unobserved eﬀect
rather than a direct causal link. The pattern of ﬁfteen relative risks exceed-
ing one and eighteen less than one suggests no broad linkage between SES
and health changes, given prior health, and the direct links that may be in-
dicated from the signiﬁcance levels (lung disease and hip fractures for
males and females, some cancers and arthritis for males) appear to be re-
lated to speciﬁc features of poverty, such as smoking history and poor
dwelling environment. There are a few cases where the relative risk for high
versus low SES is substantially less than one, irrespective of statistical sig-
niﬁcance, indicating an unproven link of suﬃcient magnitude to warrant
further investigation: lung disease, hip fracture, and the mental diseases for
females, and lung disease, diabetes, arthritis, and the mental diseases for
males. Large deviations in relative risk from one that are not statistically
signiﬁcant suggest that acceptance of the joint hypothesis of invariance
and noncausality could be due to low power. Notably, death shows no re-
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are insigniﬁcantly diﬀerent from one. This indicates that there are no
strong direct causal links from SES to mortality, which at the level of reso-
lution of this study rules out diﬀerential access to medical treatment for
life-threatening illness. Thus, the association of SES and mortality among
the elderly appears to come primarily from variation in the prevalence of
health conditions with SES, and more weakly from indirect causal links
from SES to incidence of health conditions that increase mortality risk.
The pattern of failures of the noncausality test for mental diseases sug-
gests the possibility of a direct causal link related to diﬀerential access.
Medicare limits the scope of care for mental conditions, so ability to pay
may indeed be an important factor in eﬃcacy of treatments that prevent or
control these conditions.
11.6 Tests for Noncausality from Health Status to Asset Accumulation
11.6.1 Models of Incidence
Health may inﬂuence asset accumulation of elderly households because
of the cost of medical treatment and related services. Medicare covers
acute conditions with limited copayments, but there is the possibility of
direct eﬀects from uncovered costs of drugs and living assistance. Also,
health conditions may limit the consumption of other goods, and because
health status is an indicator of longevity, an individual planning consump-
tion and precautionary reserves over remaining life may adjust target
wealth based on altered perceptions of longevity and anticipated medical
costs; see Alessie, Lusardi, and Kapteyn (2000), Attanasio and Hoynes
(2000), Hurd (1987), Hurd and Wise (1989), Hurd and McGarry (1997),
Hurd, McFadden, and Gan (1998). These eﬀects could induce an associa-
tion of SES and health status even if there were no causal links from SES
to health. In the elderly AHEAD population, we will not observe the most
likely direct causal link from health status to accumulation among work-
ers, the eﬀect of health on current labor market participation and produc-
tivity.
We analyze transitions in wealth from wave to wave using the framework
of section 11.2 and model (11) for singles and (17) and (18) for couples,
with demographics, previous wave health conditions, and current wave in-
cidence of new health conditions as explanatory variables. Statistically sig-
niﬁcant selection coeﬃcients are consistent with a direct causal link from
death to a change in household wealth, but also consistent with ecological
factors that induce an association of mortality risk and SES. Total, non-
liquid, and liquid wealth are analyzed separately, with transformation (10)
applied to each component.
Tables 11A.5, 11A.6, and 11A.7 give the detailed incidence models for
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ings, we ﬁnd that most of the variance in wealth changes over the popula-
tion is not explained by observed economic variables. This remains true af-
ter introduction of health conditions. We ﬁnd dissaving rates out of liquid
wealth, before realization of returns calculated from the S&P 500, that are
5.3 percent for couples, 4.8 percent for singles, and 6.0 percent for survivors
whose spouses have died. The dissaving rates from nonliquid wealth, again
before realization of returns, are, respectively, 6.9 percent, 6.3 percent, and
8.0 percent for intact couples, singles, and survivors. The higher dissaving
rates from nonliquid assets indicates that the wealth portfolios of the el-
derly are rebalanced to become more liquid as they age. These dissaving
rates can be compared to an average rate of dissaving of 8.3 percent of re-
maining wealth in an age seventy-plus population with life-table survival
probabilities who consume the expected annuitized value of their wealth.24
Then, observed dissaving rates out of wealth are not grossly lower than
would be expected with pure life-cycle consumption averaging over retire-
ment and full pooling of mortality risk. We ﬁnd that low income couples
and individuals have signiﬁcantly higher dissaving rates than their high in-
come counterparts, but the diﬀerences are not quantitatively large. Home
ownership is associated with signiﬁcantly less dissaving for intact couples.
The models for both singles and couples show signiﬁcant departures
from normality in the selection equations. The Edgeworth expansion pa-
rameters show positive skewness and smaller than normal kurtosis for fe-
male singles, negative skewness and insigniﬁcantly diﬀerent from normal
kurtosis for male singles. For couples, both males and females have nega-
tive skewness and larger than normal kurtosis. We also ﬁnd signiﬁcant se-
lection eﬀects, with  f   –0.49 for couples and –0.21 for singles, and  m  
–0.51 for couples and –0.89 for singles. These imply that households that
survive despite unfavorable mortality risks have increased dissaving, either
because of increased cost of overcoming health problems or because
households at elevated risk spend down more rapidly. Equation (18) in-
cludes shift parameters that modify the dependence of the wealth change
disturbance on the unobserved selection eﬀects in regimes where a spouse
dies. These are statistically signiﬁcant, and suﬃciently large to reverse the
direction of the intact couple selection eﬀects.
Table 11.10 summarizes the health conditions and other covariates that
are individually signiﬁcant in explaining changes in wealth. For intact cou-
ples, we ﬁnd some acute conditions increase saving, perhaps because they
restrict consumption, or perhaps because couples conserve assets for a po-
tential surviving spouse. For the conditions that are associated with in-
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24. This calculation is made from the 1996 life tables and assumes the historical S&P rate
of return from 1993 to 1997, and a 7 percent real rate of return on assets after 1997.creased dissaving (cognitive impairment and stroke for single females),
costs of maintenance associated with these conditions may be directly
causal to wealth changes.
11.6.2 Causality Tests
Table 11.11 summarizes our tests for invariance and absence of direct
causal links. We test for common parameters in the wealth change models
between waves 1–2 and waves 2–3, excepting intercepts and age eﬀects to
allow for the eﬀects of sample timing. Invariance is convincingly rejected
for each demographic group and wealth category, indicating that our
model fails to capture the structural determinants of wealth change. As a
consequence, our noncausality tests to follow may produce rejections due
to model misspeciﬁcation, confounding the detection of direct causal
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Table 11.10 Statistically Signiﬁcant Risk Factors for Wealth Changes
Component Health Conditions Covariates
Intact couple
Total wealth M self-rated health poor/fair (R), M  Nonliquid wealth (T), liquid wealth (T), 
new heart (R), M new hip fracture (T), income  (R), homeowner (R)
F new cancer (R)
Nonliquid  Nonliquid wealth (T), liquid wealth (R), 
wealth homeowner (R)
Liquid wealth M new heart (R), M BMI worse (T) Nonliquid wealth (R), liquid wealth (T), 
income (R), dwelling poor/fair (T)
Spouse died
Total wealth Nonliquid wealth (T), liquid wealth (T), 
income (R)
Nonliquid  Nonliquid wealth (T)
wealth
Liquid wealth F new stroke (T) Nonliquid wealth (R), liquid wealth (T), 
income (R)
Single
Total wealth M new cancer (R), F new cancer (T), F  M,F nonliquid wealth (T), M,F liquid 
new depression (T)w e alth (T), M,F income (R)
Nonliquid M hip fracture (R), M new cancer (R),  M,F nonliquid wealth (T), M liquid 
wealth M new heart (R)w e alth (R), F income (R), F home-
owner (R)
Liquid wealth F cognitive impairment (T), F new  M,F nonliquid wealth (R), M,F liquid 
stroke (T), F new cognitive impair- wealth (T), M,F income (R), F dwel-
ment (T) ling poor/fair (T)
Notes: One percent signiﬁcance level. M   male; F   female; new   incidence since last wave; R indi-
cates increased saving; T indicates decreased saving.links. A deconstruction of the invariance failures, detailed in appendix
table 11A.8, shows that for nonliquid and liquid wealth, invariance passes
for demographic and health prevalence and incidence variables, but fails
for female SES variables, and for all male variables including SES taken to-
gether. Thus, there was an unexplained regime shift before and after wave
2 of AHEAD. Possible explanations for this are an interaction between the
criterion of noninstitutionalization in the initial panel recruitment and
economic behavioral response; a wealth-linked interaction in panel reten-
tion; problems in the measurement of wealth in the AHEAD population,
which exhibits unexplained mean reversion; or a true behavioral shift with
age in a single cohort that is not captured accurately by a model that pools
wealth change observations across cohorts.
We expect that terminal medical and burial expenses, estate taxes and
other estate settlement costs, insurance payments, and bequests will have a
substantial impact on the size of a decedent’s estate and surviving spouse’s
reported wealth. We easily reject the hypothesis that the model coeﬃcients
for intact couples and for surviving spouses are the same, but note that
measurement problems associated with a change in ﬁnancially responsible
respondent could also produce this rejection.
The hypothesis of no direct causality of health conditions for total
wealth changes is rejected at the 1 percent level for intact couples and
singles. For nonliquid wealth, the hypothesis is rejected for intact couples,
and for liquid wealth, the hypothesis is rejected for all demographic groups.
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Table 11.11 Wealth Changes, Tests for Invariance and Causality
Signiﬁcance Levels
Noncausality
Demographic Group Previous Health Current Health All Health
Wealth Component Invariance Conditions Conditions Conditions
Intact couple
Total wealth 0.000 0.036 0.001 0.000
Nonliquid wealth 0.000 0.014 0.028 0.001
Liquid wealth 0.000 0.006 0.012 0.000
Spouse died
Total wealth 0.000 0.811 0.776 0.074
Nonliquid wealth 0.000 0.071 0.814 0.037
Liquid wealth 0.000 0.676 0.456 0.023
Single
Total wealth 0.000 0.004 0.022 0.001
Nonliquid wealth 0.000 0.100 0.347 0.235
Liquid wealth 0.000 0.000 0.028 0.000The failure of the invariance tests, and the possibility of confounding by
persistent common factors and selection suggest that conclusions on the
health to wealth link be interpreted with caution. Table 11A.9 deconstructs
the causality tests and identiﬁes the health conditions and genders respon-
sible for rejections. The pattern of results suggest that if there is indeed a
direct causal link, then it is most likely to involve liquid wealth and health
conditions that require assisted living.
Table 11A.10 estimates models of income change, given health condi-
tions and other covariates. One would not expect health status to have a
signiﬁcant impact on the incomes of retirees, conditioned on previous
wealth, and the empirical results are generally consistent with this expec-
tation. We have not done formal tests of invariance or causality for income.
Also included in the state vector Yt that describes individuals are changes
in home ownership status, and dwelling and neighborhood conditions.
We estimate incidence models for these components; results are in table
11A.11.
11.7 Simulation of Life Courses under Counterfactual Conditions
11.7.1 The Simulation Experiment
For policy analysis of interventions that alter delivery or cost of medical
services, or retirement ﬁnancing, one would like to trace through the direct
and indirect causal links between wealth, health, and mortality. If Markov
models of the sort developed in sections 11.2–11.6 satisfy the required in-
variance properties, then they can be used to simulate the impacts of these
interventions on the life courses of a synthetic population. In this section,
we develop such a simulation analysis and apply it to illustrative interven-
tions. Because we have not uniformly accepted invariance, and in a num-
ber of cases ﬁnd associations that may be either direct causal links or hid-
den common factors, this simulation analysis assumes more than our
estimates support. It should be interpreted only as an exercise that shows
how a model of this general structure might be used in a policy application
to unravel the dynamics of comorbidities and forecast condition-speciﬁc
morbidity and mortality and life expectancy.
We simulate the life courses of a synthetic population in which heads of
household are initially aged seventy–seventy-four. To synthesize this pop-
ulation, we start from the 1,612 households in AHEAD wave 1 whose
heads are white and aged seventy–seventy-four. Using the SES and demo-
graphic variables for each household in this subsample, we make ten
Monte Carlo draws from the prevalence models in section 11.4 to create
synthetic initial health proﬁles for the household head, and spouse if pres-
ent. This gives an initial synthetic sample of 16,120 households. We then
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sively from the Markov incidence models in sections 11.5 and 11.6, ad-
justed to annual transitions using (9) to approximate the probabilities of
moving to new states.
We ﬁrst consider a base scenario (S0) in which initial prevalence and in-
cidence transitions are given by our models estimated on the AHEAD
data. We note that the simulation outcomes can be expected to diﬀer to
some degree from the cross-cohort patterns found in AHEAD, because the
distribution of conditions at ages seventy–seventy-four will diﬀer from the
distributions of prevalence that actually prevailed for older individuals in
AHEAD when they were aged seventy–seventy-four. They should also
diﬀer to some degree from the actual experience that the aged seventy–sev-
enty-four cohort in AHEAD will have through the remainder of their lives,
because the simulation cannot anticipate the realized future distribution of
exogenous variables and because our models do not allow for drift-in dis-
ease incidence or condition-speciﬁc mortality hazards that will result from
changes in medical care. Historically, these drifts have been very signiﬁ-
cant, reducing morbidities and increasing life expectancies. If these trends
continue, then the baseline simulations will underestimate actual survival
experience.
We next consider two stylized policy interventions. The ﬁrst alternative
scenario (S1) examines the impact on life courses of the introduction of a
hypothetical medical treatment that cures diabetes, for example, by stem
cell and immune system therapy that rejuvenates the pancreas for both
type I and type II diabetics. In this scenario, we assume that prevalence of
diabetes at the start of the simulated panel drops to zero, and that there is
zero incidence of this condition as the cohort ages. We do not alter the his-
torical prevalence of conditions associated with diabetes. Thus, we assume
that the historical impact on individuals of type I diabetes, notably in-
creased prevalence of heart disease and stroke at ages seventy–seventy-
four, is not altered. The second alternative scenario (S2) examines the im-
pact on life courses of reducing the entire population from their current
SES to our deﬁnition of a low-SES individual: bottom quartile for wealth
and income, less than a high school education, and a poor or fair neigh-
borhood and dwelling. This alternative is obviously hypothetical and is not
even a stylized approximation to any real policy alternative. However, it
provides an extreme in which the interactions of health and SES are per-
mitted maximum play, giving an upper bound on the eﬀect that SES could
possibly have on health outcomes, and providing a ﬁnger exercise that tests
the plausibility of our model system.
11.7.2 Baseline Simulation
Table 11.12 summarizes the survival probabilities and prevalence of
health conditions among survivors in the simulated cohort as it ages, under
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Age
Scenario 70 75 80 85 90 95
White females
Survival probabilitya S0 1.000 0.905 0.743 0.500 0.240 0.079
S1 1.000 0.906 0.757 0.517 0.257 0.087
S2 1.000 0.884 0.662 0.359 0.125 0.027
Cancerb S0 0.112 0.174 0.219 0.245 0.257 0.262
S1 0.112 0.169 0.217 0.243 0.258 0.252
S2 0.112 0.208 0.273 0.298 0.302 0.336
Heart diseaseb S0 0.224 0.322 0.442 0.538 0.588 0.594
S1 0.224 0.321 0.429 0.515 0.569 0.608
S2 0.224 0.344 0.495 0.608 0.663 0.679
Strokeb S0 0.042 0.105 0.191 0.272 0.326 0.341
S1 0.042 0.104 0.186 0.260 0.317 0.351
S2 0.042 0.105 0.196 0.274 0.320 0.366
Lung diseaseb S0 0.105 0.151 0.179 0.190 0.168 0.143
S1 0.105 0.150 0.183 0.190 0.175 0.154
S2 0.105 0.193 0.258 0.278 0.276 0.286
Diabetesb S0 0.114 0.161 0.198 0.199 0.170 0.157
S1 0.114 0.000 0.000 0.000 0.000 0.000
S2 0.114 0.181 0.231 0.233 0.207 0.231
High Blood Pressureb S0 0.467 0.583 0.678 0.738 0.761 0.778
S1 0.467 0.585 0.678 0.742 0.783 0.804
S2 0.467 0.597 0.701 0.764 0.786 0.810
Arthritisb S0 0.232 0.501 0.677 0.791 0.857 0.901
S1 0.232 0.501 0.670 0.784 0.856 0.905
S2 0.232 0.567 0.769 0.876 0.925 0.965
Incontinenceb S0 0.232 0.416 0.601 0.751 0.843 0.891
S1 0.232 0.427 0.611 0.749 0.844 0.906
S2 0.232 0.444 0.664 0.814 0.891 0.917
Fallb S0 0.071 0.271 0.464 0.635 0.759 0.837
S1 0.071 0.268 0.456 0.628 0.754 0.846
S2 0.071 0.260 0.460 0.640 0.759 0.822
Hip fractureb S0 0.030 0.046 0.070 0.109 0.153 0.215
S1 0.030 0.043 0.069 0.109 0.156 0.190
S2 0.030 0.056 0.104 0.160 0.224 0.258
Proxy interview S0 0.038 0.056 0.103 0.163 0.230 0.294
S1 0.038 0.063 0.095 0.155 0.222 0.271
S2 0.038 0.103 0.211 0.316 0.409 0.521
Cognitive impairmentb S0 0.104 0.253 0.437 0.609 0.736 0.818
S1 0.104 0.251 0.435 0.602 0.722 0.803
S2 0.104 0.405 0.669 0.838 0.910 0.952
Psychiatric diseaseb S0 0.154 0.215 0.307 0.376 0.421 0.434
S1 0.154 0.219 0.305 0.379 0.416 0.426
S2 0.154 0.316 0.508 0.634 0.704 0.762
Depressionb S0 0.068 0.183 0.305 0.429 0.515 0.575
S1 0.068 0.179 0.305 0.424 0.521 0.596
S2 0.068 0.247 0.434 0.574 0.665 0.749
(continued)Body Mass Indexc S0 25.7 24.7 23.6 22.3 21.0 20.5
S1 25.7 24.7 23.6 22.3 21.1 20.3
S2 25.7 24.7 23.4 22.2 21.2 20.8
Current smokerb S0 0.128 0.088 0.063 0.043 0.027 0.017
S1 0.128 0.091 0.063 0.048 0.031 0.016
S2 0.128 0.109 0.084 0.056 0.039 0.020
ADL limitsc S0 0.31 0.27 0.66 1.18 1.68 2.14
S1 0.31 0.26 0.59 1.08 1.63 1.99
S2 0.31 0.45 1.21 2.08 2.77 3.33
IADL limitsc S0 0.25 0.11 0.29 0.58 0.85 1.14
S1 0.25 0.10 0.27 0.53 0.81 1.04
S2 0.25 0.25 0.73 1.34 1.84 2.30
Poor/fair self-rated healthb S0 0.254 0.305 0.441 0.540 0.585 0.613
S1 0.254 0.293 0.416 0.501 0.574 0.582
S2 0.254 0.507 0.711 0.811 0.841 0.860
White males
Survival probabilitya S0 1.000 0.828 0.558 0.279 0.091 0.019
S1 1.000 0.844 0.586 0.304 0.105 0.025
S2 1.000 0.827 0.485 0.170 0.032 0.004
Cancerb S0 0.145 0.242 0.320 0.400 0.478 0.514
S1 0.145 0.248 0.321 0.395 0.482 0.546
S2 0.145 0.281 0.391 0.479 0.555 0.596
Heartb S0 0.352 0.490 0.611 0.709 0.774 0.733
S1 0.352 0.488 0.626 0.701 0.752 0.766
S2 0.352 0.443 0.554 0.627 0.632 0.681
Strokeb S0 0.075 0.140 0.213 0.282 0.317 0.310
S1 0.075 0.142 0.213 0.287 0.323 0.351
S2 0.075 0.190 0.317 0.423 0.517 0.596
Lung diseaseb S0 0.150 0.185 0.205 0.203 0.183 0.152
S1 0.150 0.184 0.206 0.212 0.200 0.184
S2 0.150 0.183 0.201 0.195 0.190 0.085
Diabetesb S0 0.135 0.171 0.183 0.190 0.177 0.171
S1 0.135 0.000 0.000 0.000 0.000 0.000
S2 0.135 0.135 0.119 0.095 0.085 0.128
High Blood Pressureb S0 0.443 0.553 0.636 0.699 0.719 0.743
S1 0.443 0.551 0.637 0.702 0.740 0.784
S2 0.443 0.565 0.643 0.689 0.692 0.638
Arthritisb S0 0.175 0.405 0.582 0.718 0.801 0.848
S1 0.175 0.419 0.602 0.719 0.792 0.865
S2 0.175 0.581 0.806 0.913 0.948 0.915
Incontinenceb S0 0.097 0.259 0.433 0.603 0.748 0.852
S1 0.097 0.252 0.414 0.582 0.707 0.840
S2 0.097 0.309 0.528 0.703 0.849 0.872
Fallb S0 0.041 0.162 0.300 0.435 0.547 0.667
S1 0.041 0.163 0.292 0.440 0.559 0.681
S2 0.041 0.214 0.410 0.588 0.728 0.809
Table 11.12 (continued)
Age
Scenario 70 75 80 85 90 95the baseline scenario (S0), the no-diabetes scenario (S1), and the low-SES
scenario (S2). Keeping in mind that we expect the simulation model to
diﬀer from the historical cross-cohort record in AHEAD, the success of
this model in plausibly mimicking observed conditions in the AHEAD
population can be judged by comparing the results for scenario S0 with life
table survival probabilities. Life expectancy for a cohort of white females
aged seventy–seventy-four is 13.15 years from the 1996 life tables and 14.36
years in our baseline simulation. The life table probability of survival for
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Hip fractureb S0 0.025 0.032 0.044 0.066 0.119 0.167
S1 0.025 0.030 0.044 0.068 0.108 0.138
S2 0.025 0.076 0.147 0.247 0.357 0.447
Proxy Interview S0 0.111 0.110 0.114 0.125 0.155 0.157
S1 0.111 0.109 0.120 0.147 0.170 0.170
S2 0.111 0.223 0.303 0.382 0.429 0.468
Cognitive impairmentb S0 0.146 0.326 0.505 0.662 0.768 0.857
S1 0.146 0.329 0.509 0.657 0.772 0.897
S2 0.146 0.484 0.743 0.881 0.934 0.936
Psychiatric diseaseb S0 0.085 0.133 0.186 0.240 0.268 0.291
S1 0.085 0.135 0.187 0.240 0.263 0.319
S2 0.085 0.237 0.430 0.557 0.621 0.660
Depressionb S0 0.038 0.105 0.184 0.233 0.262 0.281
S1 0.038 0.110 0.196 0.259 0.263 0.344
S2 0.038 0.199 0.344 0.421 0.445 0.404
Body Mass Indexc S0 26.1 25.5 24.9 24.6 24.4 24.4
S1 26.1 25.6 25.0 24.7 24.6 24.1
S2 26.1 24.6 23.6 23.2 23.2 22.9
Current smokerb S0 0.131 0.063 0.035 0.015 0.009 0.005
S1 0.131 0.061 0.041 0.014 0.003 0.000
S2 0.131 0.075 0.038 0.013 0.000 0.000
ADL limitsc S0 0.33 0.36 0.75 1.33 1.84 2.45
S1 0.33 0.38 0.79 1.37 1.88 2.46
S2 0.33 0.94 2.11 3.24 4.15 4.51
IADL limitsc S0 0.34 0.16 0.33 0.63 0.94 1.24
S1 0.34 0.15 0.34 0.64 0.95 1.23
S2 0.34 0.52 1.22 2.00 2.65 2.85
Poor/fair self-rated healthb S0 0.282 0.355 0.445 0.487 0.514 0.543
S1 0.282 0.352 0.448 0.488 0.482 0.500
S2 0.282 0.586 0.760 0.818 0.871 0.830
Notes:S0  baseline; S1  no diabetes; S2  all low SES. See table 11.5 for explanation of abbreviations.
aProportion of age 70 population surviving to the speciﬁed age.
bProportion of surviving population at speciﬁed age who ever had condition.
cMean in surviving population.
Table 11.12 (continued)
Age
Scenario 70 75 80 85 90 95ﬁfteen years for the aged seventy–seventy-four cohort is 0.535, while the
corresponding survival probability in the simulation model is 0.500. For
white males, the life expectancy at age seventy is 11.31 years from the life
tables and 10.81 years from the S0 simulation. The ﬁfteen-year survival
probability is 0.381 from the life tables and 0.279 from the simulation
model. Thus, relative to the life tables, the simulation model underpredicts
female mortality and overpredicts male mortality. The comparison of an-
nual mortality rates for white females given in ﬁgure 11.5 indicates that ac-
tual AHEAD mortality experience was more favorable than the life tables
between waves 1 and 2, presumably due to selection in panel recruitment,
and very close to the life tables between waves 2 and 3. Then, the baseline
simulation appears to reproduce relatively accurately the cross-cohort sur-
vival experience in AHEAD. This provides a reality check for the simula-
tion model, but also suggests that if the survival experience of a current co-
hort diﬀers from the historical cross-cohort pattern, then the simulation
model will miss the drift in mortality hazards that a single cohort will face
in the future.
A comparison of prevalence rates for various health conditions among
survivors of various ages can be made between AHEAD at wave 1, given
in table 11.4, and the baseline simulation in table 11.12. There are issues of
comparability in the deﬁnition of prevalence for some conditions, but the
pattern that emerges is that the simulated prevalences are systematically
higher than the historical prevalences and increasingly so at older ages. For
example, for white females aged eighty–eighty-four, the historical and sim-
ulated prevalence rates are 0.168 versus 0.219 for cancer, 0.361 versus 0.442
for heart disease, and 0.338 versus 0.437 for cognitive impairment. One
possible explanation for this is that the links from morbidity to mortality
are stronger than the mortality model detects, perhaps because of under-
reporting of health conditions that arise prior to death, so that the simula-
tion model underestimates the selection eﬀect of mortality that reduces
prevalence among survivors. A second possible explanation is that there is
strong unobserved heterogeneity in susceptibility to various health condi-
tions, so that cumulative prevalence is overestimated by our ﬁrst-order
Markov models which describe prevalence for most conditions as the result
of one or more positives in a series of Bernoulli trials. It is possible to test
for persistent unobserved heterogeneity by asking whether the frequency
of a negative for a condition between waves 1 and 3 of AHEAD is the prod-
uct of the frequencies of a negative between successive waves. When we do
this, we do not ﬁnd persistent unobserved heterogeneity. However, the
power of the test is modest, and it is possible that even a limited degree of
persistent unobserved heterogeneity is enough to explain the diﬀerences in
AHEAD and the simulation.
A comparison is given intable 11.13between median wealth and income
by age in the AHEAD panel and in the baseline simulation. The historical
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and a less liquid portfolio with age, reﬂecting strong cohort eﬀects as well
as life-cycle and selection eﬀects. The simulation results, which exclude co-
hort eﬀects, nevertheless show even more sharply declining wealth with age
and a strong shift toward a more liquid portfolio mix. If the simulation is
correctly describing portfolio balance of a single cohort over its life course,
then there is a strong cross-cohort eﬀect, with older cohorts starting from
retirement portfolios that are more heavily invested in housing equity and
other nonliquid forms. The simulated semi-interquartile range is narrower
than its historical counterpart, particularly for older households. In the
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Table 11.13 Wealth and Income in AHEAD and in the Baseline Scenario, by Age
70–74 75–79 80–84 85–89 90 
AHEAD cross-cohort data
Total wealth (000)
1st quartile 64.38 46.92 32.76 14.05 2.17
Median 144.04 112.76 94.35 71.34 40.13
3rd quartile 314.27 242.68 203.20 185.91 117.93
Nonliquid wealth (000)
1st quartile 47.72 28.20 10.81 0.86 0.00
Median 94.94 80.48 62.01 44.19 5.44
3rd quartile 178.96 151.68 113.88 109.12 65.47
Liquid wealth (000)
1st quartile 2.18 1.31 0.54 0.33 0.00
Median 26.19 15.97 11.89 9.73 5.40
3rd quartile 98.21 70.93 70.93 55.31 37.83
Income (000)
1st quartile 14.15 11.97 9.76 8.68 6.74
Median 22.78 19.59 15.26 13.77 9.76
3rd quartile 34.92 31.65 28.06 25.10 15.29
Baseline simulation data
Total wealth (000)
1st quartile 56.67 65.69 37.07 16.08 8.22
Median 136.20 121.43 79.94 51.86 41.59
3rd quartile 299.13 206.63 136.38 91.16 74.29
Nonliquid wealth (000)
1st quartile 42.72 37.39 17.56 2.97 –3.77
Median 91.53 74.34 47.13 29.17 21.21
3rd quartile 171.34 118.09 78.90 55.44 45.07
Liquid wealth (000)
1st quartile 1.64 19.16 10.91 4.96 3.61
Median 22.79 43.77 31.16 22.01 19.38
3rd quartile 95.90 80.05 58.58 42.39 36.69
Income (000)
1st quartile 13.56 13.57 11.25 8.62 7.92
Median 21.82 18.19 15.89 13.58 11.92
3rd quartile 34.70 29.58 23.12 17.81 15.85simulation, variability (deﬁned as the ratio of the semi-interquartile range
divided by the median) falls with age, whereas in the historical cross-cohort
data variability rises with age. This suggests that in addition to cross-
cohort eﬀects, that there may be persistent heterogeneity in savings behav-
ior that is not captured in our model.
11.7.3 Alternative Scenarios
Table 11.12 gives the survival probabilities and prevalences of various
health conditions under our alternative no-diabetes scenario (S1) and the
low-SES scenario (S2). In the no-diabetes simulation, the direct mortality
risk from diabetes, and the incidence of comorbidities with diabetes are
eliminated, although our simulated population will display elevated preva-
lence of heart disease and stroke at age seventy among former diabetics.
Life expectancy at age seventy under this scenario increases from 14.36 to
14.69 years for females, and from 10.81 to 11.26 years for males. These
rates imply in turn that a former diabetic’s life expectancy increases by 2.72
years for females and 3.32 years for males. Other health condition preva-
lences that fall in the absence of diabetes are heart disease, stroke, cogni-
tive impairment, ADL and IADL impairment, and poor/fair self-rated
health. While reduction in mortality risk from one source must as a matter
of accounting eventually lead to more deaths from competing risks, there
are no substantial movements in prevalences of the remaining health con-
ditions.
The alternative low-SES scenario reduces our entire aged seventy simu-
lated population to the bottom quartile for wealth and income, gives them
less than a high school education and places them in a dwelling in poor
condition in an unsafe neighborhood. They are kept in this low-SES status
for the remainder of their lives; that is, there is no opportunity in this sim-
ulation for households to escape low SES by a lucky change in wealth or
income. However, our population displays the patterns of prevalence of
health conditions established in their earlier lives with their historical SES
status. This scenario is quite artiﬁcial, but it demonstrates the holistic eﬀect
on the broad spectrum of health conditions of low SES. Life expectancies
at age seventy in this scenario drop dramatically, from 14.36 to 12.27 years
for females, and from 10.81 to 9.56 years for males. Prevalences of cancer,
heart disease, lung disease, diabetes, arthritis, incontinence, hip fractures,
cognitive impairment, psychiatric disease, and depression all increase
sharply, as do the number of ADL and IADL impairments. Conditions
whose prevalence is not aﬀected substantially by low SES are stroke, high
blood pressure, and falls. These results indicate that if the associations of
SES and incidence of health conditions that we ﬁnd in AHEAD were en-
tirely the result of direct causal links from wealth to health, then the pro-
tective eﬀect of the prevailing pattern of higher SES is 1.26–2.08 years of
466 P. Adams, M. D. Hurd, D. McFadden, A. Merrill, and T. Ribeiroadded life expectancy. Thus, our ﬁndings that for most health conditions
the evidence is against direct causal links from SES to incidence do not ap-
pear to rule out a substantial cumulative eﬀect of SES over conditions and
time that induce a noticeable SES gradient in mortality. Given our speciﬁc
ﬁndings against direct causal links from SES to incidence of acute condi-
tions and mortality, the most obvious possible source for this gradient are
SES-linked diﬀerences in genetic susceptibility and behavior.
We have emphasized that our stylized, hypothetical policy intervention
and the changes in health they produce over the life course are strictly il-
lustrative and should be interpreted with great caution. These ﬁnger exer-
cises cannot be used to draw conclusions about any real policy initiatives.
This is particularly true since we have included within our model system
components that fail the invariance tests that we have emphasized must be
met by a valid policy model, and because in many cases our models display
somewealth or income gradients for incidence that we cannot with our sta-
tistical methods identify as the sole result of direct causal links. While most
of these eﬀects are not statistically signiﬁcant, it is possible that in a larger
or longer panel with greater statistical power, they will prove to be signiﬁ-
cant. Then, it is essential to turn to the more advanced statistical methods
of Heckman (2001) and others to identify the direct causal components in
these incidence associations and improve the models to achieve invariance.
Only after this is done, and realistically detailed policy scenarios are con-
sidered, could policy makers take our model system seriously as a policy
tool. However, we believe that our results do demonstrate that it would be
useful for health policy analysis to utilize a system of invariant models with
a causal chain structure to simulate policy impacts, in a framework that
takes into account indirect impacts, competing hazards, and direct causal
links between SES and health. We believe that analysis of the broad sweep
of comorbidities and wealth eﬀects over the life course is an important
complement to the diseasecentric orientation of many medical and epi-
demiological studies of health outcomes.
11.8 Summary and Speculations for Further Research
This paper has used innovations in health conditions and in wealth in the
AHEAD panel to carry out tests for the absence of direct causal links from
SES to health, and from health conditions to wealth. By advancing beyond
the detection of association to a framework in which there is some pos-
sibility of detecting the absence of causal links, this paper provides a
methodology that may be useful in winnowing the list of possible direct
causal mechanisms, or delimiting their domain of action. For the AHEAD
sample, a panel of U.S. elderly aged seventy and older in 1993, we conclude
generally that for mortality and for acute, sudden-onset diseases, the hy-
Tests for Direct Causal Paths between Health and Socioeconomic Status 467pothesis of no causal link from SES is accepted, and for incidence of men-
tal problems the hypothesis is rejected. The results for chronic and degen-
erative diseases are mixed. We generally reject the hypothesis of no direct
causal link from health conditions to total wealth changes but cannot rule
out confounding of the test by invariance failures.
The pattern of results suggests that incidence of acute, sudden onset
health conditions, conditioned on existing health conditions, does not ex-
hibit a signiﬁcant SES gradient, while incidence of some mental, chronic,
and degenerative conditions appear to have an association to SES due to
some combination of direct causal links and common unobserved behav-
ioral or genetic factors. The results suggest that there may be an SES gra-
dient in seeking treatment for the second class of conditions that may in-
ﬂuence detection, or for maintaining preventative regimens that may
maintain some conditions below the reporting thresholds. Our ﬁndings are
not inconsistent with the possibility that for mental and chronic illnesses
where the acute care procedures covered by Medicare are often inapplica-
ble, ability to pay may be a causal factor in seeking and receiving treat-
ment. We do not ﬁnd systematic persuasive associations of health condi-
tions and changes in total wealth, except for surviving spouses. Problems
in measuring and modeling wealth changes suggest caution in concluding
from these results that there is generally no direct causal link from health
conditions to wealth changes.
We emphasize that our results apply only to elderly individuals in the
United States, where Medicare and Medicaid programs limit out-of-
pocket medical costs, particularly for acute care, and where retired status
eliminates a possible direct causal link from health status to ability to
work. Further, in an elderly population, common factors may be manifest
in prior health conditions and economic status, so they have little impact
once incidence is conditioned on prior state. Our results provide no evi-
dence on the nature of the causal links at younger ages, during the stages
of life where association of health and wealth is emerging as a consequence
of some causal structure.
Future waves of the AHEAD (HRS) panel will allow the hypotheses of
invariance and noncausality to be tested with greater power. This will par-
ticularly be the case when full tracking of decedents, and determination of
cause of death from medical records, become part of the data. It seems
likely that some of the associations we have found between changes in
health and wealth will survive more detailed analysis, and that suitably de-
ﬁned natural or designed experiments are likely to be needed to fully un-
ravel the causal structure underlying these associations.
The modeling structure used in this paper is parametric, and the high di-
mensionality of the vector of possible explanatory variables and the rela-
tively limited information contained in binomial outcomes in the AHEAD
panel make it diﬃcult to move to a more robust nonparametric analysis.
468 P. Adams, M. D. Hurd, D. McFadden, A. Merrill, and T. RibeiroHowever, we have been ﬂexible in specifying the variable transformations
that appear in our models, and we interpret our analysis as conforming in
spirit, if hardly in fact, to a method of sieves approach to nonparametric
analysis. One of the major limitations of our models, which would be likely
to lead them to fail invariance tests in situations where a sharp test is pos-
sible, is that they do not account adequately for the multiple risk structure
of health conditions and its implications for the duration patterns that can
emerge, particularly over the relatively long intervals between waves. Some
outcomes, such as mortality and nonfatal heart disease, are competing
risks, while others, like diabetes and heart conditions, are complementary
risks. For future research, we are investigating hidden Markov models in
which a latent vector of propensities for all health and SES conditions fol-
lows a ﬁrst-order Markov process, conditioned on demographic state, and
all possible causal links across the components of this latent vector appear
in the model. Given thresholds that trigger observed states, this model pro-
vides a consistent but computationally demanding data generation process
for the vector of Markov states month-by-month. Within this model, it is
possible to carry out joint tests for the absence of classes of causal links.
The next wave of this research, incorporating wave 4 of AHEAD, will in-
clude full development of ﬂexible multiple-risk duration models.



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































.Table 11A.4 Incidence Regressions—Tests ( p-values)
Invariance
With SES Without SES
Variable Female Male Female Male
CANCER 0.5275 0.0155 0.3088 0.0071
CANCER—no previous 0.8573 0.1291 0.8116 0.0639
CANCER—previous 0.0682 0.0443 0.0789 0.0835
HEART 0.0854 0.6901 0.0517 0.6188
HEART—no previous 0.1704 0.8228 0.0604 0.4982
HEART—previous 0.5468 0.6925 0.4918 0.7248
STROKE 0.3842 0.2036 0.2663 0.1351
STROKE—no previous 0.1719 0.2584 0.1603 0.1799
STROKE—previous 0.9073 0.0448 0.7838 0.0866
MORTALITY 0.2212 0.3777 0.3153 0.4915
LUNG 0.5518 0.6892 0.4825 0.5021
DIABETES 0.1893 0.2340 0.2810 0.1282
HIGH BLOOD PRESSURE 0.0066 0.3934 0.0244 0.1718
ARTHRITIS 0.0461 0.0709 0.0319 0.1665
INCONTINENCE 0.7809 0.3505 0.5968 0.6817
INCONTINENCE—no previous 0.7057 0.1019 0.4261 0.5548
INCONTINENCE—previous 0.9620 0.7931 0.8921 0.7303
FALL 0.9035 0.2626 0.7904 0.2072
FALL—no previous 0.7918 0.1401 0.6119 0.1332
FALL—previous 0.3649 0.0000 0.3576 0.0000
HIP FRACTURE 0.4915 0.1261 0.2803 0.0530
HIP FRACTURE—no previous 0.9297 0.2997 0.7237 0.1227
PROXY INTERVIEW 0.3008 0.5908 0.4646 0.3777
PROXY INTERVIEW—no previous 0.1275 0.7948 0.4442 0.6064
COGNITIVE IMPAIRMENT 0.0053 0.2878 0.0083 0.1425
PSYCHIATRIC 0.1266 0.2949 0.0516 0.3647
DEPRESSION 0.2109 0.9437 0.2989 0.9343
BODY MASS INDEX 0.2599 0.0089 0.2511 0.0020
CURRENT SMOKER 0.4203 0.7097 0.2140 0.5042
CURRENT SMOKER—no previous 0.1331 0.0328 0.0783 0.0401
CURRENT SMOKER—previous 0.7966 0.7332
ACTIVITIES DAILY LIVING 0.0010 0.0211 0.0069 0.0377
INSTRUMENTAL ACTIVITIES 
DAILY LIVING 0.6031 0.0077 0.3883 0.0027
SELF RATED HEALTH 0.3761 0.6342 0.3408 0.6065
SELF RATED HEALTH—no previous 0.5144 0.2515 0.5578 0.2151
SELF RATED HEALTH—previous 0.2395 0.1652 0.1763 0.1886
(continued)Noncausality
Wave 1–2 Wave 2–3 Wave 1–3
Female Male Female Male Female Male
CANCER 0.9874 0.5883 0.4080 0.1653 0.6133 0.1980
CANCER—no previous 0.7038 0.6584 0.2886 0.1730 0.3130 0.1658
CANCER—previous 0.1428 0.2277 0.4719 0.0168 0.2989 0.0359
HEART 0.5398 0.0538 0.3963 0.9964 0.3978 0.2430
HEART—no previous 0.8722 0.3444 0.7495 0.4118 0.7360 0.0393
HEART—previous 0.1040 0.0707 0.1533 0.7372 0.0192 0.1716
STROKE 0.7567 0.8367 0.5845 0.0278 0.6573 0.0593
STROKE—no previous 0.4147 0.9546 0.6708 0.0639 0.7128 0.2035
STROKE—previous 0.8239 0.3012 0.8819 0.1548 0.7986 0.3827
MORTALITY 0.0980 0.2753 0.8830 0.3056 0.6516 0.3636
LUNG 0.1657 0.1739 0.8663 0.1224 0.3431 0.0097
DIABETES 0.6152 0.1413 0.0197 0.2361 0.1096 0.0250
HIGH BLOOD PRESSURE 0.3422 0.9956 0.0831 0.9409 0.5339 0.9897
ARTHRITIS 0.1786 0.0285 0.2423 0.7129 0.0848 0.3947
INCONTINENCE 0.7627 0.0191 0.2536 0.7999 0.1628 0.4632
INCONTINENCE—no previous 0.9140 0.0369 0.6018 0.1970 0.4530 0.6408
INCONTINENCE—previous 0.8996 0.2471 0.1675 0.6643 0.1490 0.2440
FALL 0.5325 0.6875 0.953 0.4539 0.6003 0.5918
FALL—no previous 0.5015 0.6973 0.9435 0.2509 0.5576 0.5321
FALL—previous 0.3286 0.0000 0.8034 0.0000 0.6959 0.0529
HIP FRACTURE 0.6125 0.5974 0.3700 0.6656 0.1586 0.4304
HIP FRACTURE—no previous 0.4606 0.4610 0.7058 0.7249 0.1277 0.2344
PROXY INTERVIEW 0.0172 0.4856 0.8700 0.1267 0.2540 0.0317
PROXY INTERVIEW—no previous 0.0016 0.7935 0.5408 0.1207 0.0874 0.0732
COGNITIVE IMPAIRMENT 0.0007 0.2587 0.2591 0.1995 0.0016 0.0262
PSYCHIATRIC 0.0428 0.2376 0.2138 0.0685 0.0036 0.0649
DEPRESSION 0.0071 0.1433 0.2605 0.3770 0.0113 0.0653
BODY MASS INDEX 0.1876 0.8388 0.9308 0.7108 0.6729 0.6640
CURRENT SMOKER 0.6031 0.2821 0.9741 0.6927 0.6251 0.1286
CURRENT SMOKER—no previous 0.3355 0.1965 0.8744 0.9802 0.5148 0.9615
CURRENT SMOKER—previous 0.3750 0.3248 0.5473 0.3248 0.2736 0.0249
ACTIVITIES DAILY LIVING 0.0771 0.0137 0.3460 0.9714 0.8278 0.3577
INSTRUMENTAL ACTIVITIES 
DAILY LIVING 0.3738 0.0510 0.8166 0.2426 0.2408 0.0085
SELF RATED HEALTH 0.0133 0.0476 0.0996 0.3006 0.0013 0.0204
SELF RATED HEALTH—no previous 0.0149 0.1874 0.2022 0.1210 0.0071 0.0337
SELF RATED HEALTH—previous 0.2250 0.1955 0.5565 0.2555 0.1934 0.1752
Table 11A.4 (continued)Joint (Invariance 
  Noncausality)
Relative Odds (high vs. low SES)
Female Male
Female Male Odds SE Odds SE
CANCER 0.5999 0.0124 1.3099 0.4606 0.7316 0.2699
CANCER—no previous 0.7778 0.0844 1.2423 0.4835 0.6733 0.2934
CANCER—previous 0.0666 0.0110 5.8494 7.7533 2.6866 3.4206
HEART 0.0986 0.5708 0.9739 0.2107 1.0196 0.2379
HEART—no previous 0.2780 0.4464 0.8190 0.2525 1.3003 0.5022
HEART—previous 0.1686 0.5161 1.1323 0.3180 0.8778 0.2629
STROKE 0.4812 0.0800 0.7308 0.2537 0.9363 0.3517
STROKE—no previous 0.2711 0.1893 0.6787 0.2666 0.8182 0.3603
STROKE—previous 0.9477 0.0537 1.1538 0.9298 1.6050 1.2472
MORTALITY 0.3076 0.3596 0.6881 0.2069 1.1677 0.4066
LUNG 0.5039 0.2032 0.3272 0.1731 0.5043 0.4315
DIABETES 0.1013 0.0622 0.6932 0.4119 1.4837 3.1948
HIGH BLOOD PRESSURE 0.0127 0.6660 0.8959 0.2884 0.7425 0.3568
ARTHRITIS 0.0204 0.0816 1.0309 0.2177 0.5433 0.1596
INCONTINENCE 0.6148 0.3733 0.8501 0.1268 1.1093 0.3031
INCONTINENCE—no previous 0.6954 0.1583 0.7738 0.1983 1.0196 0.3574
INCONTINENCE—previous 0.8574 0.6836 0.9398 0.0903 1.1258 0.2871
FALL 0.9133 0.3285 0.9845 0.1947 0.9228 0.3132
FALL—no previous 0.8079 0.1809 1.0259 0.2536 0.8638 0.3220
FALL—previous 0.4700 0.0000 1.0032 0.2718 89.6130 267.8210
HIP FRACTURE 0.3475 0.1434 0.3270 0.2205 0.2096 0.2770
HIP FRACTURE—no previous 0.7845 0.2381 0.2289 0.1690 0.1397 0.1924
PROXY INTERVIEW 0.2482 0.2610 0.4587 0.1610 0.4756 0.1750
PROXY INTERVIEW—no previous 0.0610 0.5310 0.2666 0.1094 0.3992 0.2009
COGNITIVE IMPAIRMENT 0.0002 0.0888 0.7795 0.1721 0.5920 0.1852
PSYCHIATRIC 0.0123 0.1372 0.3942 0.1529 0.1589 0.1243
DEPRESSION 0.0422 0.7534 0.3753 0.1453 0.2856 0.1530
BODY MASS INDEX 0.3452 0.0190
CURRENT SMOKER 0.4918 0.5276 0.4609 0.3702 0.9187 1.1083
CURRENT SMOKER—no previous 0.1652 0.0970 0.1055 0.1581 19.9184 132.7460
CURRENT SMOKER—previous 0.7141 0.9262 0.1595 0.9499 0.1758
ACTIVITIES DAILY LIVING 0.0036 0.0240
INSTRUMENTAL ACTIVITIES 
DAILY LIVING 0.5089 0.0008
SELF RATED HEALTH 0.0444 0.2784 0.6749 0.0780 0.6445 0.0919
SELF RATED HEALTH—no previous 0.1380 0.0907 0.5892 0.1224 0.5066 0.1290
SELF RATED HEALTH—previous 0.1773 0.1159 0.8500 0.0754 0.9227 0.0824
Notes: SE   standard error. NC = nonconvergence.
Table 11A.4 (continued)Table 11A.5 Total Wealth Regressions—(t-statistics)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statistic
XONE1 0.0610 12.72 0.0917 5.35 0.0552 4.70
XONE2 0.0487 9.94 0.0755 3.46 0.0430 3.45
XLWLTH12 –0.0528 –10.98 –0.530 –4.23 –0.0503 –7.93
XNWLTH12 –0.0673 –8.23 –0.1033 –5.61 –0.0629 –5.52
XQ1I12 –0.0037 –3.88 –0.0052 –1.58 –0.0014 –0.53
XQ4I12 0.0098 6.98 0.0040 0.58 0.0066 2.68
XHOODPF12 –0.0001 –0.05 0.0066 1.59 0.0030 1.02
XCONDPF12 –0.0031 –2.48 –0.0027 –0.52 0.0000 0.01
XDNHOUS12 0.0085 5.29 0.0124 2.74 0.0015 0.66
M_XHS12 0.0007 0.79 0.0019 0.51 0.0035 1.67
M_XCOLL12 0.0008 0.57 0.0034 0.62 0.0034 0.86
M_XAS701S 0.0000 1.69 0.0001 0.67 0.0001 1.94
M_XAS801S 0.0000 –0.80 0.0000 0.05 –0.0001 –1.29
M_XAS702S 0.0000 1.22 0.0000 –0.37 0.0001 1.82




M_XMAGEDI12 0.0000 1.24 –0.0001 –1.06 0.0000 –0.89
M_XPAGEDI12 0.0000 –0.10 0.0001 0.86 –0.0001 –1.40
M_XSMOKEV12 –0.0012 –1.17 –0.0046 –1.40 0.0012 0.44
M_XCANCER12 0.0003 0.24 0.0025 0.76 0.0004 0.15
M_XHEART12 –0.0004 –0.45 0.0009 0.28 –0.0007 –0.33
M_XSTROKE12 –0.0003 –0.16 –0.0024 –0.47 –0.0015 –0.49
M_XLUNG12 0.0039 2.15 –0.0057 –1.51 –0.0009 –0.33
M_XDIABET12 –0.0013 –1.13 –0.0004 –0.11 0.0024 0.91
M_XHIGHBP12 –0.0003 –0.36 0.0035 1.19 –0.0002 –0.09
M_XARTHRT12 –0.0007 –0.56 0.0015 0.41 –0.0011 –0.54
M_XINCONT12 0.0012 0.87 –0.0061 –1.77 –0.0008 –0.30
M_XFALL12 –0.0018 –1.26 –0.0021 –0.39 –0.0051 –0.151
M_XHIPFRC12 –0.0029 –0.84 0.0042 0.57 0.0059 1.49
M_XPROXYW12 –0.0004 –0.20 –0.0027 –0.69 0.0055 1.04
M_XCOGIM12 0.0011 0.88 –0.0048 –1.69 –0.0024 –1.10
M_XPSYCH12 –0.0012 –0.61 0.0055 1.25 0.0015 0.43
M_XDEPRES12 –0.0001 –0.02 0.0033 0.69 –0.0015 –0.54
M_XLOBMI12 –0.0009 –0.20 –0.0002 –0.09 0.0020 0.99
M_XHIBMI12 0.0000 0.25 0.0002 0.44 –0.0003 –0.88
M_XSMOKNOW12 –0.0029 –1.71 –0.0030 –0.54 –0.0045 –1.59
M_XNUMADL12 0.0001 0.17 –0.0001 –0.03 –0.0010 –1.05
M_XNUMIADL12 –0.0010 –0.93 0.0002 0.05 0.0014 1.16
M_XDHLTH12 0.0000 –0.04 0.0022 0.53 0.0039 1.62
M_XJCANCER23 0.0007 0.22 0.0011 0.10 0.0091 2.21
M_XJHEART23 0.0007 0.29 –0.0023 –0.19 0.0029 1.00
M_XJSTROKE23 0.0043 1.22 –0.0024 –0.22 0.0051 1.33
M_XILUNG23 –0.0021 –1.08 –0.0051 –0.35 –0.0033 –1.22
M_XIDIABET23 –0.0012 –0.48 0.0250 1.94 –0.0015 –0.35
M_XIHIGHBP23 –0.0006 –0.18 –0.0174 –1.15 0.0009 0.34
M_XIARTHRT23 –0.0008 –0.53 –0.0016 –0.25 –0.0020 –0.67M_XJINCONT23 –0.0006 –0.39 0.0015 0.17 0.0007 0.31
M_XJFALL23 0.0003 0.24 0.0048 0.34 –0.0029 –1.30
M_XJHIPFRC23 –0.0044 –0.57 –0.0006 –0.02 –0.0009 –0.14
M_XPROXYW23 –0.0005 –0.29 0.0017 0.20 –0.0010 –0.27
M_XICOGIM23 0.0001 0.06 –0.0057 –0.48 0.0020 0.84
M_XIPSYCH23 –0.0003 –0.18 0.0008 0.06 0.0046 1.54
M_XIDEPRES23 –0.0016 –0.72 0.0009 0.11 –0.0032 –1.07
M_XBMIBT23 0.0004 0.36 –0.0020 –0.26 0.0022 1.14
M_XBMIWS23 –0.0013 –1.00 –0.0031 –0.34 0.0008 0.39
M_XSMOKNOW23 0.0040 2.08 –0.0069 –0.38 –0.0006 –0.24
M_XNUMADL23 –0.0001 –0.12 –0.0055 –1.63 –0.0003 –0.56
M_XNUMIADL23 0.0004 0.41 0.0006 0.20 –0.0008 –1.06










F_XHS12 0.0008 0.75 0.0069 1.66 0.0016 2.16
F_XCOLL12 0.0019 1.34 0.0029 0.49 0.0026 1.80
F_XAS701S 0.0000 1.14 –0.0001 –0.83 0.0000 –0.09
F_XAS801S –0.0001 –0.75 0.0000 0.04 0.0000 0.04
F_XAS702S 0.0000 –1.88 0.0000 0.66 0.0000 –0.35




F_XMAGEDI12 0.0000 1.08 0.0000 –0.02 0.0000 0.44
F_XPAGEDI12 0.0000 –0.79 0.0000 –0.40 0.0000 –0.47
F_XSMOKEV12 0.0024 2.58 0.0007 0.17 0.0007 0.88
F_XCANCER12 –0.0012 –0.87 –0.0049 –0.86 –0.0007 –0.69
F_XHEART12 0.0002 0.21 –0.0025 –0.77 –0.0010 –1.42
F_XSTROKE12 –0.0010 –0.52 0.0021 0.29 –0.0002 –0.20
F_XLUNG12 0.0002 0.10 –0.0033 –0.71 –0.0015 –1.48
F_XDIABET12 –0.0027 –1.99 0.0041 0.86 –0.0018 –1.89
F_XHIGHBP12 0.0006 0.61 0.0047 1.55 –0.0010 –1.35
F_XARTHRT12 0.0008 0.73 –0.0018 –0.40 0.0004 0.44
F_XINCONT12 –0.0013 –1.01 0.0001 0.03 0.0006 0.66
F_XFALL12 0.0001 0.09 –0.0002 –0.05 0.0010 0.99
F_XHIPFRC12 0.0011 0.33 0.0018 0.28 –0.0005 –0.40
F_XPROXYW12 –0.0013 –0.40 –0.0013 –0.20 –0.0004 –0.25
F_XCOGIM12 –0.0003 –0.17 –0.0050 –1.11 –0.0023 –2.70
(continued)
Table 11A.5 (continued)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statisticF_XPSYCH12 –0.0005 –0.44 0.0007 0.14 –0.0010 –0.97
F_XDEPRES12 –0.0016 –0.91 –0.0012 –0.24 –0.0007 –0.61
F_XLOBMI12 0.0007 0.34 0.0013 0.58 0.0001 0.10
F_XHIBMI12 –0.0003 –1.79 –0.0011 –2.61 –0.0002 –1.47
F_XSMOKNOW12 –0.0014 –0.60 –0.0013 –0.20 –0.0026 –1.48
F_XNUMADL12 0.0013 1.58 0.0015 0.63 –0.0005 –1.64
F_XNUMIADL12 0.0002 0.20 –0.0016 –1.00 –0.0006 –1.37
F_XDHLTH12 0.0002 0.15 –0.0012 –0.21 –0.0004 –0.44
F_XJCANCER23 0.0019 0.71 –0.0002 –0.01 –0.0077 –3.19
F_XJHEART23 0.0033 1.69 –0.0045 –0.80 –0.0023 –2.00
F_XJSTROKE23 0.0041 1.77 –0.0185 –2.60 –0.0034 –1.98
F_XILUNG23 0.0044 1.15 –0.0039 –0.49 –0.0004 –0.26
F_XIDIABET23 –0.0011 –0.37 –0.0002 –0.03 0.0000 0.02
F_XIHIGHBP23 0.0023 1.09 0.0010 0.15 0.0001 0.06
F_XIARTHRT23 0.0012 0.81 0.0029 0.44 0.0010 1.09
F_XJINCONT23 0.0024 2.50 –0.0009 –0.24 0.0011 1.37
F_XJFALL23 –0.0011 –0.60 –0.0036 –0.75 0.0003 0.35
F_XJHIPFRC23 0.0010 0.27 0.0067 0.82 0.0006 0.036
F_XPROXYW23 –0.0017 –0.67 –0.0036 –0.52 –0.0011 –0.82
F_XICOGIM23 –0.0001 –0.05 –0.0023 –0.48 –0.0024 –2.42
F_XIPSYCH23 –0.0014 –0.70 –0.0158 –2.49 0.0012 0.93
F_XIDEPRES23 –0.0026 –1.52 0.0005 0.07 –0.0011 –0.78
F_XBMIBT23 0.0006 0.39 0.0017 0.34 –0.0001 –0.19
F_XBMIWS23 –0.0001 –0.10 0.0013 0.22 0.0001 0.11
F_XSMOKNOW23 –0.0038 –1.56 0.0013 0.13 0.0012 0.70
F_XNUMADL23 –0.0002 –0.33 0.0020 1.22 –0.0002 –0.93
F_XNUMIADL23 0.0006 0.73 –0.0014 –0.65 –0.0003 –0.84
F_XDHLTH23 –0.0032 –2.68 –0.0028 –0.60 –0.0003 –0.33
CF4 –0.2411 –0.18 –0.2411 –0.18 –0.0128 –0.27
CF3 –1.1433 –1.38 –1.1433 –1.38 0.5102 6.01
CM4 0.1903 1.40 0.1903 1.40 –0.1306 –1.97
CM3 –0.3582 –2.24 –0.3582 –2.24 –0.4368 –3.62
AM –0.0025 –1.87 0.0012 2.80 –0.0076 –4.39
AF –0.0008 –0.30 0.0004 0.45 –0.0019 –10.04
C 0.0000 21.10 0.0000 7.74 0.0000 6.11
VARM 0.0000 –0.88 0.0000 –0.89 0.0000 –0.81
VARF 0.0000 –2.53 0.0000 1.20 0.0000 0.48
SIGMA 0.0043 42.20 0.0000 7.74 0.0088 6.12
THETA 2.4733 19.10
RHOM –0.4882 –6.31 –0.8641 –17.28
RHOF –0.1606 –3.11 –0.2103 –5.32
Notes: Preﬁxes M_ and F_ refer to males and females, respectively. For couples and spouse died regres-
sions household-level variables are common for males and females. We report the estimates under the
male section. CF3, CF4   third/fourth order Edgeworth expansion terms for females; CM3, CM4  
third/fourth order Edgeworth expansion terms for males; AF, AM  estimates of  in equations (15) and
(19); C  estimate of k2in equation (16); VARM, VARF  estimates of  2in equation (16) for males and
females; SIGMA   estimate of   as deﬁned in page 440 of paper; THETA   estimate of   in equation
(19); RHOF, RHOM   estimate of   as deﬁned in page 442 of paper.
Table 11A.5 (continued)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statisticTable 11A.6 Nonliquid Wealth Regressions—(t-statistics)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statistic
XONE1 0.0582 14.64 0.0752 4.68 0.0482 4.74
XONE2 0.0459 11.33 0.0655 3.13 0.0438 3.94
XLWLTH12 0.0046 1.03 0.0041 0.40 0.0128 2.56
XNWLTH12 –0.1311 –15.98 –0.1646 –8.65 –0.1138 –8.91
XQ1I12 –0.0010 –1.19 –0.0011 –0.37 –0.0012 –0.50
XQ4I12 0.0021 2.17 0.0032 0.53 0.0015 0.66
XHOODPF12 –0.0017 –1.47 0.0050 1.27 0.0002 0.07
XCONDPF12 –0.0014 –1.19 –0.0008 –0.17 –0.0001 –0.03
XDNHOUS12 0.0068 4.45 0.0074 1.80 0.0013 0.50
M_XHS12 0.0000 0.04 0.0005 0.14 0.0010 0.47
M_XCOLL12 0.0000 –0.01 0.0021 0.44 –0.0008 –0.25
M_XAS701S 0.0000 0.22 0.0001 0.82 0.0001 2.71
M_XAS801S –0.0001 –1.73 –0.0001 –0.43 –0.0001 –1.88
M_XAS702S 0.0000 0.48 0.0000 0.10 0.0001 2.01




M_XMAGEDI12 0.0000 0.33 –0.0001 –1.63 –0.0001 –1.64
M_XPAGEDI12 0.0000 0.23 0.0000 0.37 –0.0001 –1.20
M_XSMOKEV12 –0.0011 –1.33 –0.0044 –1.36 –0.0016 –0.67
M_XCANCER12 –0.0004 –0.35 0.0037 1.44 0.0032 1.20
M_XHEART12 0.0003 0.36 –0.0011 –0.42 0.0002 0.10
M_XSTROKE12 0.0015 0.83 –0.0013 –0.29 0.0012 0.44
M_XLUNG12 0.0022 1.30 –0.0018 –0.50 0.0001 0.05
M_XDIABET12 –0.0019 –1.89 0.0024 0.83 0.0044 1.87
M_XHIGHBP12 –0.0005 –0.71 0.0041 1.52 0.0007 0.37
M_XARTHRT12 0.0019 1.62 0.0052 1.52 –0.0012 –0.60
M_XINCONT12 0.0004 0.33 –0.0040 –1.48 –0.0034 –1.29
M_XFALL12 –0.0002 –0.14 –0.0025 –0.50 –0.0059 –1.90
M_XHIPFRC12 –0.0015 –0.48 0.0068 0.91 0.0100 2.32
M_XPROXYW12 0.0025 1.43 –0.0049 –1.35 0.0057 1.14
M_XCOGIM12 0.0024 2.07 –0.0018 –0.71 0.0017 0.81
M_XPSYCH12 –0.0007 –0.41 –0.0058 –1.62 0.0009 0.35
M_XDEPRES12 0.0018 0.48 –0.0027 –0.65 0.0018 0.57
M_XLOBMI12 0.0010 0.21 –0.0025 –1.25 0.0061 2.21
M_XHIBMI12 0.0003 2.04 0.0002 0.32 –0.0003 –0.70
M_XSMOKNOW12 –0.0006 –0.44 0.0006 0.10 –0.0050 –1.98
M_XNUMADL12 –0.0002 –0.24 0.0010 0.49 0.0004 0.51
M_XNUMIADL12 –0.0013 –1.31 0.0007 0.22 0.0008 0.76
M_XDHLTH12 –0.0017 –1.53 –0.0029 –0.81 0.0033 1.37
M_XJCANCER23 0.0012 0.42 0.0022 0.22 0.0170 3.07
M_XJHEART23 0.0020 0.93 0.0046 0.40 0.0097 2.51
M_XJSTROKE23 0.0024 0.69 –0.0077 –0.65 0.0066 1.62
M_XILUNG23 –0.0025 –1.54 –0.0010 –0.07 –0.0062 –2.39
M_XIDIABET23 0.0001 0.06 0.0212 2.97 –0.0003 –0.07
(continued)M_XIHIGHBP23 –0.0025 –0.80 –0.0254 –1.90 0.0004 0.16
M_XIARTHRT23 –0.0010 –0.80 0.0058 0.96 –0.0023 –0.82
M_XJINCONT23 0.0000 0.00 –0.0069 –0.97 0.0014 0.78
M_XJFALL23 0.0000 0.01 –0.0034 –0.23 –0.0009 –0.49
M_XJHIPFRC23 –0.0038 –0.50 0.0221 0.91 –0.0040 –1.09
M_XPROXYW23 0.0002 0.11 –0.0017 –0.23 0.0012 0.34
M_XICOGIM23 0.0008 0.59 –0.0026 –0.20 –0.0013 –0.70
M_XIPSYCH23 –0.0004 –0.27 0.0027 0.28 0.0036 1.37
M_XIDEPRES23 –0.0007 –0.36 –0.0088 –1.15 –0.0001 –0.04
M_XBMIBT23 –0.0001 –0.15 –0.0057 –0.86 0.0005 0.31
M_XBMIWS23 –0.0004 –0.29 –0.0078 –0.97 0.0014 0.78
M_XSMOKNOW23 0.0015 0.97 –0.0128 –0.64 0.0038 1.72
M_XNUMADL23 0.0004 0.53 –0.0070 –2.30 –0.0005 –0.87
M_XNUMIADL23 –0.0002 –0.15 0.0037 1.36 –0.0008 –1.17










F_XHS12 0.0004 0.41 0.0034 0.89 0.0001 0.21
F_XCOLL12 0.0005 0.44 0.0095 1.88 0.0016 1.36
F_XAS701S 0.0000 –0.51 0.0000 –0.32 0.0000 –1.70
F_XAS801S 0.0000 0.69 –0.0001 –0.81 0.0000 0.28
F_XAS702S 0.0000 –0.45 0.0000 0.45 0.0000 –1.09




F_XMAGEDI12 0.0000 0.64 0.0000 0.73 0.0000 0.74
F_XPAGEDI12 0.0000 –0.31 0.0000 0.32 0.0000 0.47
F_XSMOKEV12 –0.0003 –0.40 –0.0025 –0.63 0.0001 0.20
F_XCANCER12 0.0007 0.57 –0.0052 –1.00 0.0001 0.07
F_XHEART12 –0.0009 –0.89 –0.0046 –1.51 –0.0006 –0.96
F_XSTROKE12 0.0029 1.83 0.0010 0.13 –0.0005 –0.44
F_XLUNG12 0.0000 –0.01 –0.0008 –0.20 –0.0012 –1.45
F_XDIABET12 –0.0002 –0.13 0.0064 1.36 –0.0012 –1.38
F_XHIGHBP12 0.0001 0.15 0.0046 1.82 –0.0014 –2.16
F_XARTHRT12 –0.0002 –0.18 0.0029 0.68 0.0004 0.59
F_XINCONT12 0.0000 –0.02 –0.0014 –0.42 0.0000 0.02
F_XFALL12 0.0005 0.33 0.0012 0.31 0.0010 1.12
F_XHIPFRC12 0.0039 1.29 –0.0018 –0.33 –0.0008 –0.69
F_XPROXYW12 –0.0007 –0.24 –0.0011 –0.19 –0.0005 –0.32
Table 11A.6 (continued)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statisticF_XCOGIM12 0.0005 0.33 –0.0043 –1.04 –0.0014 –1.70
F_XPSYCH12 0.0000 –0.01 0.0033 0.66 –0.0013 –1.48
F_XDEPRES12 0.0006 0.40 –0.0025 –0.51 –0.0008 –0.83
F_XLOBMI12 0.0017 0.90 0.0004 0.20 –0.0004 –1.16
F_XHIBMI12 0.0000 0.17 –0.0012 –3.19 –0.0001 –0.87
F_XSMOKNOW12 –0.0004 –0.18 0.0038 0.61 –0.0033 –2.14
F_XNUMADL12 0.0001 0.18 0.0011 0.49 –0.0004 –1.28
F_XNUMIADL12 0.0008 0.89 0.0000 0.00 0.0003 0.89
F_XDHLTH12 0.0006 0.47 –0.0011 –0.21 –0.0008 –1.00
F_XJCANCER23 –0.0010 –0.46 0.0028 0.33 –0.0063 –2.60
F_XJHEART23 0.0007 0.38 –0.0039 –0.79 –0.0019 –1.76
F_XJSTROKE23 0.0015 0.83 –0.0032 –0.44 –0.0022 –1.33
F_XILUNG23 0.0060 1.74 –0.0070 –1.11 –0.0019 –1.41
F_XIDIABET23 –0.0028 –1.41 –0.0050 –0.58 –0.0005 –0.31
F_XIHIGHBP23 0.0002 0.09 –0.0009 –0.15 0.0002 0.14
F_XIARTHRT23 0.0004 0.27 0.0001 0.01 0.0010 1.14
F_XJINCONT23 0.0007 0.86 –0.0006 –0.17 0.0005 0.78
F_XJFALL23 –0.0006 –0.32 –0.0042 –1.04 –0.0005 –0.73
F_XJHIPFRC23 –0.0045 –1.86 –0.0025 –0.39 –0.0003 –0.23
F_XPROXYW23 0.0006 0.23 –0.0043 –0.61 –0.0008 –0.61
F_XICOGIM23 –0.0007 –0.41 –0.0016 –0.34 –0.0016 –1.98
F_XIPSYCH23 –0.0005 –0.28 –0.0047 –0.65 –0.0001 –0.08
F_XIDEPRES23 0.0007 0.42 –0.0041 –0.65 –0.0010 –0.88
F_XBMIBT23 0.0033 0.24 0.0044 1.00 0.0024 0.61
F_XBMIWS23 0.0001 0.06 0.0026 0.44 –0.0004 –0.62
F_XSMOKNOW23 –0.0013 –0.56 –0.0075 –0.88 0.0033 2.22
F_XNUMADL23 –0.0006 –0.91 0.0019 1.06 –0.0003 –1.45
F_XNUMIADL23 0.0002 0.22 –0.0021 –1.02 –0.0007 –2.34
F_XDHLTH23 –0.0027 –2.52 0.0032 0.76 0.0005 0.65
CF4 0.1230 0.09 0.1230 0.09 0.0191 0.36
CF3 –0.2322 –0.28 –0.2322 –0.28 0.4650 4.71
CM4 0.1776 1.30 0.1776 1.30 –0.1248 –2.74
CM3 –0.2742 –1.71 –0.2742 –1.71 –0.3308 –3.87
AM –0.0015 –1.16 0.0006 2.09 –0.0118 –3.52
AF –0.0004 –0.15 0.0001 0.30 –0.0015 –7.26
C 0.0000 23.59 0.0000 0.00 0.0000 5.84
VARM 0.0000 1.34 0.0000 0.00 0.0000 –0.56
VARF 0.0000 –0.12 0.0000 0.00 0.0000 –0.23
SIGMA 0.0041 47.19 0.0000 0.00 0.0125 4.00
THETA 2.3623 11.32
RHOM –0.3532 –3.29 –0.9434 –31.26
RHOF –0.0939 –1.65 –0.1164 –3.53
Notes: See table 11A.5.
Table 11A.6 (continued)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statisticTable 11A.7 Liquid Wealth Regressions—(t-statistics)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statistic
XONE1 0.0819 12.94 0.1150 5.73 0.0802 5.66
XONE2 0.0705 10.88 0.1021 4.35 0.0652 4.39
XLWLTH12 –0.1474 –22.15 –0.1581 –9.33 –0.1583 –13.68
XNWLTH12 0.0222 2.68 0.0058 0.42 0.0272 2.55
XQ1I12 –0.0077 –6.24 –0.0100 –2.50 –0.0012 –0.43
XQ4I12 0.0103 5.38 0.0032 0.40 0.0108 3.44
XHOODPF12 –0.0014 –0.86 0.0069 1.31 0.0032 0.91
XCONDPF12 –0.0038 –2.58 –0.0066 –1.20 0.0010 0.30
XDNHOUS12 0.0008 0.47 0.0104 2.36 –0.0007 –0.25
M_XHS12 0.0003 0.28 0.0044 1.00 0.0037 1.46
M_XCOLL12 0.0016 0.83 0.0061 0.88 0.0080 1.53
M_XAS701S 0.0000 0.85 –0.0001 –1.13 0.0000 0.67
M_XAS801S 0.0000 0.90 0.0003 1.62 0.0000 0.42
M_XAS702S 0.0000 0.12 –0.0001 –0.90 0.0001 1.12




M_XMAGEDI12 0.0000 0.86 0.0000 –0.36 0.0000 –0.03
M_XPAGEDI12 0.0000 –0.34 0.0000 –0.16 –0.0001 –1.02
M_XSMOKEV12 0.0007 0.49 –0.0026 –0.68 0.0016 0.52
M_XCANCER12 0.0027 1.72 0.0011 0.28 –0.0002 –0.08
M_XHEART12 –0.0007 –0.63 –0.0042 –1.11 –0.0007 –0.28
M_XSTROKE12 0.0013 0.55 –0.0051 –0.92 –0.0036 –1.06
M_XLUNG12 0.0045 2.16 –0.0056 –1.22 –0.0047 –1.76
M_XDIABET12 –0.0023 –1.47 –0.0059 –1.39 –0.0015 –0.46
M_XHIGHBP12 0.0011 0.98 0.0021 0.66 –0.0017 –0.71
M_XARTHRT12 –0.0039 –2.48 0.0024 0.56 0.0002 0.09
M_XINCONT12 –0.0003 –0.15 –0.0015 –0.35 0.0005 0.19
M_XFALL12 –0.0025 –1.12 0.0076 1.22 –0.0007 –0.22
M_XHIPFRC12 –0.0021 –0.57 –0.0069 –0.81 0.0005 0.11
M_XPROXYW12 –0.0022 –1.00 0.0030 0.63 0.0006 0.13
M_XCOGIM12 –0.0002 –0.11 –0.0089 –2.49 –0.0070 –2.77
M_XPSYCH12 0.0004 0.17 0.0087 1.47 0.0044 1.07
M_XDEPRES12 –0.0064 –1.55 0.0109 1.99 –0.0034 –1.05
M_XLOBMI12 –0.0003 –0.05 0.0008 0.34 0.0024 0.95
M_XHIBMI12 –0.0003 –1.56 0.0012 1.76 0.0001 0.27
M_XSMOKNOW12 –0.0021 –0.85 –0.0057 –0.96 0.0002 0.05
M_XNUMADL12 0.0014 1.57 –0.0020 –0.89 –0.0011 –1.02
M_XNUMIADL12 –0.0022 –1.90 0.0005 0.14 0.0001 0.09
M_XDHLTH12 0.0031 2.01 0.0052 1.15 0.0030 1.10
M_XJCANCER23 0.0011 0.32 0.0015 0.11 –0.0010 –0.24
M_XJHEART23 0.0032 1.30 –0.0052 –0.45 0.0003 0.10
M_XJSTROKE23 0.0012 0.30 0.0079 0.71 0.0045 1.09
M_XILUNG23 0.0004 0.15 –0.0257 –1.76 –0.0024 –0.61
M_XIDIABET23 –0.0030 –0.90 0.0105 0.84 –0.0007 –0.11
M_XIHIGHBP23 0.0026 0.68 0.0003 0.02 –0.0064 –1.59M_XIARTHRT23 –0.0011 –0.59 –0.0086 –1.40 –0.0046 –1.53
M_XJINCONT23 –0.0005 –0.25 0.0043 0.50 –0.0023 –0.92
M_XJFALL23 0.0021 1.05 0.0224 1.55 –0.0033 –1.05
M_XJHIPFRC23 –0.0075 –0.94 –0.0264 –1.00 0.0093 0.97
M_XPROXYW23 –0.0018 –0.83 0.0069 0.86 –0.0038 –1.12
M_XICOGIM23 –0.0008 –0.47 –0.0046 –0.41 0.0008 0.28
M_XIPSYCH23 0.0010 0.51 –0.0156 –0.74 0.0071 1.86
M_XIDEPRES23 0.0009 0.32 0.0041 0.55 –0.0053 –1.24
M_XBMIBT23 –0.0027 –2.02 –0.0038 –0.50 0.0004 0.15
M_XBMIWS23 –0.0038 –2.47 –0.0055 –0.53 –0.0014 –0.55
M_XSMOKNOW23 0.0020 0.68 0.0047 0.25 –0.0082 –2.11
M_XNUMADL23 –0.0004 –0.46 –0.0011 –0.37 –0.0006 –0.86
M_XNUMIADL23 0.0003 0.28 –0.0077 –2.41 0.0004 0.42










F_XHS12 0.0022 1.55 0.0103 2.16 0.0025 2.84
F_XCOLL12 0.0027 1.35 –0.0007 –0.09 0.0036 1.96
F_XAS701S 0.0001 2.35 0.0000 0.33 0.0000 0.55
F_XAS801S –0.0002 –2.04 –0.0002 –0.82 0.0000 0.15
F_XAS702S 0.0000 –1.16 –0.0001 –0.79 0.0000 1.63




F_XMAGEDI12 0.0000 0.71 0.0000 –0.39 0.0000 0.66
F_XPAGEDI12 0.0000 –1.31 –0.0001 –1.07 0.0000 0.36
F_XSMOKEV12 0.0034 2.76 0.0063 1.38 0.0011 1.10
F_XCANCER12 –0.0019 –1.10 –0.0024 –0.38 –0.0010 –0.82
F_XHEART12 –0.0006 –0.41 0.0038 1.01 0.0001 0.15
F_XSTROKE12 –0.0013 –0.52 0.0032 0.43 –0.0009 –0.67
F_XLUNG12 –0.0001 –0.03 –0.0068 –1.28 –0.0011 –0.85
F_XDIABET12 –0.0028 –1.66 –0.0027 –0.51 –0.0015 –1.27
F_XHIGHBP12 –0.0010 –0.82 0.0094 2.55 –0.0006 –0.63
F_XARTHRT12 0.0019 1.43 –0.0053 –1.13 –0.0005 –0.55
F_XINCONT12 0.0004 0.22 0.0012 0.26 –0.0003 –0.29
F_XFALL12 0.0026 1.28 0.0000 0.01 0.0003 0.27
F_XHIPFRC12 0.0034 0.89 –0.0001 –0.01 0.0030 1.80
(continued)
Table 11A.7 (continued)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statisticF_XPROXYW12 –0.0023 –0.62 –0.0017 –0.25 –0.0032 –1.54
F_XCOGIM12 –0.0011 –0.56 –0.0064 –1.24 –0.0034 –3.27
F_XPSYCH12 –0.0015 –0.99 –0.0009 –0.15 0.0017 1.31
F_XDEPRES12 –0.0016 –0.74 0.0031 0.56 –0.0020 –1.59
F_XLOBMI12 –0.0006 –0.31 0.0021 0.96 0.0002 0.32
F_XHIBMI12 –0.0005 –2.31 –0.0005 –0.88 –0.0003 –2.14
F_XSMOKNOW12 –0.0016 –0.43 –0.0136 –1.83 –0.0035 –1.71
F_XNUMADL12 0.0023 2.35 0.0005 0.20 –0.0006 –1.44
F_XNUMIADL12 0.0006 0.48 –0.0046 –2.31 –0.0011 –2.45
F_XDHLTH12 –0.0019 –1.13 0.0003 0.05 –0.0006 –0.60
F_XJCANCER23 0.0073 2.04 –0.0026 –0.21 –0.0066 –2.41
F_XJHEART23 0.0029 1.36 –0.0038 –0.57 –0.0024 –1.77
F_XJSTROKE23 0.0012 0.45 –0.0235 –2.53 –0.0041 –2.04
F_XILUNG23 –0.0052 –1.48 –0.0040 –0.32 0.0012 0.62
F_XIDIABET23 –0.0050 –1.26 0.0031 0.28 0.0012 0.54
F_XIHIGHBP23 –0.0024 –0.93 0.0024 0.32 –0.0007 –0.44
F_XIARTHRT23 0.0015 0.79 0.0077 1.14 0.0006 0.46
F_XJINCONT23 0.0034 2.59 0.0041 0.86 0.0017 1.71
F_XJFALL23 –0.0010 –0.48 –0.0074 –1.16 0.0017 1.56
F_XJHIPFRC23 0.0034 0.69 0.0198 1.68 –0.0005 –0.26
F_XPROXYW23 –0.0015 –0.50 –0.0001 –0.01 –0.0001 –0.04
F_XICOGIM23 –0.0017 –0.67 0.0007 0.10 –0.0036 –2.86
F_XIPSYCH23 –0.0015 –0.60 –0.0192 –2.81 0.0014 0.81
F_XIDEPRES23 –0.0027 –1.22 0.0030 0.41 –0.0023 –1.46
F_XBMIBT23 0.0007 0.41 –0.0001 –0.02 –0.0001 –0.11
F_XBMIWS23 –0.0010 –0.67 0.0018 0.25 0.0005 0.56
F_XSMOKNOW23 –0.0060 –1.59 0.0168 1.60 0.0013 0.64
F_XNUMADL23 –0.0017 –2.52 0.0037 1.84 –0.0002 –0.46
F_XNUMIADL23 0.0022 2.35 –0.0035 –1.29 0.0006 1.42
F_XDHLTH23 –0.0002 –0.16 –0.0094 –1.81 0.0007 0.75
CF4 0.0801 0.06 0.0801 0.06 –0.0320 –0.50
CF3 –0.1813 –0.22 –0.1813 –0.22 0.5701 5.63
CM4 0.1603 1.18 0.1603 1.18 0.0101 0.07
CM3 –0.3138 –1.97 –0.3138 –1.97 –0.5973 –2.35
AM –0.0027 –2.09 0.0014 3.13 –0.0038 –2.89
AF –0.0018 –0.66 0.0009 0.93 –0.0016 –10.38
C 0.0000 24.84 0.0000 4.23 0.0000 6.13
VARM 0.0000 –0.51 0.0000 0.72 0.0000 –1.45
VARF 0.0000 –0.38 0.0000 –0.67 0.0000 1.75
SIGMA 0.0055 49.68 0.0000 4.23 0.0061 7.47
THETA 2.5207 18.63
RHOM –0.4243 –7.48 –0.6292 –5.06
RHOF –0.2826 –5.64 –0.2579 –6.27
Notes: See table 11A.5.
Table 11A.7 (continued)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statisticTable 11A.8 Wealth Regressions—Invariance Tests
Total Nonliquid Liquid
Wealth 
(DF) CHISQ p-value CHISQ p-value CHISQ p-value
Couples
All 97 468.6 0.000 355.1 0.000 377.2 0.000
All less SES 90 219.4 0.0000 168.1 0.0000 243.9 0.0000
All male 52 279.7 0.0000 232.5 0.0000 215.9 0.0000
All male less SES 45 109.1 0.0000 80.0 0.0010 117.4 0.0000
All female 52 277.2 0.0000 218.9 0.0000 200.1 0.0000
All female less SES 45 90.0 0.0001 76.9 0.0021 104.9 0.0000
All less prevalence 57 301.2 0.0000 224.6 0.0000 223.8 0.0000
All less incidence 57 358.4 0.0000 259.8 0.0000 266.1 0.0000
Only SES 7 123.4 0.0000 119.6 0.0000 69.8 0.0000
Only male demographic 5 6.9 0.2292 4.1 0.5382 8.9 0.1129
Only female demographic 5 5.2 0.3971 10.6 0.0590 4.9 0.4261
Only male prevalence 20 58.8 0.0000 34.2 0.0246 69.9 0.0000
Only female prevalence 20 57.2 0.0000 33.3 0.0310 45.8 0.0009
Only male incidence 20 38.9 0.0070 33.2 0.0324 44.0 0.0015
Only female incidence 20 31.1 0.0540 22.7 0.3060 53.5 0.0001
Spouse died
All 97 672.2 0.0000 682.7 0.0000 700.2 0.0000
All less SES 90 524.0 0.0000 645.3 0.0000 576.9 0.0000
All male 52 268.2 0.0000 370.0 0.0000 224.6 0.0000
All male less SES 45 244.1 0.0000 350.1 0.0000 161.4 0.0000
All female 52 250.0 0.0000 181.5 0.0000 358.8 0.0000
All female less SES 45 164.7 0.0000 142.7 0.0000 256.6 0.0000
All less prevalence 57 223.4 0.0000 269.2 0.0000 361.1 0.0000
All less incidence 57 240.4 0.0000 234.9 0.0000 277.3 0.0000
Only SES 7 60.0 0.0000 34.2 0.0000 37.0 0.0000
Only male demographic 5 7.8 0.1692 8.2 0.1473 12.7 0.0259
Only female demographic 5 7.3 0.2020 5.6 0.3479 16.2 0.0063
Only male prevalence 20 69.5 0.0000 65.8 0.0000 66.3 0.0000
Only female prevalence 20 56.0 0.0000 49.9 0.0002 38.2 0.0085
Only male incidence 20 71.7 0.0000 105.5 0.0000 41.5 0.0021
Only female incidence 20 74.6 0.0000 65.0 0.0000 115.2 0.0000
Singles
All 110 384.8 0.0000 353.6 0.0000 301.4 0.0000
All less SES 96 118.5 0.0594 139.9 0.0023 129.8 0.0124
All male 55 129.2 0.0000 139.4 0.0000 91.2 0.0015
All male less SES 48 43.3 0.6639 60.3 0.1094 59.4 0.1261
All female 55 255.6 0.0000 214.1 0.0000 210.1 0.0000
All female less SES 48 75.2 0.0073 79.6 0.0028 70.4 0.0192
All less prevalence 70 307.3 0.0000 296.7 0.0000 201.4 0.0000
All less incidence 70 287.4 0.0000 275.7 0.0000 222.0 0.0000
Only Male SES 7 30.2 0.0001 47.0 0.0000 16.4 0.0215
Only female SES 7 153.3 0.0000 129.3 0.0000 89.8 0.0000
Only male demographic 8 4.1 0.8446 6.5 0.5875 5.8 0.6742
Only female demographic 8 13.9 0.0842 14.9 0.0603 16.3 0.0379
Only male prevalence 20 19.0 0.5251 30.6 0.0613 30.8 0.0580
Only female prevalence 20 26.4 0.1536 30.6 0.0601 26.3 0.1559
Only male incidence 20 19.4 0.4955 23.3 0.2747 19.7 0.4759
Only female incidence 20 41.0 0.0037 40.7 0.0040 30.2 0.0663Table 11A.9 Wealth Regressions—Causality Tests
Total Nonliquid Liquid
Wealth 
(DF) CHISQ p-value CHISQ p-value CHISQ p-value
Incidence
Couple
Male 20 20.01 0.4575 16.03 0.7146 18.04 0.5847
Female 20 36.65 0.0129 33.87 0.0270 37.47 0.0103
Male & female 40 59.47 0.0243 51.44 0.1061 57.55 0.0356
Spouse died
Male 20 22.65 0.3061 51.36 0.0001 50.99 0.0002
Female 20 23.02 0.2878 16.99 0.6533 30.71 0.0591
Male & female 40 62.86 0.0120 75.29 0.0006 88.09 0.0000
Single
Male 20 18.78 0.5362 30.01 0.0696 24.38 0.2263
Female 20 32.65 0.0369 53.88 0.0001 33.03 0.0335
Male & female 40 51.43 0.1064 83.89 0.0001 57.41 0.0366
Prevalence
Couple
Male 20 27.85 0.1130 47.88 0.0004 45.58 0.0009
Female 20 24.73 0.2120 14.50 0.8041 38.30 0.0081
Male & female 40 58.87 0.0275 72.18 0.0014 111.42 0.0000
Spouse died
Male 20 20.72 0.4137 29.71 0.0746 32.32 0.0401
Female 20 13.58 0.8511 16.95 0.6559 34.18 0.0249
Male & female 40 49.79 0.1607 74.75 0.0007 76.24 0.0005
Single
Male 20 17.67 0.6093 18.07 0.5830 19.62 0.4818
Female 20 35.84 0.0161 27.75 0.1155 53.83 0.0001
Male & female 40 53.51 0.0749 45.82 0.2436 73.45 0.0010
Incidence and prevalence
Couple
Male 40 50.91 0.1157 70.14 0.0022 78.51 0.0003
Female 40 72.00 0.0014 54.30 0.0651 88.95 0.0000
Male & female 80 126.80 0.0007 124.70 0.0010 191.82 0.0000
Spouse died
Male 40 61.81 0.0150 104.07 0.0000 100.39 0.0000
Female 40 51.95 0.0977 37.35 0.5904 70.08 0.0023
Male & female 80 122.23 0.0017 174.89 0.0000 190.94 0.0000
Single
Male 40 35.35 0.6796 40.58 0.4448 49.87 0.1362
Female 40 80.77 0.0001 84.39 0.0001 79.31 0.0002
Male & female 80 116.11 0.0052 124.96 0.0010 129.18 0.0004Table 11A.10 Income Regressions—(t-statistics)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statistic
ONE –0.1417 –5.75 –0.0864 –0.79 –0.1386 –2.23
WLTH12 0.1077 6.82 0.1249 1.41 0.1061 2.57
Q1I12 0.0799 12.32 0.1009 3.42 0.0388 2.15
Q4I12 –0.0882 –14.25 –0.1171 –3.05 –0.0908 –6.83
HOODPF12 0.0019 0.23 –0.0054 –0.13 0.0261 1.55
CONDPF12 –0.0028 –0.34 –0.0904 –2.31 –0.0304 –1.79
DNHOUS12 0.0019 0.29 0.0191 0.60 0.0051 0.39
M_HS12 –0.0013 –0.22 0.0210 0.70 0.0053 0.41
M_COLL12 0.0293 4.59 0.0177 0.46 0.0040 0.23
M_AS70S 0.0000 0.49 0.0000 0.09 –0.0001 –0.56




M_MAGEDI12 0.0002 1.27 –0.0010 –1.56 0.0000 –0.13
M_PAGEDI12 0.0001 0.49 –0.0002 –0.26 0.0003 0.94
M_SMOKEV12 0.0087 1.60 0.0223 0.75 –0.0190 –1.47
M_CANCER12 0.0073 1.19 0.0109 0.36 0.0331 2.18
M_HEART12 –0.0008 –0.17 –0.0304 –1.16 0.0014 0.12
M_STROKE12 –0.0107 –1.20 –0.0404 –1.08 –0.0122 –0.62
M_LUNG12 –0.0005 –0.07 –0.0307 –0.99 –0.0072 –0.49
M_DIABET12 0.0032 0.44 –0.0709 –2.28 –0.0145 –0.88
M_HIGHBP12 0.0134 2.82 0.0456 1.89 0.0010 0.08
M_ARTHRT12 0.0045 0.73 –0.0212 –0.65 0.0211 1.52
M_INCONT12 –0.0017 –0.20 –0.0273 –0.82 –0.0006 –0.03
M_FALL12 –0.0061 –0.52 0.0800 1.75 –0.0021 –0.09
M_HIPFRC12 –0.0015 –0.11 –0.0192 –0.30 –0.0121 –0.41
M_PROXYW12 –0.0193 –2.19 –0.0173 –0.57 –0.0052 –0.14
M_COGIM12 0.0047 0.66 0.0041 0.15 0.0083 0.54
M_PSYCH12 0.0056 0.66 –0.0334 –0.77 –0.0060 –0.33
M_DEPRES12 –0.0245 –1.77 0.0050 0.12 –0.0187 –1.02
M_LOBMI12 –0.0063 –0.70 –0.0262 –1.50 –0.0244 –1.55
M_HIBMI12 0.0006 0.67 0.0031 0.67 –0.0016 –0.69
M_SMOKNOW12 0.0139 1.20 0.0429 1.08 0.0316 1.37
M_NUMADL12 –0.0054 –1.67 –0.0037 –0.34 0.0013 0.19
M_NUMIADL12 0.0000 –0.01 0.0103 0.86 0.0059 0.66
M_DHLTH12 –0.0090 –1.47 0.0394 1.30 –0.0117 –0.81
M_JCANCER23 –0.0018 –0.18 –0.0330 –0.21 –0.0077 –0.35
M_JHEART23 –0.0042 –0.56 0.1318 1.59 0.0118 0.64
M_JSTROKE23 –0.0072 –0.59 0.0482 0.25 –0.0149 –0.59
M_JLUNG23 –0.0041 –0.30 0.0001 0.00 0.0210 0.62
M_IDIABET23 –0.0216 –1.50 –0.3218 –1.49 –0.0335 –0.93
M_IHIGHBP23 –0.0123 –1.17 0.1396 0.83 0.0081 0.36
M_IARTHRT23 –0.0161 –2.10 –0.2789 –3.54 0.0138 0.69
M_JINCONT23 –0.0043 –0.58 0.0622 0.84 0.0032 0.20
(continued)M_JFALL23 –0.0018 –0.21 0.1214 0.98 –0.0080 –0.40
M_JHIPFRC23 –0.0315 –1.44 –0.0491 –0.34 0.0231 0.51
M_PROXYW23 –0.0028 –0.30 0.1074 1.70 0.0230 0.88
M_ICOGIM23 0.0042 0.58 0.0835 1.09 0.0199 1.17
M_IPSYCH23 0.0048 0.56 0.0548 0.47 –0.0164 –0.40
M_IDEPRES23 –0.0119 –0.91 –0.0135 –0.23 0.0261 0.96
M_BMIBT23 0.0068 1.09 –0.0380 –0.86 0.0219 1.53
M_BMIWS23 –0.0026 –0.39 0.0709 0.87 –0.0108 –0.77
M_SMOKNOW23 –0.0117 –0.85 –0.1375 –1.68 –0.0327 –1.32
M_NUMADL23 –0.0036 –1.18 –0.0188 –0.61 –0.0154 –2.58
M_NUMIADL23 0.0081 2.05 –0.0286 –0.97 0.0131 1.76








F_HS12 0.0044 0.69 0.0250 0.88 0.0184 3.33
F_COLL12 0.0126 1.89 0.0601 1.43 0.0275 3.54
F_AS70S 0.0000 0.08 –0.0002 –0.47 0.0000 0.14




F_MAGEDI12 0.0002 1.17 0.0004 0.72 0.0002 1.14
F_PAGEDI12 0.0002 1.26 0.0002 0.26 –0.0001 –0.47
F_SMOKEV12 0.0059 1.17 –0.0297 –1.10 0.0079 1.44
F_CANCER12 0.0104 1.47 –0.0399 –1.08 0.0105 1.57
F_HEART12 0.0070 1.24 –0.0061 –0.22 –0.0016 –0.29
F_STROKE12 0.0271 2.57 –0.0160 –0.37 –0.0008 –0.09
F_LUNG12 –0.0058 –0.70 0.0561 1.41 0.0031 0.39
F_DIABET12 0.0144 1.83 0.0003 0.01 0.0021 0.26
F_HIGHBP12 0.0093 1.98 –0.0234 –0.96 0.0003 0.07
F_ARTHRT12 0.0063 1.11 –0.0663 –2.31 0.0006 0.10
F_INCONT12 0.0042 0.70 0.0280 0.84 –0.0005 –0.08
F_FALL12 0.0117 1.40 –0.0098 –0.22 0.0008 0.10
F_HIPFRC12 0.0435 3.59 –0.0526 –0.97 –0.0031 –0.32
F_PROXYW12 0.0007 0.06 –0.0636 –1.14 –0.0005 –0.04
F_COGIM12 0.0183 2.32 –0.0273 –0.93 0.0010 0.15
F_PSYCH12 0.0027 0.41 –0.0275 –0.68 0.0082 1.07
F_DEPRES12 –0.0043 –0.46 –0.0404 –0.99 –0.0010 –0.13
F_LOBMI12 0.0039 0.99 –0.0079 –0.58 0.0017 0.46
F_HIBMI12 –0.0006 –0.89 –0.0017 –0.28 0.0006 0.66
F_SMOKNOW12 0.0079 0.44 –0.0286 –0.49 –0.0013 –0.11
F_NUMADL12 0.0036 1.10 0.0289 1.73 –0.0026 –0.94
Table 11A.10 (continued)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statisticF_NUMIADL12 –0.0074 –1.73 –0.0039 –0.25 0.0001 0.04
F_DHLTH12 –0.0050 –0.77 0.0368 1.21 0.0027 0.42
F_JCANCER23 0.0064 0.47 –0.0632 –0.89 –0.0025 –0.18
F_JHEART23 –0.0165 –1.92 –0.0496 –1.10 –0.0163 –2.08
F_JSTROKE23 –0.0189 –1.46 –0.0688 –0.95 0.0083 0.64
F_JLUNG23 –0.0075 –0.43 0.0216 0.18 –0.0003 –0.02
F_IDIABET23 –0.0025 –0.14 0.0516 0.58 –0.0036 –0.23
F_IHIGHBP23 0.0221 1.98 –0.0730 –1.32 0.0091 0.86
F_IARTHRT23 0.0095 1.24 0.0417 0.80 –0.0062 –0.85
F_JINCONT23 –0.0037 –0.64 –0.0334 –0.91 0.0056 0.89
F_JFALL23 0.0009 0.13 0.0384 0.87 –0.0040 –0.58
F_JHIPFRC23 –0.0325 –1.46 –0.0973 –0.95 0.0070 0.49
F_PROXYW23 0.0005 0.05 0.1906 3.18 –0.0135 –1.29
F_ICOGIM23 –0.0009 –0.10 –0.0727 –1.75 –0.0039 –0.53
F_IPSYCH23 –0.0023 –0.25 –0.0264 –0.66 –0.0016 –0.13
F_IDEPRES23 –0.0082 –0.71 0.0403 0.95 0.0091 0.85
F_BMIBT23 –0.0172 –2.74 0.0032 0.09 0.0008 0.11
F_BMIWS23 –0.0084 –1.33 0.0236 0.63 –0.0035 –0.53
F_SMOKNOW23 –0.0056 –0.30 0.0571 0.73 –0.0128 –0.97
F_NUMADL23 –0.0025 –0.87 –0.0088 –0.64 0.0006 0.24
F_NUMIADL23 –0.0010 –0.26 –0.0165 –0.93 0.0049 1.61
F_DHLTH23 –0.0016 –0.25 –0.0665 –1.86 –0.0124 –1.95
Table 11A.10 (continued)
Couples Spouse Died Single
Variable Estimate t-statistic Estimate t-statistic Estimate t-statisticTable 11A.11 Mobility, Ownership, Neighborhood, and Dwelling Condition
Regressions—(t-statistics)
Females Males
Variable Coeﬃcient t-statistic Coeﬃcient t-statistic
Changed Residence Regressions
one1 –8.0824 –5.1883 –8.4228 –5.5322
one2 –3.5406 –3.2190 –3.3344 –3.0886
logm1 2.0472 4.1790 2.1521 4.4979
logm2 0.5848 1.7574 0.5224 1.6023
q1wb12 0.2458 4.1263 0.2213 3.7980
q4wb12 –0.1640 –2.5800 –0.1952 –3.1669
q1ib12 0.0881 1.5198 0.0965 1.7090
q4ib12 0.1086 1.8830 0.1300 2.3259
hoodpf12 0.0351 0.4949 0.0246 0.3560
condpf12 –0.0950 –1.3343 –0.0855 –1.2402
cwlth23 –0.5547 –2.9274 –0.5864 –3.1662
male12 –0.0706 –1.0036 –0.0728 –1.0355
single12 0.3399 4.9781 0.3471 4.1435
spdied23 0.4072 3.1407 0.4890 3.3585
mspdie23 0.2545 1.4573 0.2889 1.6484
adl12 –0.0159 –0.6746 –0.0410 –1.7200
iadl12 0.0643 2.2692 0.0382 1.3670
dhlth12 –0.0307 –0.5561 0.0888 1.6706
adl23 0.0454 2.3124 0.0549 2.8570
iadl23 0.0429 1.8005 0.0539 2.2981
dhlth23 0.0003 0.0062 –0.0551 –1.0606
hmown23
hoodpf23
sadl12 0.0097 0.2181 0.0437 1.0901
siadl12 –0.1377 –2.4472 –0.0614 –1.1688
sdhlth12 0.1103 1.1330 –0.2603 –2.6730
sadl23 0.0389 0.7989 0.0780 1.7261
siadl23 0.0597 0.9476 –0.0663 –1.0395
sdhlth23 –0.0846 –0.7577 0.1738 1.6609
Likelihood –2,080.6 –2,187.5
Observations
Negative 5,395 (88.47) 6,019 (89.21)
Positive 703 (11.53) 728 (10.79)
Home Ownership—Regressions
one1 7.6815 1.7802 5.1103 1.1990
one2 –2.1898 –0.7730 –1.2400 –0.4581
logm1 –2.3714 –1.7483 –1.5396 –1.1488
logm2 0.6749 0.7907 0.4041 0.4973
q1wb12 –1.0613 –5.2262 –1.1041 –5.4193
q4wb12 1.1765 7.0422 1.0881 6.7074
q1ib12 –0.0290 –0.1684 –0.0662 –0.3924
q4ib12 0.0937 0.6125 0.1012 0.6812
hoodpf12 –0.1658 –0.7884 –0.1677 –0.8208
condpf12 0.2148 1.0574 0.2051 1.0496
cwlth23 2.3604 5.2032 2.1317 4.8227male12 0.0218 0.1130 –0.0011 –.0058
single12 –0.8657 –5.5954 –0.8716 –4.0723
spdied23 –0.0252 –0.0885 –0.0496 –0.1491
mspdie23 –0.5329 –1.2507 –0.5408 –1.2679
adl12 –0.0116 –0.1682 –0.0333 –0.4443
iadl12 –0.1099 –1.2344 –0.1499 –1.5601
dhlth12 –0.0646 –0.4219 0.0686 0.4644
adl23 0.0338 0.6406 0.0291 0.5583
iadl23 –0.1331 –1.9536 –0.1406 –2.0826











Negative 510 (72.55) 521 (71.57)
Positive 193 (27.45) 207 (28.43)
Neighborhood—Regressions
one1 –5.1638 –1.0797 –4.5901 –0.9643
one2 0.2757 0.0596 2.9740 0.6733
logm1 0.8645 0.5791 0.7609 0.5103
logm2 –0.8698 –0.6188 –1.6126 –1.1976
q1wb12 0.1013 0.5063 0.0948 0.4845
q4wb12 –0.2939 –0.9384 –0.3117 –1.0448
q1ib12 0.1348 0.7182 0.1480 0.8100
q4ib12 –0.1193 –0.4647 –0.1579 –0.6348
hoodpf12 0.8861 4.6151 0.8985 4.8188
condpf12 –0.2322 –0.9571 –0.2772 –1.1564
cwlth23 –0.7506 –0.9264 –0.7756 –0.9988
male12 0.0804 0.3313 0.0758 0.3122
single12 0.6373 2.0210 0.4454 1.3979
spdied23 0.4967 1.1126 0.3041 0.6549
mspdie23 –0.2941 –0.4464 –0.2635 –0.3990
adl12 0.0176 0.2351 –0.0175 –0.2305
iadl12 –0.0031 –0.0374 0.0065 0.0787
dhlth12 0.0773 0.4279 0.0041 0.0231
adl23 0.0088 0.1523 0.0196 0.3490
iadl23 0.0110 0.1594 –0.0004 –0.0062
dhlth23 0.3240 1.7316 0.3610 1.9610













Negative 655 (93.17) 677 (92.99)
Positive 48 (6.83) 51 (7.01)
Dwelling Condition—Regressions
one1 –5.1743 –1.0939 –6.9663 –1.4421
one2 –3.5792 –0.8303 –4.2874 –0.9590
logm1 0.8286 0.5609 1.1817 0.7866
logm2 0.2552 0.1961 0.2502 0.1862
q1wb12 0.4419 2.2384 0.3250 1.5940
q4wb12 0.1381 0.5095 0.1553 0.5661
q1ib12 0.2242 1.2029 0.3016 1.5771
q4ib12 0.0068 0.0291 0.0496 0.2087
hoodpf12 –0.1940 –0.8174 –0.1418 –0.5920
condpf12 1.2251 6.3478 1.2447 6.3933
cwlth23 0.3107 0.4315 0.2390 0.3295
male12 0.0589 0.2455 0.0409 0.1712
single12 0.5441 1.9046 1.2591 2.8052
spdied23 0.3015 0.7117 1.0219 1.8470
mspdie23 0.2957 0.5383 0.3331 0.6089
adl12 0.0211 0.2795 –0.0030 –0.0375
iadl12 0.0308 0.3609 0.0119 0.1350
dhlth12 0.1629 0.8842 0.0696 0.3692
adl23 –0.0349 –0.5898 –0.0153 –0.2606
iadl23 –0.0493 –0.6871 –0.0471 –0.6488
dhlth23 0.1229 0.6586 0.1519 0.7975
hmown23 0.4304 2.0561 0.4232 1.9598









Negative 644 (91.61) 671 (92.17)
Positive 59 (8.39) 57 (7.83)
Note: Numbers in parentheses are percentages.
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Addendum
This addendum describes updates in data and analysis since the publica-
tion of this paper in the Journal of Econometrics(2003), 112, 3–53. The dif-
ferences result from correcting some coding errors, producing a new data-
set with revised imputations, and a new treatment of the simulation of wealth
evolution. We also include in this addendum results from Lagrange multi-
plier (LM) tests of the Wold causal chain assumption that we impose on the
Tests for Direct Causal Paths between Health and Socioeconomic Status 501system of innovation equations. We comment on each of these points in
turn.
We have corrected a health condition coding problem in the AHEAD
data, described in “Data alert: Correction to F1156 [B7. Heart Condi-
tion],” from the HRS webpage. This coding problem produced a signiﬁcant
undercount of heart attack prevalence in wave 3. We have also corrected a
problem in our count of new incidences, given existing previous condition,
for the variables heart attack, cancer, and stroke, which was producing un-
dercounts for the incidence variables. Updated tables 11.2Rand 11.3Rgive
summary statistics for the revised variables. These changes do not produce
signiﬁcant alterations to our overall results, but there are some diﬀerences
in the coeﬃcients of the incidence regressions. Table 11.8 in the published
paper is updated in table 11.8R, which summarizes the coeﬃcients that are
now signiﬁcant. A notable change is that, with the exception of cancer for
males, we now obtain invariance of the models over time for the ﬁrst three
health conditions: cancer, heart disease, and stroke. The updated invari-
ance and noncausality tests are given in table 11.9R. The wealth revisions
have some impact on simulation results, which are updated in tables
11.12R and 11.13R.
In revising our code, we ﬁxed the seed for the random number generator
and produced a data set in which all imputations can be replicated. How-
ever, numerical imputations have changed, particularly imputed asset val-
ues. The tables listed above reﬂect these changes. The numerical diﬀerences
from the previous published results are minor, and all the same results are
obtained.
The simulations of wealth paths were producing, in some instances, un-
reasonable results in the ﬁrst few years of simulation, with excessive in-
creases in wealth observed in some cases. Our simulations start from a
baseline population of seventy–seventy-ﬁve-year-olds in the ﬁrst wave of
the AHEAD, and these changes in wealth in the initial years of simulation
are inconsistent with changes for the same population observed in subse-
quent waves. The observed pattern of wealth decrease is reproduced in the
simulation after a few years, leading us to postulate, in loose terms, that
our imputations and estimates capture the correct dynamics, but the wrong
initial state of the baseline population. This is consistent with the ﬁndings
of other researchers that wealth appears to be undercounted in AHEAD
wave 1, due to undercounting of the categories in which assets are held.
We therefore attempted to adjust to the correct initial state. We did this by
calibrating the constant term of the wealth regressions using a cross-
validation procedure. We calibrated the intercept so that the ﬁrst year of
simulated wealth changes (in terms of rate of change) matched, at the me-
dian, the observed transition for our baseline population. The changes in
the intercept required to obtain this match are minor, as can be seen from
table 11.14. Although we eﬀectively force the prediction to match the







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3Table 11.9R Health Innovations, Tests for Invariance and Causality ( p-values)
Invariance
With SES Without SES
Variable Female Male Female Male
CANCER 0.528 0.016 0.309 0.007
CANCER—no previous 0.867 0.129 0.812 0.064
CANCER—previous 0.068 0.044 0.079 0.083
HEART 0.085 0.690 0.052 0.619
HEART—no previous 0.170 0.823 0.060 0.498
HEART—previous 0.547 0.692 0.492 0.725
STROKE 0.384 0.204 0.266 0.135
STROKE—no previous 0.172 0.258 0.160 0.180
STROKE—previous 0.907 0.045 0.784 0.087
MORTALITY 0.221 0.378 0.315 0.491
LUNG 0.552 0.689 0.483 0.502
DIABETES 0.189 0.234 0.281 0.128
HIGH BLOOD PRESSURE 0.007 0.393 0.024 0.172
ARTHRITIS 0.046 0.071 0.032 0.167
INCONTINENCE 0.781 0.351 0.597 0.682
INCONTINENCE—no previous 0.706 0.102 0.426 0.555
INCONTINENCE—previous 0.962 0.793 0.892 0.730
FALL 0.904 0.263 0.790 0.207
FALL—no previous 0.792 0.140 0.612 0.133
FALL—previous 0.365 0.000 0.358 0.000
HIP FRACTURE 0.491 0.126 0.280 0.053
HIP FRACTURE—no previous 0.930 0.300 0.724 0.123
HIP FRACTURE—previous
PROXY INTERVIEW 0.301 0.591 0.465 0.378
PROXY INTERVIEW—no previous 0.127 0.795 0.444 0.606
PROXY INTERVIEW—previous
COGNITIVE IMPAIRMENT 0.005 0.288 0.008 0.143
PSYCHIATRIC 0.127 0.295 0.052 0.365
DEPRESSION 0.211 0.944 0.299 0.934
BODY MASS INDEX 0.260 0.009 0.251 0.002
CURRENT SMOKER 0.420 0.710 0.214 0.504
CURRENT SMOKER—no previous 0.133 0.033 0.078 0.040
CURRENT SMOKER—previous 0.797 0.733
ADL 0.001 0.021 0.007 0.038
IADL 0.603 0.008 0.388 0.003
SELF RATED HEALTH 0.376 0.634 0.341 0.607
SELF RATED HEALTH—no previous 0.514 0.251 0.558 0.215
SELF RATED HEALTH—previous 0.239 0.165 0.176 0.189Table 11.9R (continued)
Noncausality
Wave 1–2 Wave 2–3 Wave 1–3
Female Male Female Male Female Male
CANCER 0.987 0.588 0.408 0.165 0.613 0.198
CANCER—no previous 0.704 0.658 0.289 0.173 0.313 0.166
CANCER—previous 0.143 0.228 0.472 0.017 0.299 0.036
HEART 0.540 0.054 0.396 0.996 0.398 0.243
HEART—no previous 0.872 0.344 0.750 0.412 0.736 0.039
HEART—previous 0.104 0.071 0.153 0.737 0.019 0.172
STROKE 0.757 0.837 0.584 0.028 0.657 0.059
STROKE—no previous 0.415 0.955 0.671 0.064 0.713 0.203
STROKE—previous 0.824 0.301 0.882 0.155 0.799 0.383
MORTALITY 0.098 0.275 0.883 0.306 0.652 0.364
LUNG 0.166 0.174 0.866 0.122 0.343 0.010
DIABETES 0.615 0.141 0.020 0.236 0.110 0.025
HIGH BLOOD PRESSURE 0.342 0.996 0.083 0.941 0.534 0.990
ARTHRITIS 0.179 0.029 0.242 0.713 0.085 0.395
INCONTINENCE 0.763 0.019 0.254 0.800 0.163 0.463
INCONTINENCE—no previous 0.914 0.037 0.602 0.197 0.453 0.641
INCONTINENCE—previous 0.900 0.247 0.168 0.664 0.149 0.244
FALL 0.532 0.687 0.945 0.454 0.600 0.592
FALL—no previous 0.501 0.697 0.944 0.251 0.558 0.532
FALL—previous 0.329 0.000 0.803 0.000 0.696 0.053
HIP FRACTURE 0.613 0.597 0.370 0.666 0.159 0.430
HIP FRACTURE—no previous 0.461 0.461 0.706 0.725 0.128 0.234
HIP FRACTURE—previous
PROXY INTERVIEW 0.017 0.486 0.870 0.127 0.254 0.032
PROXY INTERVIEW—no previous 0.002 0.793 0.541 0.121 0.087 0.073
PROXY INTERVIEW—previous
COGNITIVE IMPAIRMENT 0.001 0.259 0.259 0.200 0.002 0.026
PSYCHIATRIC 0.043 0.238 0.214 0.069 0.004 0.065
DEPRESSION 0.007 0.143 0.261 0.377 0.011 0.065
BODY MASS INDEX 0.188 0.839 0.931 0.711 0.673 0.684
CURRENT SMOKER 0.603 0.282 0.974 0.693 0.625 0.129
CURRENT SMOKER—no previous 0.335 0.196 0.874 0.980 0.515 0.962
CURRENT SMOKER—previous 0.375 0.325 0.547 0.325 0.274 0.025
ADL 0.077 0.014 0.346 0.971 0.828 0.358
IADL 0.374 0.051 0.817 0.243 0.241 0.009
SELF RATED HEALTH 0.013 0.048 0.100 0.301 0.001 0.020
SELF RATED HEALTH—no previous 0.015 0.187 0.202 0.121 0.007 0.034
SELF RATED HEALTH—previous 0.225 0.195 0.557 0.256 0.193 0.175
(continued)Joint (Invariance 
  Noncausality)
Relative Odds (high vs. low SES)
Female Male
Female Male Odds SE Odds SE
CANCER 0.600 0.012 1.31 0.46 0.73 0.27
CANCER—no previous 0.778 0.084 1.24 0.48 0.67 0.29
CANCER—previous 0.067 0.011 5.85 7.75 2.69 3.42
HEART 0.099 0.571 0.97 0.21 1.02 0.24
HEART—no previous 0.278 0.446 0.82 0.25 1.30 0.50
HEART—previous 0.169 0.516 1.13 0.32 0.88 0.26
STROKE 0.481 0.080 0.73 0.25 0.94 0.35
STROKE—no previous 0.271 0.189 0.68 0.27 0.82 0.36
STROKE—previous 0.948 0.054 1.15 0.93 1.61 1.25
MORTALITY 0.308 0.360 0.69 0.21 1.17 0.41
LUNG 0.504 0.203 0.33 0.17 0.50 0.43
DIABETES 0.101 0.062 0.69 0.41 1.48 3.19
HIGH BLOOD PRESSURE 0.013 0.666 0.90 0.29 0.74 0.36
ARTHRITIS 0.020 0.082 1.03 0.22 0.54 0.16
INCONTINENCE 0.615 0.373 0.85 0.13 1.11 0.30
INCONTINENCE—no previous 0.695 0.158 0.77 0.20 1.02 0.36
INCONTINENCE—previous 0.858 0.684 0.94 0.09 1.13 0.29
FALL 0.913 0.328 0.98 0.19 0.92 0.31
FALL—no previous 0.808 0.181 1.03 0.25 0.86 0.32
FALL—previous 0.470 0.000 1.00 0.27 89.61 267.82
HIP FRACTURE 0.347 0.143 0.33 0.22 0.21 0.28
HIP FRACTURE—no previous 0.785 0.238 0.23 0.17 0.14 0.19
HIP FRACTURE—previous
PROXY INTERVIEW 0.248 0.261 0.46 0.16 0.48 0.17
PROXY INTERVIEW—no previous 0.061 0.531 0.27 0.11 0.40 0.20
PROXY INTERVIEW—previous
COGNITIVE IMPAIRMENT 0.000 0.089 0.78 0.17 0.59 0.19
PSYCHIATRIC 0.012 0.137 0.39 0.15 0.16 0.12
DEPRESSION 0.042 0.753 0.38 0.15 0.29 0.15
BODY MASS INDEX 0.345 0.019
CURRENT SMOKER 0.492 0.528 0.46 0.37 0.92 1.11
CURRENT SMOKER—no previous 0.165 0.097 0.11 0.16 19.92 132.75
CURRENT SMOKER—previous 0.714 0.93 0.16 0.95 0.18
ADL 0.004 0.024
IADL 0.509 0.001
SELF RATED HEALTH 0.044 0.278 0.67 0.08 0.64 0.09
SELF RATED HEALTH—no previous 0.138 0.091 0.59 0.12 0.51 0.13
SELF RATED HEALTH—previous 0.177 0.116
Notes: SE   standard error.
Table 11.9R (continued)Table 11.12R Simulation Outcomes
Scenario 70 75 80 85 90 95
White Females
Survival probabilitya S0 1.000 0.907 0.747 0.502 0.247 0.082
S1 1.000 0.912 0.761 0.526 0.268 0.092
S2 1.000 0.887 0.664 0.354 0.117 0.024
Cancerb S0 0.117 0.180 0.229 0.264 0.280 0.267
S1 0.117 0.174 0.222 0.257 0.275 0.259
S2 0.117 0.213 0.277 0.309 0.335 0.301
Heart diseaseb S0 0.225 0.329 0.457 0.561 0.630 0.667
S1 0.225 0.323 0.438 0.538 0.604 0.625
S2 0.225 0.361 0.521 0.635 0.701 0.733
Strokeb S0 0.044 0.108 0.197 0.274 0.344 0.392
S1 0.044 0.107 0.184 0.261 0.324 0.358
S2 0.044 0.119 0.223 0.311 0.393 0.458
Lung diseaseb S0 0.104 0.153 0.183 0.193 0.177 0.159
S1 0.104 0.147 0.174 0.183 0.174 0.142
S2 0.104 0.196 0.266 0.289 0.275 0.211
Diabetesb S0 0.114 0.163 0.189 0.196 0.195 0.173
S1 0.114 0.000 0.000 0.000 0.000 0.000
S2 0.114 0.202 0.252 0.266 0.253 0.213
High blood pressureb S0 0.467 0.584 0.675 0.733 0.763 0.787
S1 0.467 0.581 0.672 0.740 0.769 0.809
S2 0.467 0.622 0.729 0.799 0.842 0.890
Arthritisb S0 0.227 0.495 0.677 0.794 0.871 0.916
S1 0.227 0.506 0.676 0.800 0.874 0.935
S2 0.227 0.574 0.775 0.885 0.944 0.961
Incontinenceb S0 0.231 0.410 0.591 0.732 0.831 0.892
S1 0.231 0.422 0.601 0.747 0.842 0.901
S2 0.231 0.438 0.646 0.796 0.879 0.938
Fallb S0 0.072 0.276 0.462 0.628 0.762 0.860
S1 0.072 0.276 0.462 0.624 0.754 0.854
S2 0.072 0.273 0.473 0.652 0.776 0.854
Hip fractureb S0 0.029 0.045 0.069 0.104 0.137 0.180
S1 0.029 0.044 0.070 0.102 0.138 0.157
S2 0.029 0.064 0.112 0.183 0.240 0.298
Proxy interview S0 0.036 0.057 0.090 0.149 0.215 0.282
S1 0.036 0.062 0.089 0.144 0.209 0.279
S2 0.036 0.102 0.185 0.295 0.405 0.469
Cognitive impairmentb S0 0.108 0.254 0.440 0.619 0.741 0.812
S1 0.108 0.261 0.434 0.612 0.747 0.813
S2 0.108 0.403 0.678 0.845 0.921 0.963
Psychiatric diseaseb S0 0.153 0.223 0.310 0.382 0.425 0.459
S1 0.153 0.225 0.317 0.390 0.421 0.451
S2 0.153 0.320 0.506 0.635 0.726 0.772
Depressionb S0 0.067 0.168 0.280 0.380 0.465 0.519
S1 0.067 0.178 0.290 0.399 0.488 0.572
S2 0.067 0.253 0.429 0.573 0.664 0.711
Body mass indexc S0 25.657 24.791 23.673 22.435 21.389 20.716
S1 25.657 24.781 23.640 22.413 21.375 20.384
S2 25.657 24.424 23.018 21.782 20.852 20.483
(continued)Current smokerb S0 0.130 0.088 0.059 0.038 0.021 0.015
S1 0.130 0.086 0.057 0.037 0.025 0.016
S2 0.130 0.120 0.100 0.071 0.045 0.039
ADL limitsc S0 0.307 0.272 0.607 1.075 1.581 2.071
S1 0.307 0.245 0.558 1.029 1.529 2.013
S2 0.307 0.478 1.183 2.047 2.721 3.365
IADL limitsc S0 0.241 0.113 0.263 0.534 0.790 1.110
S1 0.241 0.106 0.257 0.503 0.770 1.096
S2 0.241 0.249 0.688 1.311 1.751 2.045
Poor/fair self-rated healthb S0 0.249 0.309 0.433 0.530 0.583 0.605
S1 0.249 0.288 0.416 0.504 0.565 0.594
S2 0.249 0.515 0.717 0.815 0.846 0.882
White Males
Survival probabilitya S0 1.000 0.822 0.555 0.285 0.090 0.018
S1 1.000 0.838 0.592 0.313 0.116 0.026
S2 1.000 0.834 0.513 0.201 0.040 0.005
Cancerb S0 0.138 0.235 0.319 0.402 0.491 0.631
S1 0.138 0.242 0.326 0.411 0.493 0.578
S2 0.138 0.233 0.309 0.391 0.480 0.660
Heartb S0 0.361 0.504 0.639 0.734 0.790 0.862
S1 0.361 0.507 0.633 0.730 0.828 0.861
S2 0.361 0.486 0.612 0.706 0.748 0.868
Strokeb S0 0.071 0.140 0.216 0.278 0.341 0.379
S1 0.071 0.134 0.212 0.282 0.311 0.366
S2 0.071 0.186 0.308 0.400 0.502 0.528
Lung diseaseb S0 0.153 0.185 0.218 0.254 0.241 0.222
S1 0.153 0.184 0.224 0.242 0.241 0.272
S2 0.153 0.167 0.181 0.211 0.232 0.189
Diabetesb S0 0.133 0.165 0.186 0.197 0.188 0.138
S1 0.133 0.000 0.000 0.000 0.000 0.000
S2 0.133 0.136 0.134 0.125 0.083 0.038
High blood pressureb S0 0.440 0.547 0.626 0.686 0.709 0.690
S1 0.440 0.548 0.631 0.687 0.740 0.833
S2 0.440 0.585 0.681 0.759 0.804 0.887
Arthritisb S0 0.175 0.398 0.576 0.706 0.782 0.803
S1 0.175 0.412 0.587 0.707 0.775 0.826
S2 0.175 0.512 0.732 0.857 0.944 1.000
Incontinenceb S0 0.099 0.250 0.416 0.584 0.724 0.808
S1 0.099 0.247 0.402 0.580 0.726 0.808
S2 0.099 0.294 0.501 0.684 0.846 0.962
Fallb S0 0.041 0.157 0.288 0.419 0.536 0.601
S1 0.041 0.151 0.284 0.411 0.500 0.592
S2 0.041 0.226 0.430 0.608 0.739 0.887
Hip fractureb S0 0.024 0.032 0.042 0.067 0.094 0.148
S1 0.024 0.030 0.045 0.064 0.091 0.139
S2 0.024 0.067 0.131 0.207 0.295 0.472
Table 11.12R (continued)
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Proxy Interview S0 0.110 0.106 0.119 0.149 0.166 0.163
S1 0.110 0.119 0.129 0.144 0.184 0.171
S2 0.110 0.181 0.256 0.313 0.353 0.340
Cognitive impairmentb S0 0.144 0.323 0.505 0.660 0.768 0.837
S1 0.144 0.326 0.508 0.668 0.778 0.829
S2 0.144 0.435 0.686 0.835 0.920 0.868
Psychiatric diseaseb S0 0.085 0.136 0.188 0.225 0.272 0.310
S1 0.085 0.133 0.183 0.237 0.268 0.265
S2 0.085 0.188 0.323 0.429 0.498 0.604
Depressionb S0 0.039 0.098 0.169 0.240 0.263 0.291
S1 0.039 0.097 0.171 0.239 0.295 0.338
S2 0.039 0.206 0.350 0.473 0.538 0.623
Body mass indexc S0 26.113 25.608 25.125 24.654 24.542 24.734
S1 26.113 25.682 25.207 24.786 24.503 24.650
S2 26.113 24.879 23.968 23.508 23.506 25.136
Current smokerb S0 0.125 0.057 0.034 0.017 0.004 0.000
S1 0.125 0.060 0.039 0.019 0.007 0.000
S2 0.125 0.085 0.060 0.031 0.011 0.000
ADL limitsc S0 0.324 0.290 0.643 1.121 1.753 2.025
S1 0.324 0.318 0.651 1.152 1.716 2.258
S2 0.324 0.734 1.741 2.773 3.938 4.340
IADL limitsc S0 0.333 0.133 0.304 0.580 0.867 1.143
S1 0.333 0.135 0.311 0.570 0.959 1.303
S2 0.333 0.392 0.894 1.676 2.444 2.415
Poor/fair self-rated healthb S0 0.286 0.370 0.461 0.507 0.511 0.483
S1 0.286 0.360 0.454 0.484 0.510 0.512
S2 0.286 0.598 0.745 0.812 0.819 0.849
Notes: S0   baseline; S1   no diabetes; S2   all low SES.
Table 11.12R (continued)
Scenario 70 75 80 85 90 95
sample values for the ﬁrst year, this is not so for subsequent years of the
simulation, which produces no anomalous results in subsequent waves.
As mentioned in a note added in proof which appeared with our reply to
published comments, LM tests for the triangular Wold causal chain struc-
ture of our model have been calculated. The results support that assump-
tion in most cases. Table 11.15 reports the t-statistics of pairwise inde-
pendence tests. The notable exceptions to acceptance of the causal chain
structure are the mortality, ADL, and IADL equations, whose pairwise
independence fails with respect to most of the remaining conditions. The
joint test for independences across equations is not rejected for the case of
males and is rejected for the case of females. The rejection for females is
eliminated by removing the equations for mortality, BMI, ADL, and IADL.Table 11.13R Wealth and Income in AHEAD and in the Baseline Scenario, by Age
70–74 75–79 80–84 85–89 90 
AHEAD cross-cohort data
Total wealth (000)
1st quartile 63.51 44.07 29.28 15.13 1.64
Median 144.04 110.76 90.62 71.19 38.37
3rd quartile 307.29 239.41 190.23 180.84 113.49
Liquid wealth (000)
1st quartile 2.18 1.09 0.54 0.32 0.00
Median 27.28 15.24 10.91 8.64 4.36
3rd quartile 100.39 70.93 64.85 54.15 34.21
Nonliquid wealth (000)
1st quartile 38.09 15.24 5.40 0.11 0.00
Median 91.66 77.00 60.02 43.38 1.63
3rd quartile 176.84 147.31 110.25 108.45 63.29
Income (000)
1st quartile 14.19 12.00 9.76 8.68 6.87
Median 24.01 19.64 15.55 13.56 10.37
3rd quartile 37.96 32.54 28.37 23.94 15.71
Baseline simulation data
Total wealth (000)
1st quartile 56.61 71.59 57.48 34.76 20.62
Median 136.41 121.52 98.82 69.50 52.88
3rd quartile 292.45 202.94 148.19 107.54 86.91
Liquid wealth (000)
1st quartile 1.64 10.24 6.68 0.98 –1.74
Median 25.10 29.24 22.28 14.39 10.63
3rd quartile 96.35 60.16 41.96 29.10 23.25
Nonliquid wealth (000)
1st quartile 34.10 53.69 43.52 26.45 15.76
Median 87.84 87.54 73.89 53.80 42.45
3rd quartile 170.85 130.09 106.62 81.51 68.95
Income (000)
1st quartile 13.69 13.36 11.98 10.00 8.68
Median 22.22 22.99 21.59 18.89 17.01
3rd quartile 36.23 35.35 34.17 30.19 26.17
Table 11.14 Calibration of Wave 1 Wealth Levels
Model Calibrated Constant Estimated Constant Standard Deviation
Liquid
Couples 0.0744 0.0751 0.0078
Spouse died 0.0876 0.0839 0.0210
Singles
Males 0.0567 0.0708 0.0156
Females 0.0635 0.0794 0.0061
Nonliquid
Couples 0.0626 0.0592 0.0046
Spouse died 0.1062 0.0954 0.0154
Singles
Males 0.0554 0.0632 0.0104
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Comment James M. Poterba
This paper presents a wealth of interesting new information on the rela-
tionship between various measures of socioeconomic status (SES) and the
health of elderly individuals. While most previous studies of the correla-
tion between SES and health status have relied on cross-sectional data, this
paper exploits panel data. Repeated observations on the same individuals
make it possible to develop more reﬁned tests than those in past studies.
In particular, the authors are able to study how income, wealth, and other
socioeconomic conditions are associated with the onset of various health
conditions, rather than simply the point-in-time correlation between SES
and health status.
The core of the study consists of two related empirical projects. The ﬁrst
explores how SES aﬀects changes in health status, while the second ex-
plores the relationship between changes in health status and changes in ﬁ-
nancial circumstances.
For the ﬁrst project, the authors develop some “central tendency mea-
sures” of socioeconomic status. They ﬁnd that some of the components of
socioeconomic status have greater impact on health than others. Wealth,
for example, has a stronger link to health than some of the other compo-
nents of SES. Many of their ﬁndings suggest only modest links between
SES and the onset of adverse health conditions. One worry is that by using
many diﬀerent variables to construct a measure of socioeconomic status,
the authors have increased the chance of ﬁnding weak links between the
SES variables and health outcomes. It is always possible to ﬁnd weak
eﬀects by including many marginally inﬂuential variables in an empirical
analysis. Focusing the analysis on a few key variables relating to socioeco-
nomic status, such as wealth, income, and education, would seem like a
natural direction for further analysis. It may ultimately be possible to rank
diﬀerent measures of income, wealth, and other aspects of socioeconomic
status in terms of their predictive power for various health events.
One by-product of the study of how SES aﬀects the onset of health con-
ditions is a comparison between measures of the incidence of chronic con-
ditions in the AHEAD sample and the aggregate population. In some
cases, there appear to be disparities between the two data sets; this seems
like a natural subject for future study. Another related suggestion for fur-
ther work involves distinguishing between long-term and short-term mea-
sures of socioeconomic status. It is possible that transitory shocks to socio-
economic status, such as a temporary decline in income, may have a less
important eﬀect on health status than persistent diﬀerences due to wealth.
James M. Poterba is the Mitsui Professor of Economics and associate head of the eco-
nomics department at the Massachusetts Institute of Technology, and the director of the
Public Economics Research Program at the National Bureau of Economic Research.520 P. Adams, M. D. Hurd, D. McFadden, A. Merrill, and T. Ribeiro
One of the most important advances in this study is the disaggregate
analysis of various measures of health status. By studying acute conditions
separately from chronic conditions, and distinguishing mental conditions
from acute physical conditions due to accidents and other factors, the pa-
per is able to show that there are important diﬀerences in the link between
SES and the onset of diﬀerent long-term health limitations. This is a key
insight if one tries to forecast how changes in future economic circum-
stances will aﬀect the health of the future elderly population.
The second component of this study explores the extent to which
changes in socioeconomic status can be explained by changes in health sta-
tus. Because some changes in health status may require expensive treat-
ment or movement to a nursing home or other costly facility, there is a pre-
sumption that health changes might account for some changes in ﬁnancial
circumstances. The results on the link from health status changes to ﬁnan-
cial status changes are weak. This is one aspect of the paper that could ben-
eﬁt from further data analysis. Disaggregating survey respondents by
health insurance status, and focusing on relatively expensive health
changes, might reveal a stronger relationship between some types of health
status change and subsequent ﬁnancial changes. For many AHEAD par-
ticipants, income ﬂows—pensions, Social Security, and related ﬂows—are
not aﬀected by health status. It is therefore possible that the links from
health changes to income changes for this age group are more muted than
the changes for younger elderly.
In addition to its two signiﬁcant empirical components, the paper also
proposes a conceptual framework for analyzing how wealth and other
measures of socioeconomic status are related to health. The “invariance”
condition proposed here requires that the relationship between SES com-
ponents and health status must be stable over time. Invariance is stipulated
as a logical precondition for a causal relationship between SES and health
status. It is not clear that this is a reasonable restriction, however. There are
many reasons to suspect that the relationship might change over time, even
if there is a true underlying link. For example, medical treatment technol-
ogy may change. A procedure that was expensive at one point in time may
become less expensive and widely available at a later date, thereby chang-
ing the relationship between SES and observed health status. Even if in-
come and wealth are positively correlated with access to this procedure at
all points in time, a decline in the price of the technology might alter the
slope of this relationship. Similarly, there could be changes over time in
behavior or other factors that affect health status. These could lead to
changes in the measured relationship between health status and socioeco-
nomic status. Once again, the diﬃculty is that even if higher socioeconomic
status is associated with a lower likelihood of chronic conditions at all
points during the sample period, a test for the stability of coeﬃcients over
time might reject this restriction. The diﬀusion of exercise or other per-sonal behaviors across the socioeconomic spectrum could lead to time-
varying coeﬃcients even in the presence of a causal link.
This paper opens a broad new ﬁeld of inquiry directly at the detailed
mapping of links from income, wealth, and other aspects of socioeconomic
status to the level of, and changes in, health status. As panel data sets be-
come more common in the study of elderly populations and researchers
have increased access to information on both medical conditions and eco-
nomic circumstances, this research is likely to reveal more and more subtle
aspects of these relationships. This paper represents a very important step
in this research program.
Response Peter Adams, Michael D. Hurd, Daniel McFadden,
Angela Merrill, and Tiago Ribeiro
The problem of how to describe, detect, and measure causal eﬀects has an
importance in economic and social policy analysis that transcends the
speciﬁcs of our paper, and our discussants provide valuable perspectives
on possible approaches. We thank them for their comments. In this re-
sponse, we identify points in the discussion that we ﬁnd particularly useful,
and try to clarify some issues where there appears to be disagreement.
The comment by Jérôme Adda, Tarani Chandola, and Michael Marmot
focuses on the association of health and wealth in panel data. They repli-
cate our statistical analysis on two data sets, the Whitehall II panel in Great
Britain and the Swedish Survey of Living Conditions (ULF) and conclude
that these replications give similar results. This is extremely valuable, pro-
viding a powerful cross-population/cross-institutions test for model in-
variance. However, their general assessment that our model is transferable
to these data sets may be overly generous; a detailed comparison reveals
some signiﬁcant diﬀerences whose exploration would be a good starting
point for further research. Their ﬁnding that mental diseases in the British
and Swedish data also fail the test for no direct causality suggests strongly
that the sources of this rejection are behavioral factors, rather than our
proposal of a possible gradient in aﬀordability of preventative mental
health services within Medicare. James Poterba points out that a detailed
look at disease-speciﬁc therapies and Medicare reimbursement rules may
permit a sharper test for a causal link from aﬀordability of preventative
care to health outcomes, and changes in medical insurance coverage over
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accounted for explicitly.
Our discussants include central contributors to three major “schools” of
causal analysis: time-series prediction criteria, or G-causality, grounded in
the empirical tests proposed by Granger and Sims (Clive Granger, John
Geweke); the structural or functional approach grounded in econometric
simultaneous equations models (Jerry Hausman, Kevin Hoover); and the
potential outcomes or counterfactual approach grounded in the statistical
analysis of experimental treatments (Jean-Pierre Florens, James Heck-
man, Fabrizia Mealli, Donald Rubin, and James Robins). As a shorthand,
we will refer to the structural approach as S-causality and the prospective
outcomes approach as P-causality.These schools diﬀer substantially in ter-
minology, perspective, and prescription for applications. Nevertheless,
there are strong links between them. Pearl (2000, chapter 7) demonstrates
a formal equivalence of S-causality and P-causality, and Heckman’s com-
ment demonstrates the utility of interweaving the S and P formulations.
Both the S and P schools are critical of G-causality, arguing that its rather
sparse characterization of causal properties is not suﬃcient to predict the
eﬀect of interventions. In the testing scheme we adopt in our paper, we start
from G-causality and add invariance tests as a way to addressing this prob-
lem. The questions then are whether our invariance requirements are con-
sistent with the more complete S or P speciﬁcations for causal modeling;
whether they are suﬃcient for the limited causality claims that we make;
and, more broadly, whether on the road to a complete causal analysis our
approach is a helpful way station or a dangerous diversion.
In linear econometrics, it is common to conduct exogeneity tests for
model speciﬁcation, which can be interpreted as invariance tests for model
coeﬃcients when instrumental variables are used, and conditional on ac-
ceptance of exogeneity tests, to use simple exclusion tests for the existence
of direct eﬀects of explanatory variables. Features of this setup are that the
alternatives to exogeneity are vague, an exogeneity test may be rejected for
a variety of model misspeciﬁcation reasons, and the procedure may have
zero power against some alternatives in which direct exogeneity failures
are confounded by other model failures. Nevertheless, the procedure is a
useful diagnostic whose robustness weighs against its lack of optimality
against speciﬁcally focused alternative structures. The scheme in our paper
for testing the absence of direct causal paths has a similar structure, and we
argue that it has similar properties.
First, a universally valid causal model in the S or P framework will pre-
dict successfully given any history, deﬁned broadly to include any changes
in geographical or temporal frame and any policy interventions. Each suc-
cessful prediction constitutes, in our terminology, a model invariance.
When one requires only that a more restricted class of invariance condi-
tions be met, there will be a family of S or P models that are not necessar-
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the speciﬁed class; see Florens and Heckman (2001). For example, the two
directed acyclic graphs (DAGs) in in ﬁgure 11.9, only one of which has a di-
rect causal path from St–1 to Ht, may nevertheless both be valid for a class
of invariance conditions that does not include interventions in which the
conditional distribution of St–1 given Ht–1 changes. The fact that a broader
class of invariance conditions could distinguish these models is not neces-
sarily important if one is interested only in policy interventions in which
the conditional distribution of St–1 given Ht–1 is itself always invariant.
James Heckman makes a related, and even more important point, stating
that “Evidence for invariance with respect to one class of manipulations
does not necessarily carry over to other classes of manipulations” (2003,
77). The class of invariances tested should be precisely those needed for a
targeted policy intervention, and these may or may not include transfer-
ability of the model across time periods or locations.
An empirical rejection of a model invariance is evidence against the va-
lidity of the family of S or P models that imply this invariance. Our pro-
posed invariance tests are nothing more than the empirical counterpart of
the logical relationships common to families of DAGs deﬁning families of
S or P models. We claim that our setup, with suitable articulation, thus pro-
vides a language for characterizing the empirical implications of causal
analysis in an S or P framework. We strongly support the suggestion that
DAGs and a full S or P analysis be used to map out the invariances that
need to be satisﬁed by a valid model for predicting the eﬀects of policy in-
terventions in an application. However, we think there is methodological
merit in developing “bottom up” approaches to causality that seek the
broadest families of full causal models consistent with a particular policy
application, to compliment “top down” approaches that start from full
causal models embodying all prior information, and we then map out the
policy applications for which they are valid. We recognize that the invari-
ance test we actually conduct, for invariance of selected Markov transition
probability parameters, falls far short of the battery of tests necessary to
exhaust the empirical implications of a full causal model, or the relevant
invariances for many policy applications, and note further that there are
classes of causal models in which stationarity is not required.
Second, we claim in our paper that if our invariance and no direct
causality (hereafter, NDC) tests are accepted, this is indeed evidence
against the existence of a direct causal path. There are obvious limits to our
claim in ﬁnite samples, particularly given the dimensions of invariance that
remain untested. In light of the comments and the last paragraph, a more
precise, and limited, statement is that acceptance of these tests is evidence
against the existence of a direct causal path that is active (or, in genetic
terms, expressed) within the class of invariances under consideration. In
addition, there are an abundance of possible sources of model misspeciﬁ-
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cation that may confound our analysis and limit its power, particularly its
linear single-index structure, untested treatment of “instantaneous causal-
ity,” and ﬁrst-order Markov dynamics. The power of the tests against
plausible alternatives appears to be low; the observation that simulation
using the models “as is” generates strong wealth–health links despite the
acceptance of our tests for most conditions suggests this to be the case.
Several discussants, and also David Bloom in a personal communica-
tion, claim that our setup is statistically inconsistent so that there are cir-
cumstances where NDC will be accepted even when a direct causal link is
present in a valid fully speciﬁed causal model. Kevin Hoover states that “A
ﬁnding of invariance in the conditional model does not indicate a true
causal relationship unless there is simultaneously a failure of invariance in
the marginal model for the conditioning variable” (2003, 124). This is a
succinct way of stating that our tests have power only against active direct
causal links. In particular, we agree that one can devise examples where a
direct causal eﬀect is exactly oﬀset by an unobserved common factor, or an
ignored common factor exhibits no variation across populations that allow
its eﬀect to be identiﬁed, and our tests will have zero power against these
alternatives, but we believe it improbable that these will occur and go un-
detected when the class of invariance tests is suﬃciently broad. Speaking
loosely, in the space of full causal models we expect manifolds on which
eﬀects are unvarying or exactly oﬀsetting and thus not separately identiﬁ-
able to have a priori probability zero, and if alternatively the eﬀects can be
identiﬁed under some circumstance, say by comparing populations with
diﬀerent initial conditions, then there will be a corresponding invariance
test that should be rejected.
Finally, consider the broad question of whether our testing setup is a use-
ful way station or a distraction. There are some legitimate concerns. Our
testing procedure is generally insuﬃcient for a full S or P causal analysis.
Our treatment can be criticized as limited in applicability, because it is
silent in the likely circumstance that direct causal eﬀects are present but are
Fig. 11.9 Direct acyclic graphconfounded by unobserved common factors, and we oﬀer no way of de-
scribing and identifying direct causal eﬀects when they are in fact present.
We agree with the discussants’ suggestion that drawing conclusions on
causality within an incomplete framework for causal modeling invites mis-
chief. We have ourselves used our model in a simulation mode with hypo-
thetical policy alternatives, with an untested assumption that “instanta-
neous causality” has a speciﬁc causal chain structure, and it is somewhat
disingenious for us to argue that the results can be used only for model
evaluation, not for policy analysis. On the positive side, we believe that for
policy applications, framing causality analysis in terms of the minimal
conditions needed to support evaluation of speciﬁc policy alternatives is a
useful counterpoint to a full S or P analysis, and for this reason it is scien-
tiﬁcally useful to provide “pullouts” on the road to causal modeling.
We conclude with a few speciﬁc responses to points raised by individual
discussants. First, Jerry Hausman notes that if the ﬁrst-order Markov as-
sumption for our speciﬁed state vector is not satisﬁed, then our estimation
procedure is not statistically consistent. We agree; a test for this assump-
tion will be practical when the panel is a little longer, and is important to
do. He observes correctly that our invariance tests will have low power if
there is limited variability in explanatory variables. For this reason, the
transferability invariance tested by Adda, Chandola, and Marmot is par-
ticularly helpful.
Several discussants, including John Geweke, Jean-Pierre Florens, and
James Heckman, observe that our treatment of “instantaneous causality”
is untested and possibly disputable. The order we have selected for health
conditions is based, roughly, on the etiology of the various diseases, but we
agree that this is a potential source of serious model misspeciﬁcation. If
our hypothesized causal chain is not valid, then instantaneous causality in-
duces a simultaneous equations problem that causes our model estimates
to be statistically inconsistent. We have emphasized time aggregation be-
tween panel waves as a source of simultaneous causality, but agree that
across some health conditions there could be true mutual instantaneous
causality, perhaps in the form of the multivariate jump processes discussed
by Florens. If our hypothesized causal chain is incorrect, then this should
be detectable via a relatively straightforward invariance test using a joint
probit structure for the various health conditions. It is possible to conduct
such a test in a LM form that does not require estimation of the joint pro-
bit model.
John Geweke comments that portfolio management under life-cycle
consumer theory may produce discontinuous shifts in portfolio mix, as
well as discrete changes in measured wealth due to transfers and tax-
motivated reorganizations. In our models for wealth component changes,
this would produce outliers that are linked across asset categories. This
may explain some of the noise we observe in wealth components. A good
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in total wealth are suﬃciently large and frequent to suggest that much of
the noise we see is measurement error rather than true variation in the
underlying economic variables.
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The AHEAD study has notiﬁed users that incidence of new heart conditions in wave 3 was
not collected and coded properly for subjects who had no previous history of a heart condi-
tion. In our working sample, the recorded 310 wave 3 incidences are then an undercount, and
we estimate that approximately 122 additional incidences were not recorded. Because the in-
tercepts for wave 2 to wave 3 incidence of heart conditions were allowed to vary freely in our
models, this data problem will not aﬀect our substantive conclusions if the undercount occurs
at random, but will have a direct impact on our models for incidence of heart conditions be-
tween waves 2 and 3, and on the invariance tests based on comparing these transitions to the
extent that the undercount does not occur at random. Because remaining models for health
condition incidence and wealth change are conditioned on heart condition incidence, any di-
rect impact of this data problem will have some eﬀect on all the models in our paper.
In response to reviewer comments, we suggest that it would be possible to conduct a LM
test for correlation of disturbances in our chain of incidence models. We have now calculated
these tests and accept the hypothesis of no correlation of these disturbances in the equations
for various health conditions. We note, however, that these tests are likely to have low power.